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Introduction
The discovery and development of antimicrobial drugs was a major step forward in 
medical history. With the increasing use of these drugs however, the antimicrobial 
resistance started to develop and nowadays, this is a global problem in the battle 
against infectious diseases.1-3 Although many mechanisms are responsible for the 
development of antimicrobial resistance, overconsumption and inappropriate use of 
antibiotics is the main driving force.4,5 The development of new antimicrobial drugs 
is not keeping pace and able to tackle the problem of antimicrobial resistance. In 
addition, new antimicrobials only give temporarily relief.6,7 This gradually led to the 
global awareness that controll of the use of antibiotics is concern for health care 
authorities, and national and international initiatives were launched to provide 
recommendations for antibiotic use.8
The Netherlands has a tradition of prudent use of antibiotics which until now has 
resulted in a low incidence of methicillin-resistant Staphylococcus aureus (MRSA) 
and penicillin-resistant pneumococci.9
To formalize and advocate the prudent use of antibiotics in the Netherlands, the 
Dutch Working Party on Antibiotic Policy (SWAB) was established in 1996 by the 
Dutch Society of Infectious Diseases (VIZ), the Dutch Society of Medical Microbiology 
(NVMM), and the Dutch Society of Hospital Pharmacists (NVZA). One of the 
spearheads of the SWAB was to promote the optimal antibiotic use by guideline 
development for antimicrobial treatment and prophylaxis. Regarding optimal use, 
antibiotic choice, duration and timing are essential elements of quality improvement. 
In case of antibiotic choice, the primary goal is to choose an antibiotic which is 
effective against the presumed causative pathogen and at the same time avoid an 
unnecessary broad spectrum to prevent selective pressure as much as possible. 
Drugs with low toxicity profiles are preferred. Regarding the duration of treatment, 
treatment must be long enough to guarantee a good clinical outcome but in the 
mean time be as short as possible to avoid unnecessary toxicity, development 
of resistance and high costs. Proper timing of administration of antibiotics is a 
keystone of antibiotic management in prophylaxis as well as in therapy. It improves 
morbidity and mortality as well as length of stay of patients with community-
acquired pneumonia and sepsis.10,11 In surgical prophylaxis, correct timing proved 
to be essential for its efficacy.12,13 In addition to these factors, issues of dosage 
adjustment to renal function, streamlining, and switching from the intravenous to 
the oral route need to be addressed in a good antibiotic policy.
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Data from an intervention study conducted in a large University hospital in 
the Netherlands in 1992 showed that there was still room for improvement in 
prophylaxis as well as in therapy.14,15 This conclusion was in line with many other 
studies in the international literature.16-19 In the Dutch study, the implementation of 
new guidelines for surgical antimicrobial prophylaxis and improvement of logistics 
resulted in a reduction in the use of broad-spectrum antibiotics, a shorter duration 
of prophylaxis, an improvement of timing and in cost-savings.15,20
Unfortunately, only a few intervention studies have focused on patient outcome, 
and opponents fear that reducing the use of antibiotics in prophylaxis could lead 
to decreased efficacy, resulting in a higher incidence of surgical site infections. 
Therefore, there was a need for studies not only taking into account process 
outcome but also patient outcome.
In 1996, the National Institute for Public Health and the Environment (RIVM) and 
the Dutch Institute for Healthcare Improvement (CBO) had started a national 
surveillance program of surgical site infection, PREZIES, that could serve as a 
basis for intervention studies.21 In 1998, the SWAB initiated the development of 
national guidelines for surgical prophylaxis, which were released in 2001. A joint 
application of researchers at SWAB , RIVM and CBO resulted in a grant awarded by 
the Prevention program of The Netherlands Organization for Health Research and 
Development (ZonMw). Thus the Surgical Prophylaxis and Surveillance of Wound 
Infections project (Chirurgische profylaxe en Postoperatieve wondinfecties, CHIPS) 
could be started in 1999. The aim of the CHIPS project, a multi-center intervention 
project, was to improve the quality of prophylaxis in Dutch hospitals and to promote 
prudent use while maintaining or improving the efficacy of prophylaxis in reducing 
surgical site infections (SSI). This would be achieved by implementing the SWAB 
guideline for surgical prophylaxis and using audit and feedback as implementation 
methods and monitoring patient outcome by recording the incidence of surgical 
site infections before and after the intervention. The results of these studies are 
presented in this thesis.
Chapter 1.1 describes the methodology of the CHIPS study and the process of 
hospital recruitment. In Chapter 1.2, the SWAB guideline for surgical prophylaxis 
that served as the basis for implementation of recommendations in the CHIPS study 
is presented.
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Chapter 2 reports on the presence and use of local guidelines for surgical prophylaxis 
in the participating hospitals prior to the intervention and asks the question how 
healthcare workers adhere to them. In this analysis the question is investigated 
what potential barriers to guideline adherence are.
Chapter 3 deals with the question what the effect of implementation of the SWAB 
guideline for surgical prophylaxis on the quality of prophylaxis is in the participating 
hospitals. Antibiotic choice, duration and timing of antibiotic use before and after 
an intervention were investigated by using time-series analysis.
Chapter 4 reports on the effect of the intervention on the incidence of surgical site 
infections and addresses the question whether a prudent antibiotic policy does or 
does not have a detrimental effect on the antibiotic efficacy.
Chapter 5 describes the relationship between several aspects of surgical prophylaxis 
and patient outcome in terms of incidence of surgical site infections following 
total hip implant surgery. Special attention is paid to timing of the first dose of 
prophylaxis.
Chapter 6 addresses the effect of the implementation of recommendations 
on antibiotic therapy, in an University Hospital. The study focuses on timely 
administration of antibiotics next to dosage adjustment to renal function, antibiotic 
streamlining and intraveneus to oral switch therapy.
Chapter 7 is an inventory of the barriers to change that were encountered in the 
CHIPS prophylaxis study and their correlation to the process outcome. Here, we 
explored whether general recommendations can be formulated that can predict the 
success of implementation.
In the general discussion, the results of the study are put into perspective, and 
recommendations for the future are discussed.
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Introduction
The aim of the CHIPS multi-center intervention project (Surgical prophylaxis and 
surveillance), was to improve the quality of prophylaxis in Dutch hospitals and to 
promote prudent use while maintaining or improving the efficacy of prophylaxis in 
reducing SSI. This was intended by implementing a framework of national guidelines 
on surgical prophylaxis of the Dutch Working Party on Antibiotic policy (SWAB). The 
study was conducted within the PREZIES-surveillance network.
The PREZIES surveillance system of SSI in The Netherlands
The PREZIES national surveillance network of nosocomial infections is an initiative 
of the Dutch Institute for Healthcare Improvement and the Centre for Infectious 
Disease Epidemiology of the National Institute for Public Health and the Environment 
(RIVM). It is funded by the Ministry of Health, Welfare and Sports.1 Within this 
network, surveillance of surgical site infections has been operational since 1996 and 
contact between the network‘s coordination center and the hospitals is maintained 
through the hospital infection control committees. Members of these committees 
are infection control practitioners (ICPs), medical microbiologists, clinicians and 
pharmacists. 
In the Netherlands, every hospital employs one ICP per 250 beds. These ICPs 
have a background as a nurse or as a medical laboratory technician and 1.5-year’s 
training at accredited infection prevention schools. Most ICPs are supported by 
medical microbiologists 2 although ICPs often operate independently. ICPs occupy 
an unique position in the hospital by having access to various patient data and 
having contacts with many different medical disciplines. Although the assessment 
of SSI is also done by physicians, the final responsibility for the surveillance in the 
PREZIES surveillance network lies with the ICP.1 The PREZIES coordination center 
supports ICPs through a telephone-helpline, workshops and occasional visits.
Study design of the CHIPS-project
The CHIPS-project was a prospective multi-center intervention study with a before-
and-after design without a control group. 
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The study consisted of five parts with the following time schedule:
– Recruitment and enrollment of hospitals, preparation of data collection  
(6 months).
– Pre-intervention study (6 months).
– Educational intervention (6 months).
– Post-intervention study, identical to the pre-intervention study (6 months).
– Data analysis (12 months).
Recruitment of hospitals and local setup
As a representation of the 135 Dutch hospitals, a minimal sample of eight hospitals 
was considered for the CHIPS study. These were geographically spread over the 
country and included small and large hospitals as well as teaching and non-teaching 
hospitals. The hospitals had to commit themselves to perform surveillance of SSI 
according to the PREZIES-protocol including post discharge surveillance (PDS).1 
Since CHIPS could not provide any financial support, the motivation of hospitals 
to participate was of utmost importance. Hospital staff had to be convinced of the 
value of the study for their own quality program and hospitals were expected to 
facilitate data collection and to create a climate for intervention. 
At the time of the grant application, the infection control committees of the PREZIES 
hospital network were approached for their interest in the study. In order to recruit 
a maximum number of hospitals, the following strategy was designed at the start 
of the CHIPS-project:
– A letter containing a synopsis of the protocol was sent to the infection control 
committees of all Dutch hospitals. Hospitals could obtain the complete study 
protocol on request. 
– Hospitals of the PREZIES-network that did not respond to this letter but had 
expressed an earlier interest in the study, were contacted by telephone.
– A workshop was organized for potential participants. ICPs, microbiologists, and 
members of infection control committees from all hospitals that had showed an 
interest in the study were invited to attend. 
– The CHIPS study group established a multidisciplinary advisory committee, 
comprising academic opinion leaders from different universities (a surgeon, an 
anesthetist, a medical microbiologist, a pharmacist and an infection control 
specialist), which was invited to participate in the workshop. 
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– At the workshop, both scientific and practical aspects of the study were discussed 
and hospital representatives had the opportunity to sign up for the study. 
– Principal responsibility in each hospital was assigned to an appointed specialist. 
This specialist, along with the CHIPS researchers and the ICP, organized 
meetings within the hospitals. At these meetings, written information about the 
CHIPS-study and the method of data collection was to be distributed among 
anesthetists, surgeons, nurses and pharmacists.
– After approval by the clinicians and the hospital management, contracts for 
participation were signed.
– Special local conferences were organized for surgeons and anesthetists since 
their role during the intervention was considered crucial. 
– Confidentiality was secured at patient level.
– Approval of the hospital medical ethics committee was not considered mandatory 
since the study would be part of the hospital’s quality improvement program.
Out of the 58 PREZIES hospitals that were contacted in 1998, initially 32 (55%) 
had been interested in participating in an intervention study on prophylaxis (Figure 
1). However, in 1999 when the grant for the CHIPS-study had been obtained, there 
was a very low response from the correspondence sent to all 135 hospitals in the 
Netherlands. Eighteen hospitals answered favorably (13%) of which only two were 
PREZIES hospitals that had been interested in 1998. Of these hospitals only those 
performing post-discharge surveillance (PDS) were consulted by telephone (28 
hospitals), and thereafter another eight of these (29 %) reconsidered participation 
(Figure 1). The other 20 PREZIES-hospitals declined participation for various reasons: 
no priority issue (nine hospitals), lack of time of the local ICP (four hospitals), 
vacancy for ICPs (two hospitals) and not specified (five hospitals). A total of 26 
hospitals requested the complete studyprotocol. 
In July 1999, the infection control teams from the 26 hospitals that had requested 
the protocol were invited to the organized study workshop. Fourteen teams 
attended the workshop. The teams consisted mainly of ICPs (n=11/14) and medical 
microbiologists (n=3/14), one pharmacist and two medical specialists (one surgeon 
and one infectious diseases specialist). The complete CHIPS study team and four 
out of the five advisory committee members were present at the workshop.
Due to logistics in the hospitals and the absence of hospital staff during summer 
holidays, the approval by the clinicians and the hospital management took several 
months. By the end of 1999, 6 months behind schedule, 13 hospitals actually 
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started the study, of whom only four had attended the workshop. Ten hospitals 
withdrew due to the anticipated extra workload for the local ICP, four were unable 
to start due to ICP-vacancies or sick leave of the local ICP. One hospital, that had 
declined to participate in 1999, joined the study after a new ICP was appointed. 
Ten of the 13 hospitals that participated in the study had previous experience with 
surveillance in the PREZIES-network. There were four small hospitals (<400 beds), 
six medium size hospitals (400-800 beds) and three large hospitals of more than 
800 beds, including two university hospitals. The 13 participating hospitals were 
geographically spread throughout the country.
In eight hospitals, the local conferences for the medical specialists were coordinated 
by the investigator and the ICP of the project. In five hospitals, the local ICPs 
preferred to inform the specialists themselves. 
mailings to all hospitals in 
the Netherlands
n=135
mailings to PREZIES hospitals
n=58
interested in 1998 & 1999
n=2
          interested       not interested    no response
                                      n=18               n=8               n=109
not interested in 1998                interested in 1998
n=26                                     n=32
not interested after mail in 1999
n=30
interested new
n=16
1999
telephonic consultation
no PDS
n=2
PDS
n=28
not interested
n=20
interested
n=8
final participation
n=13
32
8
1998
1999
Figure 1. Recruitment of hospitals for the CHIPS project  
Response to inquiries requesting willingness to participate in the CHIPS-study. In 1998 letters were sent 
to hospitals participating in the PREZIES-SSI-network. In 1999 an outline of the CHIPS study was sent to 
all hospitals in the Netherlands (including hospitals of the PREZIES-network). Hospitals of the PREZIES-
network that performed post-discharge surveillance (PDS) but that did not respond to the inquiry were 
approached by phone. Those without post-discharge surveillance were not contacted.
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Selection criteria for surgical procedures 
Frequently performed procedures in four major medical disciplines were selected. 
(Table 1). To avoid disagreement regarding indication for prophylaxis, procedures 
were selected for which antibiotic prophylaxis is generally recommended in the 
international literature.3-5 To ensure that prophylaxis was recorded and not antibiotic 
therapy, procedures with suspected or established infection prior or during surgery 
were excluded. Non-elective procedures were also excluded. 
To facilitate the evaluation of the quality of surgical prophylaxis broken down 
by medical discipline or by hospital, a minimum number of 20 procedures per 
discipline was aimed at before and after intervention in each hospital. 
Hospitals were free to choose which of the selected procedures they included 
in the study. During the study it became clear that orthopaedic procedures were 
overrepresented. The minimum number of 20 procedures required per discipline 
was attained in all but one hospital (vascular surgery).
Table 1. Selected procedures according to estimated wound class (Altemeier) 26 for inclusion in the 
CHIPS-study.
Clean Clean-contaminated 
Total hip replacement Vaginal hysterectomy (with or without vaginal repair)
Femoral hemiprosthesis Abdominal hysterectomy*
Reconstruction of the aorta Colon resection 
Femoropopliteal bypass Anterior resection of the recto-sigmoid
Femorotibial bypass Abdominoperineal resection of the sigmoid
* depending on the procedure; supravaginal or not, this procedure can be classified as clean or clean-
contaminated.
Data collection, data sources and data sets
Data collection of SSI was performed by the local ICPs in each hospital according 
to the PREZIES protocol.1 The surgical departments were visited at least twice 
weekly and this included inspection of the surgical wounds of patients in the wards. 
SSI were diagnosed according to the criteria of the Centers for Disease Control 
translated into a Dutch guideline.6,7 PDS was done until 30 days after discharge, 
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except for implant surgery for which the PDS surveillance period was extended to 
one year. Data collection on surgical prophylaxis was performed by the local ICP (10 
hospitals) or by the ICP of the project (3 hospitals). 
Table 2 shows the set of data collected on SSI. The ICPs entered these data into 
the standard software program that they used for the ongoing PREZIES surveillance. 
The parameters that were collected on antimicrobial prophylaxis for the CHIPS 
study were recorded manually on separate record forms (Table 3).
Source documents were defined as medical records, nursing and anesthetic records, 
operation protocols and medication charts. In the surgical suite, only drugs that 
were written down in the anesthetic records were considered to be administered. 
In the ward, only prescriptions initialed by the nurse were assumed as being 
administered.
In every hospital a pilot study of five random procedures was conducted. In these 
pilot studies, the availability and quality of the data collection was evaluated by the 
investigators. If necessary, the method of data collection was improved. 
Table 2. Collected parameters in the CHIPS study concerning SSI 
Demography Surgery SSI in case of SSI 
Hospital code date of procedure Y/N pus Y/N
date of birth COTG code of procedure* wound explored Y/N
gender type of procedure superficial or deep 
date of admission duration of procedure diagnosis surgeon Y/N
date of discharge surgical wound class abscess Y/N
ASA-score antibiotic prophylaxis Y/N
elective/urgent
code of surgeon
code of resident
microbiological test performed Y/N 
 specimen 
  isolated micro-organisms
 antibiotic sensitivity of isolates 
* COTG code is a financial administration code of the Dutch Central Organization for Charges in Healthcare 
in the Netherlands. The code is based on anatomy and surgical maneuvers. Items in italics are optional. 
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Table 3. Collected parameters concerning antibiotic prophylaxis in the CHIPS study
Demography procedure antibiotic prophylaxis
CHIPS code * date of surgery generic name of antibiotic(s)
date of birth COTG-code of procedure dose
gender description of procedure time of administration of antibiotic 
doses
date of admission duration of procedure mode of administration B / I **
date of discharge elective procedure Y/N total number of doses 
ASA-score surgical wound class 1-4
antibiotic prophylaxis administered Y/N
suspected infection at surgical site prior 
to surgery Y/N
suspected infection at surgical site 
during surgery Y/N
time of induction of anesthesia
time of first incision
number of units of an antibiotic 
per dose
allergy to antibiotics Y/N, name of 
antibiotic
topical prophylaxis Y/N
*   unique code for every procedure in the study, including a specific hospital code.   
** B = bolus, I = infusion
Validation of the data collection 
To validate the data collected on SSI, the national validation team of PREZIES visited 
the participating hospitals once during the study period. A visit lasted one day and 
consisted of a process and outcome validation. During the validation process, 
the procedure of inclusion, the method to detect SSI, the handling of criteria for 
the assessment of SSI and the feedback of surveillance results were evaluated.8 
The outcome validation was carried out as a prevalence-study assessing the 20 
most recent cases of patients with a SSI. In addition, five random cases could be 
submitted to the validation team for discussion. During the validation visits, a very 
good conformity was found with the collection of SSI data. In two hospitals minor 
flaws were observed and corrected.
To validate the data collection on antimicrobial surgical prophylaxis, either the 
investigator (MvK) or the ICP of the CHIPS-study (MR) visited the hospitals every 
6-8 weeks. The case record forms were compared with the source documents. At 
the first visit, a minimum of 25% of the procedures was checked. In the case of 
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discrepancies, the method of data collection and SSI assessment were discussed 
and optimized if necessary. During the next validation visit, again 25% of the cases 
were evaluated. If there were no discrepancies, the outcome of a minimum of 10% 
of the recorded procedures was validated at subsequent visits. There was a very 
good conformity on the outcome after two visits in each hospital. 
Data processing
The local ICPs sent the SSI data on diskette to the PREZIES-center for checks 
on data integrity and completeness, and for aggregation. The NNIS risk index, 
developed by the Centers for Disease Control, was calculated. A wound class of 
3 or 4, an ASA score of 3 or more and a duration of surgery longer than the 75th 
percentile of all procedures in a given category, each added a value of 1 to the NNIS 
index which could vary from 0 to 3.9 Data on antibiotic prophylaxis were sent on the 
record forms to the investigator who entered them in a spreadsheet and checked 
for consistency. 
Data assessment
Process outcome: qualitative and quantitative evaluation of prescription at the 
patient level including costs. 
The investigator performed the evaluation of the quality-of-use of antimicrobial 
prophylaxis by two methods: comparison with the local hospital guideline and 
comparison with the SWAB-guideline. To determine the evaluation of adherence 
to hospital guidelines, the most recent version of local guidelines for surgical 
prophylaxis, issued by the committees for antibiotic policy, was requested from 
each hospital. Criteria for this evaluation of adherence are described elsewhere.10 
To evaluate quality-of-use according to the SWAB-guideline, a modification of 
the method that has been previously described 11 was sed. Every parameter of 
prophylaxis, i.e. antibiotic choice, duration, dose, interval and timing, was evaluated 
separately.
The amount of antibiotics used per hospital was expressed in DDD/ 100 bed-days 
12 and DDD/operation.13 Purchase costs (wholesale) of antibiotics and costs for 
administration (materials and personnel) were calculated and expressed in Euro. Some 
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parameters, e.g. timing and duration of prophylaxis, were analyzed quantitatively. The 
adherence to the local and SWAB -guidelines was analyzed using SPSS for Windows 
(release 10.0). 
Patient outcome: incidence of surgical site infections.
It was hypothesised that improvement in the quality of surgical prophylaxis would 
result in a similar or reduced incidence of SSI than before the intervention. A 
power calculation was carried out with a two-sided significance level of 0.05 and 
a power of 80%.  Based on SSI rates of the PREZIES-network for the selected 
procedures, it was estimated that the mean initial SSI rate would be 7.5 %.  At the 
start of the study it was assumed that the mix of surgical procedures in the pre- 
and post-intervention study would be similar, that all disciplines would be equally 
represented and that data from different hospitals could be aggregated. A sample 
size of 1600 surgical procedures would be needed in the pre- and post-intervention 
period to detect a statistical significant decrease in SSI rate of 7.5 % to 5.0 %. 
To study the relation between the quality-of-use of surgical prophylaxis and the 
incidence of SSI, the aggregated data of SSI and surgical prophylaxis were analyzed 
in SAS for Windows (release 8.1; SAS Institute, Cary NC). The databases were 
aggregated by matching the procedures based on date of birth of the patient, date 
of admission, date of procedure and date of discharge.
Discussion 
The CHIPS-study shows that a national surveillance network for nosocomial infections 
can serve as an infrastructure to set up an intervention study on the quality of 
care. There are however pro’s and cons of the set-up which are in part related to 
this network. The collaboration between research groups from medical universities 
and the national surveillance network on nosocomial infections led to stimulating 
multidisciplinary team work. On the one hand, the medical research groups had 
crucial scientific and practical experience with antibiotic intervention policies 13-16 
which might have motivated hospitals to participate in this study. On the other 
hand, the national surveillance network provided a number of hospitals already 
involved in collaborative efforts with existing systems for recruitment, data collection 
and data assessment.1 The involvement of hospital ICPs enabled the study to be 
performed without extra funding for data managers. The performance of ICPs as 
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data managers was excellent. The experience of the ICPs in performing surveillance 
guaranteed the quality of the data collection, as shown by the validation of both 
the surveillance of SSI and of antimicrobial prophylaxis. ICPs also played a key-role 
in the recruitment of hospitals which was initiated through the surveillance network 
and its contacts. A major strength of this study was the multi-center approach 
of both measurement of the effect on process outcome (quantity and quality of 
surgical prophylaxis) and on patient outcome (SSI). Most other recent intervention 
studies on surgical prophylaxis have been performed in a single hospital.17 18-21 Only 
a few studies have been performed in multiple centers, 22,23 or have focused on the 
correlation between surgical prophylaxis and the incidence of SSI.24,25
The study set-up suffered however from several shortcomings. First, because of 
the lack of funds to support hospitals for the data collection, the CHIPS-team was 
dependent on the time that the local ICPs could make available to perform the 
data collection. Vacancies for ICPs and an already high workload in the hospitals 
was probably the main reason for a relatively low number of participating hospitals 
after an initial favorable response. Financial support for participating hospitals may 
therefore be warranted to motivate hospital staff to continue data collection during 
a relatively long follow-up period. Second, because the recruitment of hospitals was 
done through the PREZIES network, the primary contacts of the CHIPS team were 
with ICPs and medical microbiologists. There was no direct communication of the 
CHIPS-team with surgeons to discuss participation. Although the multidisciplinary 
advisory committee was present at the first workshop, hardly no surgeons visited 
this workshop and therefore were not reached at a primary stage of the study. 
In future studies on prophylaxis, professional societies of surgeons should be 
approached at an early stage and invited to act as facilitators for recruitment for 
such a study. They could assign local opinion leaders and launch such a project 
through their members.
Third, because participation in the study was on a voluntary basis, a selection bias 
cannot be excluded. Nevertheless, the included hospitals seemed to represent in-
patient care in the Netherlands since the number of procedures finally recorded in 
the recruited hospitals was quite large, different disciplines were represented in 
different types of hospitals and there was a wide geographic distribution of the 
hospitals. Fourth, the time-schedule of the study turned out to be too optimistic. 
Recruitment of hospitals took much more time than was foreseen and also the time 
needed to obtain approval of all participating medical specialists and the hospital 
management was much longer. Once the data collection had started, the time 
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needed to include the required minimum number of 1600 procedures appeared 
longer than the originally planned six months due to a relatively low incidence of 
performed procedures in some hospitals. Due to an over-representation of clean 
procedures (which reflected the PREZIES network) the true SSI incidence in the 
preintervention period was lower than the estimated incidence used for the power 
calculation. Therefore the number of recorded procedures had to be increased and 
the periods of data collection had to be extended. More attempts to increase the 
inclusion of procedures with a relatively high intrinsic rate of SSI, e.g. intestinal 
procedures, might have prevented this. 
In conclusion, a national SSI surveillance network provided a valuable framework for 
hospital recruitment, data collection and data management for intervention strategies 
on surgical antibiotic prophylaxis. However these activities are time-consuming and, 
without extra financial support for hospitals, are only possible by a strong commitment 
by all participants. To enhance commitment for such a study, it could be helpful to 
involve professional associations of surgeons at an early stage. 
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Abstract
The Dutch Working Party on Antibiotic Policy (Stichting Werkgroep Antibioticabeleid 
SWAB) has developed guidelines for perioperative antibiotic prophylaxis in Dutch 
hospitals.
Prophylaxis is not indicated for all procedures. In particular, patients should be 
considered for perioperative antibiotic prophylaxis when the procedure is associated 
with a relatively high risk for surgical site infections or if the development of such 
an infection would have very serious consequences.
Studies have demonstrated that prophylaxis administered within 2 hours of the start 
of the procedure is most effective. Short-term, preferably single-dose, prophylaxis 
was found to be just as effective for most procedures as multiple-dose regimens; the 
former is to be preferred from the standpoint of cost management and prevention 
of the development of resistance.
The antibiotic of first choice for perioperative prophylaxis is preferably not an 
important therapeutic drug, is as selectively active as possible against mircoorganisms 
expected to cause a surgical site infection and has a half-life which is long enough 
to make one preoperative dose of the drug to be sufficient.
For the above reasons, cefazolin is often administered as perioperative prophylaxis.
Introduction
The Dutch Working Party on Antibiotic Policy (Stichting Werkgroep Antibioticabeleid 
SWAB) develops guidelines for the use of antibiotics in hospitals, with the aim to 
optimize antibiotic policies and thus to contribute to the control of the development 
of resistance.1
The SWAB guidelines described here for perioperative antibiotic prophylaxis for 
adults are meant as a framework for the Antibiotic Policy Committees in diverse 
hospitals. For guidelines for children, see “Blueprint for paediatric antimicrobial 
therapy”.2
The guidelines are based on the following important criteria for the use of 
antibiotics: 
1. The indication for prescription of the antibiotic must be correct, 
2. The antibiotic must be directed against the expected causative microorganisms, 
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3.  The antibiotic must be administered at the correct time and administration should 
not last longer than necessary, the spectrum must be as narrow as possible, the 
antibiotic must be as safe and inexpensive as possible, and it must be possible 
to administer it via the desired route. At the end of this article there is a list of 
recommended literature.3-32 
Definition of perioperative antibiotic prophylaxis
“Perioperative antibiotic prophylaxis” is the administration of an antibiotic for a 
surgical procedure within a short period of time to prevent postoperative infections 
at the surgical site (SSI). These SWAB guidelines do not cover all surgical procedures 
in detail but focus on those which are performed relatively often, those with a 
relatively high percentage of wound infections, those for which the consequences 
of a wound infection would be severe and those for which the benefit of prophylaxis 
has been studied extensively. These guidelines therefore are not presumed to be 
complete. However on the basis of the general principles outlined in this guideline 
every hospital can draw up detailed guidelines which are tailored to the local 
situation. Prophylaxis which is administered as part of a diagnostic procedure falls 
outside the scope of this guideline.
The use of antibiotics to prevent postoperative infections at the surgical site 
is generally accepted nowadays. It represents however only a small part of the 
strategy to prevent these infections. Antibiotics do not compensate for inadequate 
perioperative care and/or poor surgical techniques. In addition the benefit of 
perioperative prophylaxis has not been established for all procedures.
Postoperative wounds are classified into different classes according to the system 
of Mayhall (Table 1). The relevance of this classification system is that there is a 
difference between classes in the risk that a postoperative infection will develop 
at the surgical site. The indication for perioperative prophylaxis is determined to 
a large extent by this risk. That is why wound classification is estimated before 
surgery: the prophylactic plan is based on this classification.
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Table 1. Surgical wound classification (according to Mayhall).6,32
Wound Class Description of the wound
Clean Elective surgery, primarily closed without drains*
Non traumatic, not infected
Good asepsis
Respiratory, digestive of urogenital tract not opened
Clean-contaminated Respiratory, digestive or urogenital tract opened under controlled conditions 
and without unusual contamination
Oropharynx opened
Vagina opened
Genitourinary tract opened in the absence of positive culture of urine 
Biliary tract opened without suspicion of cholangitis
Contaminated Open, fresh (less than 6 hours old) traumatic wound 
Visible spill of faecal material from gastrointestinal tract
Opening of urogenital tract in presence of positive culture of urine
Opening or perforation of biliairy tract in case of suspected cholangitis
Surgery in acute non-purulent inflammated area
Dirty-infected Traumatic wounds with necrotic material
or traumatic wound with corpus alienum 
Delayed surgery of traumatic wound
Perforated organ, faecal contamination
Acute inflammation with pus 
* The SWAB considers that a wound with a drain left in place for a short time (1-2 days) for drainage 
of blood or fluid can still be classified as a “clean” wound. This is for example the case for total hip 
arthroplasty with a so-called Redon drain.
Indications for prophylaxis
Clean wounds
In general prophylaxis is not indicated for procedures where a clean wound is 
expected (postoperative risk of infection less than 2-5% under normal conditions) 
(Figure 1). Examples are most procedures in Plastic surgery, Vascular surgery without 
implant of synthetic materials and without an incision in the groin, and procedures 
of the ear or nose (without implants).
Despite the low percentage of SSI, there are clean procedures for which a SSI can 
have such severe consequences that prophylaxis is indicated. This applies for a 
large number of procedures involving implantation of synthetic materials (Table 2). 
Implantation of synthetic mesh is as yet not considered by SWAB to be a procedure 
for which prophylaxis is indicated.
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Table 2. Procedures for which, according to general consensus, perioperative antibiotic prophylaxis is 
indicated.
Wound Classification Clean
Ear Nose Throat – Stapedectomy
– Implant surgery, bone transplant
Neurosurgery – Craniotomy
Vascular surgery – Implant surgery / synthetic material
– Aorta reconstruction and vascular surgery with groin incision
Cardiovascular – Open-heart surgery including coronary bypass surgery and 
implantation of artificial valve
Orthopaedic / bone surgery – Implant joint prothesis
– Osteosynthesis
– Amputation in ischaemic area
Wound Classification Clean-contaminated/ contaminated
Head Neck Surgery – Opening oral cavity / pharynx or oesophagus
Neurosurgery – Procedures by naso- of oropharyngeal route
Thoracic surgery – Lobectomy and pneumectomy
Surgery digestive tract – Gastric and duodenal surgery in patients with hypochlorhydria, 
disturbed gastric motility or in extremely obese patients
– Biliary tract surgery in patients with cholangitis, stone in common 
bile duct, obstructive icterus or in patients >70 years old
– Colo-rectal surgery
– Appendectomy without appendicitis
Surgery urogenital tract – Surgery of urinary tract with non-sterile urine
– Vaginal / abdominal hysterectomy
– Secondary caesarean section
– Manual removal of placenta
– Abortion in 2nd trimester or after pelvic inflammatory disease in 1st 
trimester
– Vulvectomy
Trauma – Open fracture
– Penetrating abdominal or thoracic trauma, <6 hours old
For a number of procedures with a presumed clean wound, such as craniotomy and 
coronary bypass surgery, it has appeared that in fact the risk of wound infection 
is clearly higher than 5%, i.e. 8-20% according to various studies. This is probably 
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attributable to the prolonged duration of the procedure. Prophylaxis for these 
procedures has indeed been found to be beneficial. 
Recently a number of studies have been performed concerning the effectiveness 
of prophylaxis in clean non-implant surgery. For mastectomy and herniorraphy 
prophylaxis significantly reduced the incidence of SSI.25 The absolute risk of SSI 
was however low and one must administer antibiotic prophylaxis to a very large 
number of patients undergoing such surgery in order to prevent one SSI. SWAB 
considers this undesirable in view of the possible induction of resistance and 
therefore believes that the advantages of prophylaxis for these procedures do not 
outweigh the disadvantages and therefore does not advise prophylaxis for these 
procedures.
Clean-contaminated/contaminated wounds
For procedures for which a so-called clean-contaminated or contaminated wound 
is expected, the risk of a SSI increases to 10 and 20%, respectively. Thus the 
advantages of prophylaxis do outweigh the possible disadvantages. The most 
important measures for prevention of SSI of contaminated wounds are incidentally 
local management of the wound and leaving the wound open. For exploration of 
open traumatic wounds (except bite wounds), antibiotic prophylaxis can often be 
excluded from the list of measures to be taken. Table 2 presents a survey of a 
large number of procedures for which the indication for perioperative prophylaxis is 
generally accepted. For procedures involving some organs, perioperative prophylaxis 
is essential only under certain circumstances or for a certain group of patients. The 
method of surgery, i.e. conventional or laparoscopic, does not appear to be a 
determining factor. 
For two procedures in Table 2, abdominal hysterectomy and pulmonary surgery, the 
benefit of prophylaxis is somewhat controversial according to the literature. Many 
studies have been published on the effectiveness of prophylaxis for abdominal 
hysterectomy but in general they were without sufficient statistical support. 
Furthermore in a number of studies, the prevention of both a SSI and, for example, 
infection of the urinary tract served as an outcome measure of the success of 
prophylaxis. Several studies showed the advantage of prophylaxis for specific risk 
categories, such as obese patients. According to several meta-analyses however 
prophylaxis is beneficial in abdominal hysterectomy and therefore the majority of 
the consultants of SWAB agreed with prophylaxis in both vaginal and abdominal 
uterus extirpation.
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For pulmonary surgery only a few placebo-controlled studies have been carried 
out with relatively small numbers of patients. The results of these studies are 
controversial and the success of prophylaxis is evaluated on the basis of several 
outcomes (superficial SSI alone or together with postoperative pneumonia). In 
an American guideline, published in the Medical Letter of 1997, prophylaxis is 
recommended for pneumonectomy and lobectomy,3 and in view of the positive 
results with prophylaxis in a number of recent studies, SWAB supports this 
standpoint.
Environmental and patient-related factors
In addition to the nature of the procedure, environmental and patient-related factors 
can contribute to the risk of infection (Table 3). Patients with these risk factors 
have a greater chance of SSI than those without these risk factors. However, as yet 
controlled studies have not been able to show that the risk of SSI decreases when 
patients with one of these risk factors receive prophylaxis for a procedure for which 
prophylaxis is not generally indicated. Furthermore there are no official guidelines 
in which the presence of these risk factors has played a role in the decision to 
administer prophylaxis. In general it is accepted that if there is no consensus about 
the effectiveness of prophylaxis it is better not to administer it.
For procedures at an infected site, administration of antibiotics is therapeutic instead 
of prophylactic and the administration of the antibiotic is usually continued until 
several days after surgery. This subject falls outside of the scope of this guideline.
Microorganisms that cause surgical site infections
The most common causative microorganism of SSI is Staphylococcus aureus. In 
addition, Staphylococcus epidermidis (especially infections of joint prostheses and 
artificial valves), streptococci and, in a limited number of cases, enterobacteriaceae 
and Pseudomonas species are important. This applies mainly for colorectal 
procedures and surgery involving infected bile ducts or an infected genitourinary 
tract. Patients with a malignancy in the oral pharyngeal region regularly carry 
enterobacteriaceae, especially if they have received radiotherapy. The role of these 
enterobacteriaceae however in the development of SSI is controversial. Although 
enterococci are often isolated from superficial and deep wounds after surgery 
involving the digestive tract, the clinical relevance of the presence of these micro-
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organisms is not completely clear. In the case of a procedure involving the digestive 
tract, the pharynx or the genitourinary tract, not only aerobic but also anaerobic 
bacteria play a role. 
Antibiotic choice for prophylaxis
Antibiotic prophylaxis represents a substantial proportion of the total use of 
antibiotics in the hospital and therefore contributes to the problem of selectivity 
of hospital flora and the normal flora of the patient. For this reason it is important 
to choose drugs for perioperative prophylaxis which are selectively active against 
the expected microorganisms and which preferably are not an important part of 
the therapeutic arsenal of the hospital. In addition safety, a favourable dosage 
profile and limited costs are important. Studies in which several antibiotics (usually 
different cephalosporins) were compared show few differences in efficacy. However 
most studies have insufficient statistical power to be able to demonstrate these 
differences. In Figures 1 and 2, the drugs which can be considered for perioperative 
prophylaxis, according to SWAB, are listed for different procedures.
Cefazolin
Considerable experience has been collected with the first-generation cephalosporins, 
in particular cefazolin. It meets the criteria listed and offers good protection 
against the most common facultative aerobic microorganisms that cause SSI (this 
applies for a patient who has not had extensive prior treatment with antibiotics 
and has not been hospitalized for a prolonged period). The spectrum of cefazolin 
includes streptococci, staphylococci (with the exception of the methicillin-resistant 
staphylococci) and a limited number of enterobacteriaceae. Anaerobic intestinal 
bacteria are not susceptible, as are enterococci. After intravenous administration 
high serum concentrations are achieved and despite strong protein binding the 
concentration of cefazolin in surgical wounds is more than sufficient. The half-life of 
cefazolin with respect to that of other first and second-generation cephalosporins is 
relatively long, i.e. 1.5 – 2 hours. For a procedure that lasts no longer than 4 hours, 
one dose is sufficient.
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On the basis of the excellent results of clinical studies, SWAB concludes that 
cefazolin can play an important role in perioperative prophylaxis. Cephalosporins 
of the second or third-generation do not offer any advantages with respect to 
effectiveness and due to the broader spectrum probably lead to more intense 
selective pressure and the risk of the development of resistance. In general they 
must therefore be avoided. On the other hand they should be administered when 
Haemophilus influenzae is the cause of a SSI, such as after lobectomy whereby a 
postoperative pneumonia due to H. influenzae must be considered as a deep SSI.
Metronidazole
When an anaerobic flora is expected, it is recommended that intravenous 
metronidazole be added to cefazolin. An alternative is intravenous amoxicillin with 
clavulanic acid. However, in hospitals in which amoxicillin clavulanic acid plays a 
prominent role in therapy, this drug should not be administered as prophylaxis. 
Cefoxitin, a second-generation cephalosporin with a spectrum which covers aerobic 
and anaerobic causative microorganisms, is a less attractive alternative because of 
its high cost. In addition it has a short half-life (40-60 minutes) so multiple doses 
are often required.
Although the combination of oral neomycin and erythromycin is effective as 
prophylaxis for colon surgery, this approach is fairly time-consuming and expensive. 
One must start administration 18 hours before the start of the procedure and 
mistakes are easily made. SWAB therefore prefers the above-mentioned intravenous 
alternatives.
Part of the anaerobic oral flora is not sensitive to first-generation cephalosporins. 
For this reason in major surgery of the head-neck region whereby the oral cavity 
or pharynx is opened, in particular, metronidazole is added. Although amoxicillin 
with clavulanic acid is an alternatve, this combination is preferably reserved for 
therapeutic purposes. A controversial point is whether, for procedures involving the 
head-neck area, antimicrobial drugs without activity against enterobacteriaceae can 
be used. As far as perioperative prophylaxis is concerned, good results have been 
reported for clindamycin alone as well as in combination with aminoglycosides.
For surgical procedures which are associated predominantly with SSI caused by 
staphylococci such as neurosurgical procedures, flucloxacillin can also be used for 
prophylaxis. Flucloxacillin is however usually reserved for therapeutic purposes in 
most hospitals. Moreover the half-life of flucloxacillin is relatively short. In the case 
of a neurosurgical procedure which usually is quite prolonged, repeated doses 
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will be required which increases the chance of errors. Clindamycin could be an 
alternative drug but it is more expensive and is better reserved for patients with a 
penicillin allergy.
Because glycopeptides are the only effective drug against a number of micro-
organisms and because large-scale use leads to resistance, glycopeptides should 
only be administered for antibiotic prophylaxis when SSIs are caused regularly by 
meticillin-resistant staphylococci. In such cases prophylaxis with a first-generation 
cephalosporin or flucloxacillin is no longer sufficient. Obviously in the event of 
infections with meticillin-resistant S. aureus extensive hospital hygienic measures 
are required.
Topical prophylaxis
In a number of cases topical prophylaxis can (also) be applied. Examples are antibiotic 
eye drops for ophtalmologic surgery and gentamicin bone cement for orthopaedic 
procedures. The application of mupirocin or chlorhexidine nose ointment before 
vascular thoracic surgery is also considered topical prophylaxis. This ointment is 
applied from day 1 before the operation to 5 days after surgery in order to eliminate 
the possibility of becoming a carrier of staphylococci. Although a number of studies 
have demonstrated that this is an effective method to decrease the number of SSI 
with staphylococci, SWAB considers further research necessary before mupirocin 
nose ointment can in general be recommended for vascular thoracic surgery.
Timing of antibiotic prophylaxis
For optimal efficacy of prophylaxis it is essential that an adequate concentration of 
the antibiotic be present at the site of the wound from the time of the first incision 
to time of closure of the wound. If prophylaxis is administered approximately 30 
minutes before the first incision or before inflation of the tourniquet, then for 
most antibiotics an adequate tissue concentration will be achieved at the time of 
the incision. Studies on the optimal time for administration show that prophylaxis 
administered within 2 hours of the start of the procedure is most effective. Studies 
of surgical practice reveal that for timing of prophylaxis there is still much room 
for improvement. Intravenous administration of prophylaxis by the anaesthetist at 
induction of anaesthesia offers the best condition for correct timing.
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Duration of prophylaxis
Prophylaxis which lasts longer than 24 hours is not beneficial and can lead to 
unnecessary disturbance of the microbial flora. Comparative studies have shown 
that one single dose of an antibiotic with a half-life of at least 1-1.5 hours, is just as 
effective as multiple doses over 24 hours For this reason SWAB prefers one single 
preoperative dose. If the procedure lasts longer than 3 times the half-life of the 
administered antibiotic, or in case of considerable blood loss (more than 2 litres) or 
extracorporeal circulation, administration of the antibiotic must be repeated.
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Abstract
Objective: To study the adherence to local hospital guidelines for antimicrobial 
prophylaxis in surgery and explore reasons for non-adherence.
Methods: A prospective multicentre audit of elective procedures, without prior 
suspicion of infection, was carried out in 13 Dutch hospitals. By reviewing medical 
anaesthetic and nursing records, and medication charts, the prescription of 
antibiotics was compared with the local hospital guideline on antibiotic choice, 
duration of prophylaxis, dose, dosing interval and timing of the first dose.
Results: Between January 2000 and January 2001, 1763 procedures were studied. 
Antibiotic choice, duration, dose, dosing interval and timing of the first dose 
were concordant with the hospital guideline in 92 %, 82 %, 89 %, 43 % and 50 
% respectively. Overall adherence to all aspects of the guideline, however, was 
achieved in only 28 %. The most important barriers to local guideline adherence 
were lack of awareness due to ineffective distribution of the most recent version 
of the guidelines, lack of agreement of surgeons with the local hospital guidelines, 
and environmental factors such as organisational constraints in the surgical suite 
and in the ward.
Conclusion: This study shows that, although adherence to separate aspects of local 
hospital guidelines for surgical prophylaxis in the Netherlands is favourable, overall 
adherence to all parameters is hard to achieve. Adherence to guidelines on dosing 
interval and timing needs improvement, in particular. To increase the quality of 
antimicrobial prophylaxis in surgery, effort should be put into developing guidelines 
acceptable to surgeons, in adequately distributing the guidelines and to facilitating 
logistics. Audits of surgical prophylaxis may help hospitals to identify barriers to 
guideline adherence. 
Introduction
The use of antimicrobial prophylaxis for selected surgical procedures is one of the 
measures used to prevent the development of a surgical site infection (SSI).1 In past 
decades, many papers have described optimal prophylaxis, and guidelines for surgical 
prophylaxis have been developed.1-6 Despite the availability of these guidelines, 
recent studies assessing the current practice of prophylaxis throughout the world 
have shown that over-consumption of antimicrobial drugs and inappropriate timing 
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remain a problem in surgical prophylaxis.7-14 Historically, the Netherlands has a 
restrictive antibiotic policy.15 Nevertheless, misuse of antibiotics has been reported 
in Dutch hospitals. An intervention study, which analysed antibiotic utilization in 
surgical departments of a single university hospital in the Netherlands between 
1990 and 1992, showed that over-consumption and suboptimal timing of antibiotics 
for surgical prophylaxis was found in up to 66 % and 56 % of the procedures, 
respectively.16,17 
Since the early 1990’s, most hospitals in the Netherlands have developed local 
hospital guidelines to improve the quality of prophylaxis. However, quality 
improvement is not confined to guideline development. Facilitation of adherence to 
these guidelines and their effective implementation, are as important.18 Since the 
latter is often underestimated, many guidelines are abandoned in daily practice. 
In 1999, the CHIPS (surgical prophylaxis and surveillance) project, an audit and 
improvement programme looking at the quality of surgical prophylaxis related to 
SSI, was started in the Netherlands. Part of this project was to study the adherence to 
local hospital guidelines for prophylaxis and to explore reasons for non-adherence. 
The results are presented in this paper.
Methods
Frequently performed surgical techniques, for which the efficacy of antibiotic 
prophylaxis has been researched extensively in well-conducted trials, were selected 
for this prospective multicentre study. To observe normal daily routine, only 
elective procedures were included. Four major surgical disciplines were audited, 
and techniques with a differing intrinsic risk for SSI were selected. In orthopaedic 
surgery and vascular surgery, procedures classified as “clean” 19 included total hip 
implant, femoral hemiprosthesis, grafting of the aorta and femoropopliteal and 
femorotibial bypass. In gynaecological and intestinal surgery, approaches classified 
as “clean-contaminated” 19 included abdominal and vaginal hysterectomy with or 
without vaginal repair and various colorectal procedures. To avoid difficulties in 
discriminating prolonged prophylaxis from post-operative therapy, procedures with 
suspected or established infection during surgery were excluded. The study was 
conducted in 13 hospitals participating in a national survey of SSI, the PREZIES-
project.20 The hospitals represented inpatient care in the Netherlands, since 
university, non-university teaching and non-teaching hospitals were included. 
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Between January 2000 and January 2001, the adherence to local guidelines for 
antimicrobial surgical prophylaxis in these hospitals was reviewed. The study 
period per hospital varied between 6-10 months depending on the incidence of 
the selected procedures in the hospitals. The following aspects of antimicrobial 
prophylaxis were audited: antibiotic choice, duration, dose, interval between doses, 
timing of first dose, and antibiotic choice in case of allergy. Wound-class,19 physical 
condition of the patient according to the classification of the American Society of 
Anesthesiologists (ASA-score),21 time of induction of anaesthesia, the time of the 
first incision, and the duration of the procedure, were recorded. Data were collected 
by infection control practitioners from medical, anaesthetic and nursing records, and 
medication charts. Before the start of the project, as well as during the study, data 
collection was validated at regular intervals (M.E.E. van Kasteren, A.S. de Boer, M. 
Ridderhof – van ‘t Veer, J. Mannien, J. Wille, B.J. Kullberg & I.C.Gyssens, unpublished 
data). Each hospital was requested to provide their most recent version of local 
guidelines for prescription of surgical prophylaxis. Only guidelines composed by 
the committees for antibiotic policy of the participating hospitals, printed in an 
official hospital guide for antibiotic prescription, were considered. The prophylaxis 
actually given was assessed according to these guidelines by the same investigator 
for all procedures. A modificied standardized qualitative method for evaluation was 
used.22 The criteria for evaluation of adherence are summarized in table 1. 
Courses of antimicrobial drugs were evaluated. If more than one drug was 
prescribed for a single procedure, all parameters were evaluated separately for 
each drug. Subsequently, a final assessment of the antibiotic course was composed 
by combining these separate drug evaluations. Any divergence from the guideline 
in the prescription of one of the drugs led to a final assessment of the prophylactic 
course as discordant with the guideline. If no antibiotic prescriptions had been 
recorded, it was assumed that antibiotics were not given. If data on a certain 
parameter of the antibiotic prescription were lacking, this was classified as missing 
data on this parameter only. If an antibiotic was given while it was not indicated, 
the parameters of antibiotic choice, duration, dose, dosing interval and timing were 
not evaluated. 
The infection control practitioners collected data prospectively using standardized 
forms. These data were entered in a database, double-checked by the investigator 
and infection control practitioner of the project, and analysed using SPSS 10.0.
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Table 1. Criteria for assessment of adherence to local guidelines 
Parameter Discordant if
Antibiotic choice Agent differed from recommendation 
Duration Duration differed from recommendation
Dose (all agents except gentamicin) Dose differed from recommendation
Dose of gentamicin Dose deviated >20 mg from recommended dose
Dosing interval during surgery Dosing interval exceeded the guideline by >30 min
Dosing interval on the ward Dosing interval deviated from the guideline by >60 min
Timing of first dose at fixed time before incision Timing of fist dose deviated >15 min from the 
recommended time
Timing of first dose within fixed time-range Timing of first dose was outside the recommended time-
range
Timing of first dose before incision Timing of first dose was at or after the incision
Results
Between January 2000 and January 2001, 1763 surgical procedures were recorded 
in 13 Dutch hospitals. Table 2 shows the demographic data of the patients and 
the distribution of the procedures according to surgical specialty and wound class. 
Not every hospital performed all types of procedures. Almost two-thirds of the 
procedures were clean, and the majority were orthopaedic. The main features of the 
guidelines obtained from the participating hospitals are summarised in Table 3.
Overall assessment of all parameters
In 1598 out of 1763 procedures (91%), data on all parameters of prophylaxis were 
available and a complete evaluation of the prophylaxis could be performed. In 439 
procedures (28 %), there was full adherence to local guidelines for all parameters. 
Without including the dosing interval for antibiotics given in the ward or in the 
operating theatre, prophylaxis was completely concordant with the guidelines in 
543 cases (34 %). Parameters were also evaluated separately, so that missing data 
of one parameter did not preclude assessment of the other.
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Table 2. Demographic data
Characteristics Number (%)
Number of patients 1763
Sex male / female 524 / 1239
Age (years) median 
 range
67
19-93
ASA-score
 1
 2
 3 
 4
 5
 Unknown
 561 (32)
 860 (49)
 274 (16)
 26 (2)
 1
 41 (2)
Procedure
  Orthopaedic
  wound class clean a
 Gynaecological
  wound class clean-contaminated a
 Vascular
  wound class clean a
  wound class clean-contaminated a
 Intestinal
  wound class clean-contaminated a
   wound class contaminated a
 
 
 942 (53)
 
 398 (23)
 
 171 (10)
 1 (<1)
 
 244 (14)
 7 (<1)
a wound-classification according to Altemaier et al.19
Indication
Procedures for which antibiotics are generally indicated were selected, although, one 
hospital’s local guidelines recommended no prophylaxis for abdominal hysterectomy 
(unless performed for carcinoma). According to the hospital guidelines, antibiotics 
were indicated in 1737 procedures. In 33 procedures (2 %), no prophylaxis was 
given and in 17 procedures (1 %), one out of two drugs was omitted. 
Antibiotics were administered in 1712 procedures. In eight of these procedures, no 
antibiotics were recommended. These were all abdominal hysterectomies performed 
in the one hospital that did not recommend prophylaxis. In 11 cases, two types of 
antibiotics were administered whereas only one was indicated. In one case, three 
types of antibiotic were administered whereas only two were indicated. So in the 1704 
procedures, at least one antibiotic was indicated and, when available, data on antibiotic 
choice, duration, dose, dosing interval and timing were evaluated (Table 4). 
Chapter 2
58
Ta
bl
e 
3.
 L
oc
al
 h
os
pi
ta
l g
ui
de
lin
es
 f
or
 s
ur
gi
ca
l p
ro
ph
yl
ax
is
 in
 t
he
 p
ar
tic
ip
at
in
g 
ho
sp
ita
ls
.
Su
rg
ic
al
 
sp
ec
ia
lty
H
os
pi
ta
l 
An
tib
io
tic
 c
ho
ic
e 
an
d 
do
se
 
Du
ra
tio
n 
Re
pe
at
ed
 d
os
e 
in
 t
he
 t
he
at
re
 b
 
Do
si
ng
 In
te
rv
al
 
in
 t
he
 w
ar
d 
f
Ti
m
in
g 
of
 f
irs
t 
do
se
 (
m
in
) 
g 
¤
La
te
st
 r
ev
is
ed
 
ve
rs
io
n 
(y
ea
r)
 h
Re
co
m
m
en
de
d 
dr
ug
  
in
 c
as
e 
of
 a
lle
rg
y
Gy
na
ec
ol
og
ic
al
 
su
rg
er
y
A
Am
ox
ic
ill
in
 2
00
0 
m
g 
+ 
m
et
ro
ni
da
zo
le
 5
00
 m
g
si
ng
le
 a
-
-
30
 m
in
 P
I
20
00
ge
nt
a 
+ 
m
et
ro
 i
B
Ce
fu
ro
xi
m
e 
75
0 
m
g 
+ 
m
et
ro
ni
da
zo
le
 5
00
 m
g
si
ng
le
 a
>4
h 
c
-
PI
20
00
-
C
Am
ox
ic
ill
in
 -
cl
av
ul
an
ic
 
ac
id
 2
20
0 
m
g
si
ng
le
 a
>6
h
-
w
ith
in
 6
0 
m
in
 P
I
19
99
-
F
Am
ox
ic
ill
in
 -
cl
av
ul
an
ic
 
ac
id
 1
20
0 
m
g
si
ng
le
 a
-
-
PI
20
00
-
J
Ce
fu
ro
xi
m
e 
15
00
 m
g 
+ 
m
et
ro
ni
da
zo
le
 5
00
 m
g 
d
si
ng
le
 a
>3
h 
c  
-
30
 m
in
 P
I
19
98
-
O
rt
ho
pa
ed
ic
 
su
rg
er
y
B
Ce
fu
ro
xi
m
e 
75
0 
m
g
si
ng
le
 a
>4
h
-
PI
20
00
-
C
Ce
fu
ro
xi
m
e 
15
00
 m
g
si
ng
le
 a
>6
h
-
w
ith
in
 6
0 
m
in
 P
I
19
99
-
D
Ce
fu
ro
xi
m
e 
15
00
 m
g 
 
(7
50
 m
g 
e )
 
24
 h
>4
h
8h
w
ith
in
 3
0-
15
 
m
in
 P
I
19
98
-
E
Ce
fa
m
an
do
l 1
00
0 
m
g
si
ng
le
 a
>3
h
-
w
ith
in
 3
0 
m
in
 P
I
19
97
cl
in
da
m
yc
in
F
Ce
fa
zo
lin
 1
00
0 
m
g
24
 h
-
6h
PI
20
00
-
G
Ce
fu
ro
xi
m
e 
15
00
 m
g 
 
(7
50
 m
g 
e )
24
 h
>4
h
8h
w
ith
in
 3
0-
15
 
m
in
 P
I
19
98
-
H
Ce
fa
zo
lin
 1
00
0 
m
g
24
 h
-
8h
w
ith
in
 3
0 
m
in
 P
I
19
98
-
I
Fl
uc
lo
xa
ci
lli
n 
20
00
 m
g 
(1
00
0 
m
g 
e )
24
 h
-
6h
PI
19
97
-
J
Ce
fu
ro
xi
m
e 
15
00
 m
g
si
ng
le
 a
>3
h
-
30
 m
in
 P
I
19
98
-
K
Ce
fu
ro
xi
m
e 
15
00
 m
g 
(7
50
 m
g 
e )
24
 h
>4
h
8h
w
ith
in
 3
0-
15
 
m
in
 P
I
19
98
-
L
Ce
fu
ro
xi
m
e 
15
00
 m
g
si
ng
le
 a
>3
h
-
w
ith
in
 3
0 
m
in
 P
I
19
98
cl
in
da
 +
 g
en
ta
 i
 Adherence to local hospital guidelines for surgical antimicrobial prophylaxis
59
Su
rg
ic
al
 
sp
ec
ia
lty
H
os
pi
ta
l
An
tib
io
tic
 c
ho
ic
e 
an
d 
do
se
 
Du
ra
tio
n
Re
pe
at
ed
 d
os
e 
in
 t
he
 t
he
at
re
 b
 
Do
si
ng
 In
te
rv
al
 
in
 t
he
 w
ar
d 
f
Ti
m
in
g 
of
 f
irs
t 
do
se
 (
m
in
) 
g 
¤
La
te
st
 r
ev
is
ed
 
ve
rs
io
n 
(y
ea
r)
 h
Re
co
m
m
en
de
d 
dr
ug
  
in
 c
as
e 
of
 a
lle
rg
y
In
te
st
in
al
 
Su
rg
er
y
B
Ce
fu
ro
xi
m
e 
75
0 
m
g 
+ 
m
et
ro
ni
da
zo
le
 5
00
 m
g
si
ng
le
 a
>4
h 
c
-
PI
20
00
-
E
Ce
fa
m
an
do
l 1
00
0 
m
g 
+ 
m
et
ro
ni
da
zo
le
 5
00
 m
g
si
ng
le
 a
>3
h 
c
-
w
ith
in
 3
0 
m
in
 P
I
19
97
cl
in
da
 +
 g
en
ta
 i
H
Am
ox
ic
ill
in
-c
la
vu
la
ni
c 
ac
id
 2
20
0 
m
g 
 
(1
20
0 
m
g 
e )
24
 h
-
8h
w
ith
in
 3
0 
m
in
 P
I
19
98
- 
  
0
J
To
br
am
yc
in
 4
 m
g/
kg
 
+ 
m
et
ro
ni
da
zo
le
 5
00
 m
g
si
ng
le
 a
-
-
30
 m
in
 P
I
19
99
-
L
Ce
fu
ro
xi
m
e 
15
00
 m
g 
+ 
m
et
ro
ni
da
zo
le
 5
00
 m
g
si
ng
le
 a
>3
h 
c
-
w
ith
in
 3
0 
m
in
 P
I
19
98
-
M
Ce
fu
ro
xi
m
e 
15
00
 m
g 
+ 
m
et
ro
ni
da
zo
le
 5
00
 m
g 
si
ng
le
 a
>4
h 
c
w
ith
in
 3
0 
m
in
 P
I
19
94
ge
nt
a 
+ 
m
et
ro
 i
Va
sc
ul
ar
 S
ur
ge
ry
B
Ce
fu
ro
xi
m
e 
75
0 
m
g
si
ng
le
 a
>4
h
-
PI
20
00
-
E
Ce
fa
m
an
do
le
 1
00
0 
m
g
si
ng
le
 a
>3
h
-
w
ith
in
 3
0 
m
in
 P
I
19
97
cl
in
da
m
yc
in
L
Ce
fu
ro
xi
m
e 
15
00
 m
g
si
ng
le
 a
>3
h
-
w
ith
in
 3
0 
m
in
 P
I
19
98
er
yt
hr
o 
+ 
ge
nt
a 
i
M
Ce
fu
ro
xi
m
e 
15
00
 m
g
si
ng
le
 a
>4
h
-
w
ith
in
 3
0 
m
in
 P
I
19
94
-
a 
si
ng
le
 d
os
e 
pr
op
hy
la
xi
s,
 t
o 
be
 r
ep
ea
te
d 
du
rin
g 
su
rg
er
y 
in
 c
as
e 
th
e 
pr
oc
ed
ur
e 
is
 p
ro
lo
ng
ed
 o
r 
w
he
n 
bl
oo
d 
lo
ss
 e
xc
ee
ds
 2
 L
. 
b  
du
ra
tio
n 
of
 t
he
 p
ro
ce
du
re
 a
ft
er
 w
hi
ch
 a
 r
ep
ea
te
d 
do
se
 
is
 r
ec
om
m
en
de
d 
in
 t
he
 t
he
at
re
; 
c  
fo
r 
ce
ph
al
os
po
rin
 o
nl
y;
 d
 n
o 
pr
op
hy
la
xi
s 
re
co
m
m
en
de
d 
fo
r 
ab
do
m
in
al
 h
ys
te
re
ct
om
y;
 e
 d
os
e 
of
 r
ep
ea
te
d 
an
tib
io
tic
 p
re
sc
rip
tio
n 
in
 t
he
 w
ar
d;
 f  
do
si
ng
 
in
te
rv
al
 o
f r
ep
ea
te
d 
pr
es
cr
ip
tio
n 
in
 t
he
 w
ar
d;
 g
 t
im
in
g 
of
 t
he
 fi
rs
t 
do
se
 e
xp
re
ss
ed
 in
 n
um
be
r 
of
 m
in
ut
es
 p
rio
r 
to
 t
he
 fi
rs
t 
in
ci
si
on
 (
PI
) 
; h
 Y
ea
r 
of
 p
ub
lic
at
io
n 
of
 t
he
 h
os
pi
ta
l g
ui
de
 in
cl
ud
in
g 
th
e 
m
os
t 
re
ce
nt
 v
er
si
on
 o
f 
th
e 
lo
ca
l g
ui
de
lin
es
; i
 g
en
ta
, 
ge
nt
am
ic
in
; 
cl
in
da
, 
cl
in
da
m
yc
in
; 
m
et
ro
, 
m
et
ro
ni
da
zo
le
; 
er
yt
hr
o,
 e
ry
th
ro
m
yi
n.
Chapter 2
60
Table 4. Non-adherence to local guidelines for prophylaxis according to the assessment defined in table 1.
Parameter
Nonadherence
Number of procedures (%)
N %
Antibiotic choice 129 (8)
Duration
  too short
 too long
299
42
257
(18)
(3)
(15)
Dose
 too high
 too low
 combined error a
175
123
15
37
(11)
(8)
(1)
(2)
Interval 457 (57)
Timing
 too early
 too late
 combined error b
810
358 
448
4
(50)
(22)
(28)
(<1)
a combined error indicates: dose of one of the drugs too high and of the other too low
b combined error indicates: timing of one of the drugs too early and of the other too late
Antibiotic choice
In 1560 of 1689 evaluable procedures (92 %), antibiotic choice was concordant 
with the hospital guideline and discordant in 129 (8 %) (Table 4). More than 80 % 
of the discordant cases were reported in two hospitals (hospital F and H). In these 
hospitals, the antibiotic choice was discordant in more than 30 % of the procedures 
because the surgeons used a protocol that differed from the guideline issued by 
the hospital committee for antibiotic policy. The adherence of the surgeons to their 
own protocol was 100 %. The remaining errors were incidental and almost equally 
distributed over the hospitals. In many instances where an allergy to β-lactams was 
suspected, antibiotic choice was incorrect. In 15 cases, the antibiotic choice could 
not be evaluated because the hospital guideline did not provide an alternative for 
allergy to the primary drug of choice.
Duration
In 1389 of 1688 evaluable procedures (82 %), duration was concordant with the 
hospital guideline. In 257 procedures (15 %), duration was longer than recommended 
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and shorter in 42 (3 %) (Table 4), including eight procedures in which a second dose 
was not administered during prolonged surgery. In three hospitals (C, H and L), more 
than 25 % of the prescriptions were continued longer than recommended (range 25-
50 %). In hospital C, the prolonged use was fully attributable to orthopaedic surgeons, 
who followed their own protocol rather than the hospital guideline. Adherence to this 
protocol was almost 100 %. In hospital H, deviation from the hospital guideline was 
unintentional, and the result of inaccurate “stop” orders for antibiotics in the ward. 
In hospital L, local hospital guidelines were violated because some surgeons felt 
insecure about the length of prophylaxis recommended by these guidelines.
In 16 cases (1%) duration could not be evaluated because medication charts were 
incomplete.
Dose 
In 1461 of 1636 evaluable procedures (89 %), the dose was concordant with the 
local hospital guidelines. In 15 procedures (1 %) the dose was lower, and in 123 
procedures (8 %) the dose was higher than recommended (Table 4). Higher doses 
were mainly recorded in one hospital (F), in all participating specialties. In 37 
procedures (2 %), performed in hospital J, the dose of one of the agents was 
too high and of the other too low. Reasons for incorrect dosing were: application 
of outdated guidelines instead of the most recent version in hospital F and J, 
and deliberate use by orthopaedic surgeons in hospital F of higher doses than 
recommended in the hospital guidelines. In 68 of 1704 procedures (4 %), data on 
dosing were missing or the hospital recommendation was incomplete. In almost 
half of the hospitals that provided guidelines of what to administer in case of 
allergy to the primary drug of choice, dosing recommendations for these alternative 
drugs were lacking. 
Dosing interval 
In 835 of 1704 procedures (49 %), more than one dose was administered. Of 
these, the dosing interval of antibiotics repeated during surgery or on the ward, 
could be calculated in 802 procedures. In 345 procedures (43 %) dosing intervals 
were concordant with the guidelines and discordant in 457 (57 %) (Table 4). In 
seven hospitals, more than 50 % of the dosing intervals were discordant with the 
guideline, and in four hospitals (G, H, I, L) almost all intervals were incorrect. Most 
errors were because of administration of antibiotics by nurses on the ward at fixed 
clock rounds, instead of adjusting this to the time of the previous dose. 
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In 55 of the evaluable cases, antibiotic doses were repeated during surgery. In six 
cases (11 %) the interval exceeded the recommended interval. 
Timing
In 809 of 1619 evaluable procedures (50 %), timing was concordant with the hospital 
guideline. Timing was earlier than recommended in 358 (22 %) procedures and later 
in 448 (28 %) (Table 4). In four procedures, timing of one of the drugs was too early 
and of the other too late. 
In three hospitals (B F, and I), an assessment of “timing too early” could not be made, 
since specific recommendations for the timing of the first dose other than “before 
the incision”, were not given (Table 3). In three hospitals (G, H, and K), prophylaxis 
was administered earlier than recommended in more than 80 % of the cases. In 
eight hospitals, prophylaxis was administered later than recommended in more than 
25 % of the procedures. There was a striking difference in timing per specialty. In 
general, timing in orthopaedic procedures was earlier than recommended. However, 
in intestinal surgery and gynaecological surgery, timing of the first dose was later 
than recommended in more than 50 % of the cases. This pattern was observed in 
almost all hospitals. Errors in timing were mainly due to logistics in the surgical 
suite and not because of deliberate deviation from the guidelines. The time of 
arrival at the operating complex and the type of anaesthesia, epidural or general 
anaesthesia, was an important determinant for timing of the first dose. In one 
hospital (H), timing was too early for almost all procedures because the first dose 
of prophylaxis was given in the ward instead of in the operating theatre. In 85 of 
1704 procedures (5 %), data on timing were missing because the moment of the 
first incision, or the moment of the administration of the first antimicrobial dose, 
could not be retrieved from the records.
Discussion 
The present study demonstrates that, although in the Netherlands adherence to 
separate aspects of prophylaxis was favourable, adherence to all aspects of a 
guideline for surgical prophylaxis was difficult. It is noteworthy that the criteria 
for assessment of adherence were strict and that the guidelines recommended a 
prudent use of antibiotics. Taking into account the adherence in some hospitals 
to non-official hospital guidelines drawn up by surgeons, it can be concluded that 
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the willingness to adhere to guidelines in general is good. Hardly any variation in 
antibiotic choice, dose and duration were observed that were based on individual 
decisions of surgeons. In only one hospital (L), did surgeons decide individually to 
extend the duration of prophylaxis. A study by Motola et al. showed that in Italy the 
willingness to adhere to guidelines is disappointing.14
In contrast to the present study, most studies in other countries have assessed 
the quality of prophylaxis according to an international or a national standard. 
Only a few have studied the adherence to local guidelines.23-25 One report from a 
tertiary teaching hospital in Brazil,23 showed that in only 3 % of the procedures 
prophylaxis was given according to hospital guidelines in terms of antibiotic choice, 
duration, dose and timing. In the present study, concordance with local guidelines 
on antibiotic choice, duration, dose and timing was 34 %. In the study of Finkelstein 
et al.,25 performed in Israel, adherence to duration and timing was comparable to 
the present study. In the study by Vaisbrud et al,24 also performed in Israel, the 
adherence was slightly better, especially for timing of the first dose. 
Guideline adherence can be hindered by various barriers.26,27 In exploring these 
barriers in the present report, the process of guideline development and distribution 
was studied. With a few exceptions, guidelines were revised regularly (Table 3), but 
revised versions did not always reach the people that had to use them. In some 
hospitals, several revised versions of a guideline were distributed within a short 
time, leading to confusion about which one to apply. Sometimes, a revised version 
of the hospital guideline was printed in the antimicrobial hospital guide without 
changing local protocols in the ward or without updating reminders in the operating 
theatre. This lack of awareness of the appropriate guideline was the main barrier to 
guideline adherence regarding antimicrobial choice and dose. Acquaintance may be 
improved by electronic distribution of the guidelines and by pre-printing sections 
of the guideline on prescription charts.
Some hospital committees continued to produce guidelines with which they 
knew surgeons disagreed. In two hospitals, lack of agreement of the orthopaedic 
surgeons with the recommended duration of prophylaxis was the most important 
barrier to adherence to the local hospital guideline. Testing the feasibility and 
acceptance of clinical guidelines among the target group is important for effective 
implementation.18,28,29 It is just as important to ensure that recommendations 
in the guideline agree with the current evidence base and that links between 
recommendations and scientific evidence are made explicit.30 Therefore, more effort 
should be put into providing surgeons with evidence of the content of the guideline 
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and in trying to achieve consensus, before implementing new guidelines. Finally, 
antibiotic policy makers are often unaware of logistic problems in the surgical suite 
or in the ward. Logistical constraints were the most important barriers to adherence 
to guidelines for timing and dosing intervals. The difference in time of arrival at 
the operating complex could have been responsible for most variations in timing 
of the first antibiotic dose between orthopaedic surgery versus gynaecological and 
intestinal surgery. Studying these logistic constraints in more detail can help to 
create conditions that facilitate guideline adoption. 
Our study has several limitations. First, the hospitals participating in this study, 
comprised only 10% of the hospitals of the Netherlands. However, the selection 
seems to represent daily practice since the number of procedures recorded was 
large, different specialties were represented in different types of hospitals, and the 
geographic distribution of the hospitals was wide. Nevertheless, since participation 
was voluntarily, it is possible that we have included a favourable selection of 
hospitals, and that adherence to local guidelines in other Dutch hospitals may be 
poorer in comparison. Second, adherence to guidelines does not automatically 
imply that the quality of surgical prophylaxis is optimal and inappropriate guidelines 
may explain some of the deviation in practice from guidance. To evaluate this, a 
critical appraisal of the content of the guidelines is needed. However, focussing 
only on the content of guidelines, without paying attention to their adoption, is a 
main reason for the failure of guidelines as an instrument for quality improvement, 
and therefore both processes are needed.18 For most hospitals in this study, several 
problems of adherence to guidelines in this study were similar, and therefore this 
study might provide general information for those involved in quality improvement 
of surgical prophylaxis. Other problems seemed specific for the local situation. 
For this reason and for constant reinforcement of guidelines, repetitive audits of 
surgical prophylaxis are recommended. Since these studies are time-consuming, 
adequate financial resources are required.
In conclusion, this study shows that in the Netherlands, the willingness to adhere to 
guidelines for surgical prophylaxis is good. To achieve optimal adherence, antibiotic 
policy makers should develop evidence-based guidelines in unison with surgeons, 
need to guarantee an effective distribution of the guidelines, and facilitate situations 
to make them more applicable.
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Abstract
Objectives: Misuse of antibiotics in surgical prophylaxis is still quite common. The 
objectives of this study were to reduce the quantity and improve the quality of 
surgical prophylaxis and to reduce costs.
Methods: Prospective multi-site study of elective procedures in 13 Dutch hospitals. 
The quality of prophylaxis was audited before and after an intervention consisting 
of performance feedback and implementation of national clinical practice guidelines. 
Process outcome parameters were antibiotic choice, duration, timing, antibiotic 
volume and costs. Segmented regression analysis was used to estimate the effect 
size of the intervention. Patient outcome was documented by the incidence of 
surgical site infections (SSI). 
Results. Before the intervention, 1763 procedures were recorded and 2050 
thereafter. Antimicrobial use decreased from 121 to 79 DDD (defined daily doses) 
/100 procedures and costs reduced by 25 % per procedure. After the intervention, 
antibiotic choice was inappropriate in only 37.5% of the cases instead of in 93.5% 
expected cases had the intervention not occurred. Prolonged prophylaxis was 
observed in 31.4 % instead of 46.8 % expected cases and inappropriate timing 
in 39.4 % instead of the expected 51.8%. Time series analysis showed that all 
improvements were statistically significant (P<0.01) and that they could be fully 
attributed to the intervention. The overall SSI rates before and after intervention 
were 5.4% (95% CI: 4.3-6.5) and 4.6% (95% CI: 3.6-5.4) respectively.
Conclusion: The intervention led to improved quality of surgical prophylaxis and to 
reduced antibiotic use and costs without impairment of patient outcome.
Introduction
Surgical site infections (SSI) are the most common nosocomial infections in surgical 
patients and lead to prolonged hospital stay,1 readmissions to the hospital, and 
increased morbidity and mortality. For many procedures, perioperative antimicrobial 
prophylaxis has proven to be effective in reducing the incidence of SSI.2 However, 
inappropriate use of surgical antimicrobial prophylaxis, in terms of prolonged duration 
and use of broad-spectrum antibiotics, can select for resistant microorganisms and 
leads to high costs.3 Moreover, incorrect timing of prophylaxis reduces its efficacy.4 
Therefore, the quality of prophylaxis has been the subject of many audits 5-9 and 
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intervention studies 10-17 and national guidelines have been developed to support its 
correct use.18-21
In the Surgical Prophylaxis and Surveillance project (CHIPS) we studied the adherence 
to local hospital guidelines for surgical prophylaxis in Dutch hospitals 22 and 
implemented a national guideline issued by the Dutch Working Party on Antibiotic 
Policy (SWAB).19 The effect of the intervention on process outcome parameters 
(administration of prophylactic antibiotics) and patient outcome (incidence of 
surgical site infections) was studied and is presented in this article.
Materials and methods 
Setting
This prospective multi-site intervention study, with a before and after design, 
was performed in 13 different hospitals throughout the Netherlands that were 
participating in the national surveillance network of nosocomial infections, PREZIES.1 
Elective procedures for which antibiotic prophylaxis is generally accepted in the 
literature 18,23 were studied. These procedures were distributed among four surgical 
disciplines: orthopaedic surgery, vascular surgery, gynaecological surgery and 
intestinal surgery. The following procedures were included: total hip arthroplasty, 
hemiarthroplasty, grafting of the aorta, femoropopliteal and femorotibial bypass, 
abdominal and vaginal hysterectomy with or without vaginal repair and various 
colorectal procedures. 
Although this was a before and after intervention study of which the main objective 
was to improve process outcome, i.e. the quality of prophylaxis, the study was also 
powered to observe an improvement in patient outcome, i.e. a decrease in the overall 
SSI rate. The required sample size was calculated using the following assumptions: 
overall risk of SSI before the intervention of 7.5% and an estimated achievable 
decrease in SSI rate to 5% after intervention. The figure of 7.5 % was based upon 
PREZIES data for the selected procedures in previous years and assumed an equal 
distribution of the selected procedures (orthopaedic, gynaecological, vascular and 
bowel surgery) in the CHIPS study. With a significance level of 5% and a power of 
80%, 1600 surgical procedures before and 1600 after intervention would suffice to 
demonstrate a decrease in SSI incidence to 5.1% or less, or increase to at least 
10.3%.
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Data collection
During the pre-intervention and post-intervention periods, all consecutive procedures 
meeting the inclusion criteria were recorded by the local infection control practitioner 
(ICP) of each hospital. Data were extracted from medical, anaesthetic and nursing 
records and medication charts. Hospitals participating in the study contributed 
data for all types of procedures studied or for only a selection of procedures. ICPs 
collected the following patient and procedure characteristics: gender, date of birth, 
dates of admission, surgery and discharge, ASA score,24 wound contamination class 
25 and data on allergy for antibiotics. For patients receiving antibiotics, the choice of 
the antibiotic, unit doses, number of post-operative doses, time of administration 
of first dose and subsequent doses, time of anaesthesia and time of first incision 
were recorded. The duration of prophylaxis was derived from the number of post-
operative doses and the timing of subsequent doses. The ICP performed surveillance 
of SSI, including post-discharge surveillance, according to the PREZIES-protocol 
using the criteria of the Centers for Disease Control and Prevention.1,23 Superficial 
SSI was defined as an infection which occurs within 30 days after the operative 
procedure and which involves only the skin or subcutaneous tissue. Deep SSI was 
defined as an infection that appears to be related to the operative procedure and 
occurs within 30 days of surgery, or within one year in case of implant (non-human 
vascular graft or prosthesis) surgery, and involves deep soft tissues, organ or spaces 
which have been opened or manipulated during surgery. The duration of the pre- 
and post- intervention period of data collection depended on the incidence of the 
procedures in each hospital and therefore varied between hospitals. To obtain a 
balanced distribution of the selected procedures, i.e. a similar case-mix between the 
hospitals, it was aimed to record within each hospital a minimum of 20 procedures 
per surgical specialty in the period before and after the intervention. However, the 
CHIPS study was dependent on the PREZIES network protocol, according to which 
hospitals were free to select the procedures for surveillance.
Data assessment
Antimicrobial use was analyzed quantitatively by calculating the defined daily doses 
(DDD) per 100 procedures. DDDs were obtained from the ATC/DDD Index 2003 of 
the WHO Collaborating Centre for Drugs Statistics Methodology.26 Total costs of 
antibiotics were calculated by adding purchase costs to indirect costs of personnel 
and supplies for administration of the antibiotics. The lowest price for generic drugs 
from the Royal Dutch Pharmaceutical Society price list (G-standard, Z-index, July 
Chapter 3
74
2003) was used for calculation. Wholesale discounts for individual hospitals were 
not taken into account.
The first author (MvK) performed an audit to measure the adherence to the SWAB-
guideline for surgical prophylaxis 19 according to a standardized method.27 Review 
criteria derived from the key recommendations in the guideline are presented in 
Table 1. 
Table 1. Criteria for evaluation of prophylaxis according to the SWAB guidelinea for antimicrobial 
prophylaxis.
Parameter of prophylaxis Criteria for evaluation
Antibiotic choice
efficacy
toxicity
antibiotic spectrum
costs
therapeutic use
Inappropriate if agent is less effective than agent recommended in 
SWAB guideline b
Inappropriate if agent is more toxic than agent recommended in SWAB 
guideline c
Inappropriate if agent has a broader spectrum than agent recommended 
in SWAB guideline 
Inappropriate if agent is more expensive than agent recommended in 
SWAB guideline d
Inappropriate if agent is more frequently used in therapeutic setting 
than agent recommended in SWAB-guideline
Duration of prophylaxis Inappropriate if prophylaxis is prolonged after the end of surgery 
(=postoperative dosing)
Timing of prophylaxis Inappropriate if prophylaxis is administered more than 30 minutes 
before the first incision or after the first incision
a The SWAB-guideline 19 recommends single dose prophylaxis with a first-generation cephalosporin, 
preferably cefazolin (with metronidazole in case of need for anaerobic coverage), administered within 
30 minutes before the first incision or tourniquet. During surgery, prophylaxis has to be repeated 
when the procedure exceeds three times the half-life of the administered drug or when blood loss is 
extensive (>2L). 
b  An agent was classified as less effective if the antibiotic did not cover the spectrum of the most frequent 
causative microorganisms causing SSI after that particular procedure. 
c  An agent was classified as more toxic when more allergic reactions were reported in the literature than 
with the use of the agent in the SWAB-guideline (i.e. penicillins, vancomycin) or when more nephrotoxicity 
was reported with that drug.(i.e. aminoglycosides). 
d  An agent was classified as more expensive based upon costs of one pre-operative dose using the lowest 
price for generic drugs from the Royal Dutch Pharmaceutical Society price list (G-standard, Z-index, July 
2003), including costs of administration by bolus injection or infusion.
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The SWAB guideline recommends intravenous single dose prophylaxis of an inexpensive 
non-toxic antibiotic with a limited spectrum, which is not used extensively in therapy, 
administered within 30 minutes before the first incision. Cefazolin (combined with 
metronidazole if activity against anaerobic microorganisms is needed) is the drug 
of first choice, since it meets many of the above characteristics. Repeated dosing is 
recommended when blood loss during the procedure exceeds 2 L or when surgery is 
prolonged beyond three times the half-life of the administered antibiotic.
Courses of antimicrobial drugs were audited for antibiotic choice, dosage, duration 
and timing of prophylaxis. If more than one drug was prescribed for a single 
procedure all parameters were evaluated separately for each drug. Subsequently, 
assessment of the complete antibiotic course was composed by combining these 
separate drug evaluations. Divergences from the SWAB guideline in the prescription 
of one of the drugs lead to a final assessment of the prophylactic course as 
discordant with the SWAB guideline. If no antibiotic prescriptions were recorded, 
it was assumed that antibiotics had not been administered. If data on a certain 
parameter of the antibiotic prescription were lacking, these were classified as 
missing data on this parameter only. 
Intervention
After the pre-intervention period, every hospital received feedback of its own data 
on antibiotic prophylaxis. The hospitals’ auditing report and the SWAB-guideline 
were discussed with surgeons, anaesthetists, pharmacists, microbiologists, nurses 
and the local antibiotic policy committee. The CHIPS study group formulated 
recommendations for local improvement in each hospital and discussed them with 
the participants. In addition, educational meetings were organized for medical 
specialists and nurses. Depending on the results of the audit, the intervention 
focused on modification of the local guidelines, guideline adherence or both. The 
day of the first feedback was considered as the start of the intervention period 
in each hospital. The intervention period varied between 2-9 months (median 6 
months) depending on the number of activities and the time needed to achieve 
approval on updated guidelines.
The post-intervention data collection started immediately after all the intervention 
activities had ended and, if necessary, after a new antibiotic policy was implemented. 
An assessment identical with the pre-intervention period was performed for the 
prophylaxis and the data on surgical site infections. Finally, the effect of the 
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intervention on all aspects of the use of antibiotic prophylaxis and the occurrence 
of SSI was evaluated. 
Statistical analysis
The graphs of the different outcome parameters over calendar time were visually 
inspected. The length of data collection for the different hospitals ranged between 
6 and 13 months although all hospitals had data for at least 6 months before and 
6 months after the intervention. For clarity, only data for the means of these 12 
months are shown. The figures were not corrected for procedure mix. 
In order to assess the effect of the intervention, we estimated the expected number 
of inappropriate cases if no intervention had taken place taking into account 
changes in mixes and differences in follow-up period of the different hospitals. To 
estimate these expected numbers, time series segmented regression analysis was 
used which includes changes in level and trend, as recommended by The Cochrane 
Effective Practice and Organisation of Care Group (EPOC).28 In this study, data 
were collected on an individual patient level. As the interventions were targeted 
at hospitals with different mixes of surgical specialties, a hierarchical structure had 
to be taken into account in the analyses. Most response variables were binary (i.e. 
appropriate versus inappropriate prophylaxis). For these variables, a non-linear 
mixed model, SAS PROC NLMIXED (release 8.2; SAS Institute Inc. Cary, NC, USA) was 
used. For the continuous response variables duration and antibiotic use, SAS PROC 
MIXED was used. In the models, the hospital was treated as a random variable 
while surgical specialty and calendar time of the pre-intervention, intervention 
and post-intervention period were treated as co-variables. In this way, the model 
corrected for unequal distribution of procedures in the pre- and post-intervention 
period, for unequal distribution within surgical specialties and hospitals as well as 
for differences in length of registration and intervention periods. The model did not 
correct for seasonal trends.
A conservative model was chosen to ensure that the effect of the intervention was 
not overestimated. In this model, a trend in the pre-intervention period towards an 
increase in inappropriate prophylaxis was ignored while a trend towards a decrease 
in inappropriate prophylaxis was included in the analyses. For each parameter, 
the following outcome measurements were generated: mean level in the pre- and 
post-intervention period, change in level immediately after the intervention and the 
pre- and post-intervention slope. In the results section, only the P values of these 
outcome measurements are shown since the quantitative outcome values do not 
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represent the absolute change in outcome on a numeric scale. The observed and 
expected numbers of inappropriate prophylaxis were tested using the cumulative 
binomial distribution with the zero-hypothesis of no impact of the intervention. In 
this test, the hierarchical structure was not taken into account.
Results
Data were collected between January 2000 and January 2001 (pre-intervention 
period) and between July 2001 and October 2002 (post-intervention period). Before 
the intervention, 1763 procedures were recorded compared with 2050 after the 
intervention. The length of both pre- and post-intervention period varied between 
6 and 13 calendar months per hospital depending on the incidence of the recorded 
procedures in the participating hospitals. Table 2 shows the distribution of the 
procedures in each period according to hospital and surgical specialty. In the pre- 
and post-intervention period, the overall number of procedures that were needed 
to assess the effect of the intervention on the incidence of SSI was met.
Indication
After the intervention, the observed number of cases for which prophylaxis was 
indicated but not administered was significantly lower than expected; 26 versus 
55 (Table 3). Time series analysis showed that this effect was sustained during the 
post-intervention period (P<0.02 for change in level, P=0.25 for post-intervention 
slope). 
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Antimicrobial use
Figure 1 shows the antimicrobial use over time. There was a significant decrease 
in antibiotic use immediately after the intervention (P<0.01 for change in level). 
This use further decreased during the post-intervention period (P<0.01 for post-
intervention slope). The number of DDD per 100 procedures decreased from 121 
before to 79 after the intervention. The antibiotic costs per procedure decreased by 
25 % from EUR 10.96 to EUR 8.24.
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Figure 1. Antimicrobial use in 13 hospitals before and after the intervention. The horizontal axis shows the 
time in months to the intervention. The length of both registration periods to the intervention differed 
per hospital from 6 to 13 months, but all hospitals registered at least 6 months before and after the 
intervention. To be representative for all hospitals, only these 6 months are illustrated in the figure. 
Antibiotic choice
The antimicrobial drugs used over time are shown in Figure 2. For each parameter of 
antibiotic choice, the observed number of inappropriate cases after the intervention 
was significantly lower than the expected number of cases had the intervention 
not occurred (P<0.01, Table 3). Immediately after the intervention, the use of the 
first generation cephalosporin cefazolin increased significantly (P<0.01 for change 
in level). This increase continued during the post-intervention period (P<0.01 for 
post intervention slope). After the intervention, the observed number of cases not 
using cefazolin was significantly lower than expected, 758 instead of 1893 (P<0.01, 
Table 3).
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For the qualitative parameters of antibiotic choice, i.e. efficacy, spectrum, toxicity, 
costs and use in therapy, there was a significant decrease in the number of cases 
with inappropriate prophylaxis immediately after the intervention (P<0.05 for 
change in level) which paralleled the increased use of cefazolin. For the parameters 
spectrum, toxicity, costs and use in therapy, this effect was sustained or even 
improved during the post-intervention period. For the parameter efficacy, there was 
a significant trend towards an increase in inappropriate prophylactic drugs (P<0.02 
for post intervention slope). This was almost completely attributable to the use of 
drugs which were alternatives in cases of an allergy to β-lactam antibiotics but that 
did not cover the most frequent causative microorganisms of SSI of that particular 
procedure, e.g. erythromycin for bowel surgery.
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Figure 2. Antibiotic choice before and after the intervention in 13 hospitals. The horizontal axis shows 
the time in months to the intervention. The length of the registration periods to the intervention differed 
per hospital from 6 to 13 months but all hospitals registered at least 6 months. To be representative for 
all hospitals, only these 6 months are illustrated in the figure. Abbreviations: 1st gen, first-generation; 
2nd gen, second-generation.
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Duration of prophylaxis
The duration of prophylaxis before and after the intervention, expressed as number 
of post-operative doses, is shown in Figure 3. The observed number of cases with 
prolonged prophylaxis after the intervention was significantly lower than expected: 
631 instead of 944 (P<0.01, Table 3). Immediately after the intervention, there was a 
significant decrease in the number of cases with prolonged prophylaxis (P<0.01 for 
change in level). This effect was sustained in the post-intervention period (P=0.50 
for post-intervention slope). The median time between the first dose at the surgical 
suite and the last dose at the ward decreased from 16 h (range 1.5 h - 5 days) 
before the intervention to 12 h (range 8 h - 2.5 days) after the intervention. There 
was a marked difference in duration of prophylaxis between surgical specialties 
(Figure 4). Extended prophylaxis was mainly recorded in orthopaedic departments. 
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Figure 3. Duration of prophylaxis before and after the intervention in 13 hospitals. The horizontal axis 
shows the time in months to the intervention. The length of the registration periods to the intervention 
differed per hospital from 6 to 13 months, but all hospitals registered at least 6 months. To be 
representative for all hospitals, only these 6 months are illustrated in the figure. 
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Figure 4. Duration of prophylaxis according to surgical specialty in 13 hospitals. For each surgical specialty, 
the percentage of procedures with an appropriate, prolonged or too short duration of prophylaxis 
is shown before and after the intervention. Orth, orthopaedic surgery; vasc, vascular surgery; gyn, 
gynaecological surgery; intest, intestinal surgery. Too short means that a repeat dose of the prophylactic 
antibiotic was omitted during surgery, although surgery exceeded more than three times the half-life of 
the administered drug.
Timing of prophylaxis
The timing of prophylaxis before and after the intervention is shown in Figure 5. The 
intervention resulted in a slight decrease in the number of cases with inappropriate 
timing (P=0.07 for change in level). However, during the post-intervention period, 
there was a significant trend towards a further decrease in the number of cases 
with inappropriate timing (P<0.01 for post-intervention slope). This resulted in a 
significant difference between the observed and expected cases with inappropriate 
timing after the intervention, 779 instead of 1024 (P<0.01, Table 3). The total 
number of cases that received prophylaxis at an optimal timing, within 30 minutes 
before the first incision, improved from 805 cases before (50%) to 1197 cases (61%) 
after the intervention. 
In general, timing of prophylaxis in orthopaedic surgery was much earlier than in 
intestinal surgery and gynaecological surgery (Figure 6). Although the number of 
procedures in intestinal surgery with a timing of the first dose after the incision 
decreased, the difference in timing between the surgical specialties remained. 
0
10
20
30
40
50
60
70
80
90
100
 too long
too short
correct
orth vasc gyn intest orth vasc gyn intest
Before intervention After intervention
%
 o
f p
ro
ce
du
re
s
Chapter 3
84
Figure 5. Timing of prophylaxis before and after the intervention in 13 hospitals. The horizontal axis shows 
the time in months to the intervention. The length of the registration periods to the intervention differed 
per hospital from 6 to 13 months, but all hospitals registered at least 6 months. To be representative for 
all hospitals, only these 6 months are illustrated in the figure. 
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Figure 6. Timing before and after the intervention according to surgical specialty in 13 hospitals. Orth, 
orthopaedic surgery; vasc, vascular surgery; gyn, gynaecological surgery; intest, intestinal surgery
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Overall quality 
Prophylaxis was completely administered according to the recommendations of 
the SWAB guideline in only 6 of 1615 (0.4%) cases before the intervention and in 
494 of 1967 (25%) cases after the intervention. Time series analysis could not be 
performed because the number of adherent cases before the intervention was too 
small to run the model.
Surgical site infection
The incidence of surgical site infections could be evaluated in 12 out of 13 hospitals. 
One hospital could not provide data on SSI because of lack of personnel to perform 
the data collection in 63 procedures before and 60 procedures after the intervention. 
The data on the quality of prophylaxis were linked to the PREZIES database of 
surgical site infections by matching date of birth, date of admission and date of 
surgery. This linkage failed 27 times before and 22 times after the intervention due 
to missing data or errors in the data entry. Therefore, data on SSI were available of 
1673 patients before the intervention and of 1968 patients after the intervention. 
The overall SSI rate decreased from 5.4% (95% CI: 4.3-6.5) to 4.6% (95% CI: 
3.6-5.4), a difference which was not statistically significant. Time series analysis 
showed that there were no significant trends in SSI rate during the pre- and post-
intervention periods. The SSI rates before and after the intervention in the four 
categories of surgical specialty are shown in Table 4.
Table 4. SSI rates in the four categories of surgical specialties before and after the intervention.
Before intervention After intervention
no. SSI rate, % 95 % CI no. SSI rate, % 95 % CI
Vascular surgery 165 9.1 4.7-13.5 152 12.5 7.2-17.8
Intestinal surgery 250 14.8 10.4-19.2 257 10.9 7.1-14.7
Gynaecological surgery 328 1.5 0.2-2.9 402 1.5 0.3-2.7
Orthopaedic surgery 925 3.6 2.4-4.8 1142 3.1 2.1-4.1
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Discussion 
This study shows that the implementation of a national guideline for peri-operative 
prophylaxis improves the quality of prophylaxis and significantly decreases antibiotic 
use. The remarkable decrease in antibiotic use and costs per procedure was due to 
a reduction in the number of postoperative doses, the use of less costly antibiotics 
and, to a small extent, to the use of lower dosages (data not shown). 
The magnitude of quality improvement between the different parameters differed 
remarkably. Changing the antibiotic choice proved to be relatively easy and the use of 
a low-cost non-toxic antibiotic of limited spectrum, not extensively used in therapy, 
increased significantly. The use of cefazolin for surgical prophylaxis is justified in the 
Netherlands because the prevalence of methicilline-resistant Staphylococcus aureus 
is very low, (<1% data from NethMap) 29 as is the percentage of cefazolin resistant 
Escherichia coli in patients on admission and in the community.30 The duration of 
prophylaxis after the intervention was shortened but several orthopaedic surgeons 
were still reluctant to use single dose prophylaxis. They based their opinion on the 
results of a Dutch study of 2651 hip replacements 31 in which the incidence of SSI 
tended to be lower in the 24 h prophylaxis group than in the single dose group. 
Although this difference was not significant, the study may not have had the power 
to detect small potential benefits of prolonged prophylaxis. For this reason, some 
orthopaedic surgeons still favoured 24 h prophylaxis whereas antibiotic policymakers 
used the results of this study to recommend single dose prophylaxis.19,20 In this 
study, the timing of surgical prophylaxis improved only to a limited extent and the 
absolute number of cases with optimal timing in the post-intervention period was 
still disappointing. These results are comparable to the studies by Welch et al.13 
and Schell et al.14 in which the percentage of procedures with appropriate timing 
of prophylaxis improved from 46 tot 67% and 42 to 52 %, respectively. In our 
study, the targets of improvement were more ambitious than in other studies, e.g., 
duration shortened to single dose instead of 24 h and timing within 30 min before 
incision instead of within 1 or 2 h before the incision. These more ambitious goals 
could explain why improvement in duration and timing of prophylaxis was harder 
to achieve. On theoretical grounds and based on earlier studies,4,32,33 the most 
optimal timing seems to be as near as possible to the incision. One might argue, 
that aiming at a timing within 1 h before incision would already be a qualitative 
improvement and more feasible to adhere to in daily practice.
The low figure of overall adherence to the national guideline after implementation 
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in 25% of cases is thus explained by the use of very strict criteria. According to the 
recent advisory statement of the National Surgical Infection Prevention Project,21 
many antibiotics are considered appropriate, a duration of 24 h or even 48 h is 
accepted and timing is considered appropriate within 60 min before incision. When 
applying this broader timing criterion to the CHIPS data, 80 % of the cases would 
be considered appropriate in the post-intervention period instead of 61%. This 
quality level is similar to findings in the second quarter of the continuous quality 
improvement program in US hospitals (80%).34 
The difference in success rates of quality improvement between the parameters of 
prophylaxis may partially be explained by the nature of the changes that had to be 
brought about to achieve improvement. Barriers to implementation of guidelines 
and guideline adherence are various 35 and some are easier to overcome than 
others. The fact that the sudden change in appropriate timing of prophylaxis 
after the intervention was limited while the timing gradually improved over time, 
suggests that changing the timing is a logistical process with a continuous learning 
curve. In contrast, changing the antibiotic choice has been described as an on-off 
phenomenon.10,11 
Audits of antimicrobial use have shown that the quality of surgical prophylaxis 
varies greatly among hospitals around the world but improvement is almost 
universally desirable.5-7,9 However, only few studies have reported the results of 
interventions to achieve improvement. Most of these studies were performed in 
one hospital,10-13,15,17 regarding one type of surgery 10,14,16 or focusing at a single 
aspect of prophylaxis (e.g. timing).13,16 We are aware of only one other intervention 
study that mirrored the real-life implementation of surgical prophylaxis guidelines 
in a variety of hospitals, the recently published report on the National Surgical 
Infection Prevention Collaborative.34 Our study was performed simultaneously in 
many different hospitals, covering different surgical specialties and intervening 
on different aspects of prophylaxis. The methodology of surveillance and the 
qualitative assessment were highly standardized using a national protocol and 
strict criteria for assessment. This renders these data reliable and reproducible. 
By using segmented regression analysis with an interrupted time series design, it 
could be excluded that the improvement had been the result of a gradual change 
over time not related to the intervention and that the results are robust. Recently, 
Ramsay et al. critically reviewed the literature to evaluate the methodology of 
studies on improving antibiotic prescribing.36 Most studies have only reported the 
mean numbers with appropriate prophylaxis before and after an intervention and 
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did not correct for secular trends. With the use of at least 5 to 12 time points 
before and after the intervention (number varying per hospital), our study meets 
the criteria of the Cochrane EPOC Data Collection Checklist for correct interrupted 
time series analysis.28 Although seasonal variation was not taken into account, it is 
not expected to be an important issue in surgical prophylaxis. 
A limitation of this intervention study is the lack of control groups. The changes 
in antibiotic prophylaxis could have been due to local initiatives rather than being 
the result of the intervention by the study group. However, when a control group 
is lacking, interrupted time series analysis is the strongest quasi-experimental 
approach to evaluate longitudinal effects of intervention.37 
This quality intervention study did not only evaluate the process outcome, but also 
the patient outcome, i.e. the incidence of SSI. Because the overall SSI rate and the 
SSI rates in the four surgical specialties were generated from a specific case-mix, they 
can only be compared within the study and not with SSI rates from other published 
studies. We hypothesised that changing the prophylactic drugs to a single dose first-
generation cephalosporin would be non-inferior to actual practices, but that improving 
the timing would result in a decrease of the SSI rate. The study was powered to 
demonstrate a decrease in SSI rate from 7.5% to about 5%. The actual SSI rate 
before intervention however was lower, 5.4%, mainly due to overrepresentation of 
orthopaedic procedures in the study. On the other hand, more evaluable procedures 
were included in the study than we had anticipated (1673 before and 1968 after 
intervention). With this sample size and pre-intervention SSI rate, the study had 
enough power to demonstrate an improved outcome at post-intervention SSI rates of 
3.4% or beyond, or poorer outcome at rates of at least 7.7%. However, we observed 
no change in SSI rate before and after intervention, as the difference between rate 
estimates was minor, with largely overlapping 95% confidence intervals. 
In conclusion, this study shows that an intervention using audit and feedback as 
an instrument for change can improve the quality of prophylaxis and can decrease 
the antibiotic use with sustained efficacy in preventing SSI.
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Abstract
Objective: To compare the rate of surgical site infection (SSI) before and after an 
intervention period in which an optimized policy for antibiotic prophylaxis was 
implemented. To demonstrate that a more prudent, restrictive policy would not 
have a detrimental effect on patient outcomes.
Design: Before-after trial with prospective SSI surveillance in the Dutch nosocomial 
surveillance network (Preventie Ziekenhuisinfecties door Surveillance [PREZIES]), 
using the criteria of the Centers for Disease Control, including postdischarge 
surveillance for up to 1 year.
Methods: During a preintervention period and a postintervention period (both 6-
13 months), 12 Dutch hospitals collected data on antimicrobial prophylaxis and 
SSI rates. The study was limited to commonly performed surgical procedures in 
4 specialties: vascular, intestinal, gynecological and orthopedic surgery. Selected 
risk factors for analysis were sex, age, American Society of Anesthesiologists 
classification, wound contamination class, duration of surgery, length of hospital 
stay before surgery, and urgency of surgery (elective or acute).
Results: A total of 3,621 procedures were included in the study, of which 1,668 were 
performed before the intervention and 1,953 after. The overall SSI rate decreased 
from 5.4% to 4.5% (P=0.22). Among the procedures included in the study, the 
largest proportion (55%) were total hip arthroplasty, and the smallest proportion 
(2%) were replacement of the head of the femur. SSI rates varied from 0% for 
vaginal hysterectomy to 21.1% for femoropopliteal or femorotibial bypass surgery. 
Crude and adjusted odds ratios showed that there were no significant changes in 
procedure-specific SSI rates after the intervention (P>0.1).
Conclusions: An optimized and restrictive prophylactic antibiotic policy had no 
detrimental effect on the outcome of clean and clean contaminated surgery, as 
measured by SSI rate.
Introduction
Surgical site infections (SSIs) account for 38% of surgical infections and 17% of all 
nosocomial infections.1,2 In the United States in the 1990s, SSIs prolonged hospital 
stay by an average of 6.5 days, doubled the risk of death, and were associated with 
a risk of readmission to the hospital 5 times that for patients without SSI.3 In the 
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Netherlands, the mean postoperative length of stay for patients with an SSI is 8.2 
days longer than for patients without an SSI.4
Decades ago, the effectiveness of antimicrobial prophylaxis in reducing SSI rates 
was demonstrated in randomized clinical trials.5-10 For optimal prophylaxis, an 
antibiotic with a targeted spectrum should be administered at sufficiently high 
concentration in the serum, tissue, and the surgical wound during the entire time 
that the incision is open and at risk of bacterial contamination.11 In the United 
States, the Surgical Infection Prevention Guideline Writers Workgroup (SIPGWW) 
reached a consensus that infusion of the first dose of antimicrobial should begin 
within 60 minutes before surgical incision and that antimicrobial prophylaxis should 
be discontinued within 24 hours after the end of surgery.12 Studies showed that the 
prolonged use of antibiotic prophylaxis leads to emergence of bacterial resistance 
13-15 and high costs,16,17 and inappropriate timing of the administration leads to 
decreased efficacy.18,19
As part of the prospective, multisite, Surgical Prophylaxis and Surveillance (CHIPS) 
project, an optimized and restrictive antibiotic policy based on the national 
guideline was implemented in The Netherlands.20 This guideline recommends 
prophylaxis with a single dose of antimicrobial administered intravenously within 
30 minutes before the first incision. In view of the very low incidence of infection 
with methicillin-resistant Staphylococcus aureus in The Netherlands (less than 1% 
of all S. aureus infections), cefazolin (combined with metronidazole, if coverage for 
anaerobic pathogens is needed) is recommended. 
The goal of the study intervention was to slow down the development of antibiotic 
resistance and reduce the costs of antimicrobial prophylaxis without decreasing the 
efficacy of prophylaxis, as measured by a higher SSI incidence. 
In the present report, the patient outcome of this optimized and restrictive 
antimicrobial prophylaxis policy is assessed by comparing the SSI rate before and 
after the intervention. 
Methods
Setting
The CHIPS project was a prospective intervention study conducted at 13 Dutch 
hospitals, which participated voluntarily. These hospitals give a representative 
picture of inpatient care in The Netherlands, since they were geographically spread 
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over the country, according to the population density (Figure 1), and various types 
of hospitals (small, large, university and general hospitals) were included. At 1 
of the 13 hospitals, data on SSIs could not be recorded because of the sudden 
absence of the infection control professional (ICP). 
Figure 1. Location of participating hospitals (filled circles) in The Netherlands (population, 16 million; 
area, 41,526 km2)
Data on antimicrobial prophylaxis and SSIs were collected in these 12 hospitals 
between January 2000 and November 2001 (the preintervention period) and between 
July 2001 and November 2002 (the postintervention period). The duration of these 
periods in each hospital ranged from 6 to 13 months, depending on how often 
the selected procedures were performed. During the intervention period, which 
lasted 2-9 months, a restrictive antibiotic-use policy was implemented. The policy 
was based on the national guideline for surgical prophylaxis issued by the Dutch 
Working Party on Antibiotic Policy (SWAB).21
Four major surgical specialties were selected for this study: vascular, intestinal, 
gynecological and orthopedic surgery. The study was limited to frequently performed 
procedures for which antimicrobial prophylaxis is generally recommended 21,22: 
grafting of the aorta, femoropopliteal or femorotibial bypass, various colorectal 
procedures, abdominal and vaginal hysterectomy with or without vaginal repair, 
total hip arthroplasty and replacement of the head of the femur.
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Only elective procedures were included, so that the normal daily routine of 
administering antimicrobial prophylaxis would be observed. To avoid assessment 
of procedures in which antibiotics were given for therapeutic reasons rather 
than prophylactic reasons, procedures with a dirty or infected wound (ie, wound 
contamination class 4) 1,23 were excluded. 
Data collection
The methods used to collect data on antimicrobial prophylaxis have been described 
elsewhere.20,24 Data were collected prospectively by infection control professionals 
from medical, nursing, anesthesia, and medication records. Before the start of 
the project, as well as during the study, the collection of data on antimicrobial 
prophylaxis was validated at regular intervals through on-site review of the 20 most 
recently recorded patient files.
All CHIPS hospitals participated in the module ”Surgical site infections” of the Dutch 
national nosocomial infections surveillance network (Preventie Ziekenhuisinfecties 
door Surveillance; PREZIES;4 general information is available at the network’s Web 
site, http://www.prezies.nl). From 1996 to 2003 within the PREZIES network, 62 of 
the 98 Dutch hospitals participated and collected SSI data on 129,142 procedures. 
According to the PREZIES protocol, infection control professionals collected 
information on the demographic characteristics of patients and on the surgical 
procedure, risk factors for SSI, and incidence of SSI. The selection of risk factors was 
based on the literature and included the patient’s sex, age, and physical condition 
(American Society of Anesthesiologists classification);25 wound contamination class; 
duration of surgery; preoperative length of hospital stay; and whether surgery was 
elective or acute.26-29 The criteria of the Centers for Disease Control and Prevention 
were used for the assessment of SSIs.22,30 If an SSI occurred in a patient, the 
surveillance staff recorded the day the SSI became manifest, whether it was a 
superficial or deep SSI, and which microorganisms were isolated. Deep incisional 
SSIs and organ/space SSIs were combined and termed deep SSIs. All patients 
were followed up to 30 days postoperatively; in case of insertion of a prosthetic 
implant the duration of follow-up was 1 year. To monitor the quality and reliability 
of the surveillance data used in this study, SSI surveillance was validated in each 
participating hospital. 
To achieve a significance level of 5% and a power of 80%, the required sample 
size for observing a change in the SSI rate was 1,600 surgical procedures before 
the intervention and 1,600 after. This was calculated using the assumptions that 
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the overall risk of SSI before the intervention was 7.5% and that the estimated 
achievable SSI rate after the intervention was 5%. The figure of 7.5% was based 
upon PREZIES data for the selected procedures in previous years and assumed an 
equal distribution of the selected procedures (orthopedic, gynecological, vascular 
and bowel surgery) in the CHIPS study. However, the CHIPS study was dependent 
on the PREZIES protocol, according to which hospitals were free to choose the type 
of procedures for surveillance.
Data analysis
The Χ2 test or Student t test was used to screen potential risk factors for SSI. 
Variables with a P value of less than .2 for their univariate association with SSI 
were candidates for multivariable analysis. Logistic regression analysis was used 
to calculate odds ratios (ORs) for SSI after the intervention compared with before 
the intervention, according to the type of surgical procedure, and after adjusted 
for procedure-specific confounders. The best model was selected by considering 
the -2 log likelihood as well as the c-index. The c-index is a measure of predictive 
performance and represents the proportion of instances in which a patient who 
develops an SSI is assigned a higher probability of SSI than a patient who does 
not develop an SSI.31
As recommended by the Cochrane Effective Practice and Organization of Care Group 
(EPOC),32 we used segmented time series analysis, which includes changes in level 
and in trend, to estimate the effect size of the intervention. Data were collected on 
individual patient level, whereas the interventions were targeted towards hospitals 
with different mixes of surgical procedures. Therefore, the resulting hierarchical 
structure was taken into account in the analyses. As the response variable was 
binary (SSI present or absent), a non-linear mixed model analysis was applied using 
SAS Proc NLmixed, version 8.2 (SAS Institute). In the model, the hospital where the 
procedure was performed was treated as a random variable, and surgical procedure 
and calendar time of the preintervention, intervention and postintervention 
periods were treated as covariables. In this way, the model corrected for unequal 
distribution of procedures in the preintervention and postintervention periods, for 
unequal distribution within hospitals, and for differences in length of registration 
and intervention periods. The following outcome measurements were generated: 
mean SSI rates in the preintervention and postintervention periods, change in SSI 
rate immediately after the intervention, and the slopes of the curve of the SSI rates 
before and after the intervention.
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All analyses were performed in SAS for Windows, release 8.2 (SAS Institute). A P level 
of less than 0.05 was considered statistically significant.
Results
Overall results of the optimized antibiotic policy
The optimized antibiotic policies led to a decrease of 35% in the use of prophylactic 
antibiotics (calculated as the number of defined daily doses (DDD) per procedure) 
and a decrease of 25% in the costs per procedure, mainly as a result of a shorter 
period of administration of prophylaxis.20 After the intervention, antibiotics were 
administered inappropriately in 37.5% of the procedures, instead of the expected 
93.5% had the intervention not occurred. Administration of doses after closure 
of the wound, instead of the recommended single dose before the first incision 
(with a second dose if there is major blood loss or the procedure has a long 
duration), was observed in 31.4% of procedures instead of the expected in 46.8%. 
Inappropriate timing of antibiotic administration (ie, not within 30 minutes before 
the first incision) was observed in 39.4% of procedures, instead of the expected 
51.8%. Time series analysis showed that these improvements were statistically 
significant (P<0.01) and that they could be fully attributed to the intervention.20 
The percentage of procedures in which antimicrobial prophylaxis was administered 
within 1 hour before the first incision changed only slightly, from 72% to 79%.20
SSI results before and after the intervention
The results described here are for a total of 3,621 procedures, of which 1,668 were 
performed before the intervention and 1,953 after. The overall SSI rate decreased 
from 5.4% (95% confidence interval [CI]: 4.3%–6.5%) before to 4.5% (95% CI, 
3.6%-5.4%) after the intervention (P=0.22).
Table 1 summarizes the characteristics of each participating hospital. Three of 
the 12 hospitals had fewer than 400 beds, and 3 hospitals had more than 800 
beds. There were 5 teaching hospitals, of which 2 were university hospitals. The 
total recorded number of surgical procedures at each hospital varied from 97 to 
581. Vascular procedures were recorded at 4 hospitals, intestinal procedures at 6 
hospitals, gynecological procedures at 4 hospitals, and orthopedic procedures at 
11 hospitals.
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The distribution of risk factors before and after the intervention is shown in Table 2. 
More than half of the patients were over 65 years old, 31% of the patients were male, 
and less than 20% of the patients had an American Society of Anesthesiologists 
classification of 3 or higher; 66% of the procedures were classified as clean 
procedures. Twenty percent of the recorded procedures were performed in university 
hospitals and 32% in other teaching hospitals. There were no significant differences 
in the distribution of the risk factors before and after the intervention (P≥0.3).
Table 3 shows PREZIES SSI rates 4 and SSI rates before and after the intervention 
in the present CHIPS study, according to the type of surgical procedure. The 
distribution of the surgical procedures was fairly similar before and after the 
intervention. However, the recorded number of femoropopliteal or femorotibial 
bypasses decreased significantly (P=0.04).
For 4 procedures the SSI rate decreased after the intervention, and for 3 procedures 
the SSI rate increased after the intervention. Table 4 shows the crude and adjusted 
ORs, according to the type of procedure, for the comparison of the SSI rate after the 
intervention with the rate before the intervention, adjusted for procedure-specific 
confounders. These ORs did not differ significantly from 1, indicating that the SSI 
rates had not changed remarkably during the intervention.
Table 2. Comparison of risk factors before and after the intervention
Percentage of procedures with risk factor present
Risk factor
Before intervention  
(n=1,668)
After intervention  
(n=1,953) P 
Age >65 years 56.4 58.1 0.30
Male sex 30.9 30.4 0.76
ASA classification ≥3 17.7 17.6 0.89
Wound class ≥2 34.7 33.7 0.54
Duration of surgery >P75 24.6 24.1 0.76
Teaching hospital 48.9 47.3 0.33
University hospital 20.4 20.0 0.75
Note. ASA, American Society of Anesthesiologists, P75, 75th percentile
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Table 3. Surgical Site Infection (SSI) Rates in the Dutch National Preventie Ziekenhuisinfecties door 
Surveillance (PREZIES) Network and in the Surgical Prophylaxis and Surveillance (CHIPS) project
CHIPS
PREZIES*: Before intervention After intervention
Surgical procedure
SSI rate, %
(95% CI) n
SSI rate, %
(95 % CI) n
SSI rate, %
(95 % CI)
Reconstruction of the 
aorta
 1.9  (0.4-3.5) 95  5.3 (0.8-9.8) 95  7.4 (2.1-12.6)
Femoropopliteal or 
femorotibial bypass
 6.3  (3.7-8.9) 70  14.3  (6.1-22.5) 57  21.1 (10.5-31.6)
Colorectal surgery  7.3  (5.6-9.0) 250  14.8  (10.4-19.2) 257  10.9 (7.1-14.7)
Abdominal hysterectomy  1.6  (0.6-2.5) 205  2.4  (0.3-4.6) 239  1.7 (0.0-3.3)
Vaginal hysterectomy  0.3  (0.0-0.8) 123 0 163  1.2 (0.0-2.9)
Replacement of the 
head of the femur
 3.5  (2.5-4.5) 25  20.0  (4.3-35.7) 42  11.9 (2.1-21.7)
Total hip arthroplasty  2.8  (2.4-3.2) 900  3.1  (2.0-4.2) 1,100  2.7 (1.8-3.7)
Note. CI, confidence interval. * PREZIES data from 2000-2002, without the CHIPS data
Table 4. Crude odds ratio (OR) and Adjusted OR of the Surgical Site Infection rate after the intervention 
compared with before the intervention
Procedure
Crude OR  
(95 % CI)
Adjusted OR  
(95% CI) Variables adjusted for:
Reconstruction of the 
aorta
1.4 (0.4-4.7) 1.4 (0.4-4.6) Sex
Femoropopliteal or 
femorotibial bypass
1.6 (0.6-4.0) 1.1 (0.4-3.1) Age (≥65 years), university 
hospital
Colorectal surgery 0.7 (0.4-1.2) 0.7 (0.4-1.1) Age (≥65 years)
Abdominal 
hysterectomy
0.7 (0.2-2.6) 0.6 (0.2-2.4) Duration of surgery (>P75)
Vaginal hysterectomy Not calculable Not calculable
Replacement of the 
head of the femur
0.5 (0.1-2.1) 0.6 (0.1-2.6) Age (continuous), duration of 
surgery (>P75)
Total hip arthroplasty 0.9 (0.5-1.5) 0.9 (0.5-1.5) Age (≥75 years), ASA 
classfication (≥3), duration of 
surgery (>P75)
Note. ASA, American Society of Anesthesiologists; CI, 95% confidence interval; P75, 75th percentile.
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Time series analysis that took into account possible changes over time in hospitals 
concerning unmeasured factors confirmed that the optimized and more-restrictive 
administration of antibiotic prophylaxis did not have a significant impact on the 
SSI rate (P=0.99) and that there were no significant trends in SSI rates during the 
preintervention and postintervention periods. Specific changes in different aspects 
of prophylaxis (e.g. choice, timing, and duration of antibiotic prophylaxis) after the 
intervention are described elsewhere.20
Discussion
Our results demonstrate that implementing an optimized and more-prudent 
antibiotic policy in hospitals did not change the risk of SSI. Our findings are in line 
with the results of studies that have shown that narrow-spectrum antimicrobials 
are as effective as broad-spectrum antimicrobials for preventing SSIs 33-35 and that 
single-dose prophylaxis is as effective as multiple-dose prophylaxis.34-39 Furthermore, 
Classen et al.18 have demonstrated that the SSI incidence is lower if antimicrobial 
prophylaxis is administered within 2 hours before the first surgical incision, 
compared with administration earlier or later. Despite the evidence, surgeons are 
still reluctant to follow guidelines that advocate use of narrow-spectrum antibiotics 
and single-dose prophylaxis, because they fear an increase in the incidence of SSI. 
Many guidelines, therefore, have not found their way into daily practice. However, in 
the present study, implementation of these recommendations was successful, and 
the improvement in quality resulted in less use and improved use of antibiotics,20 
and the effectiveness of the antibiotics for SSI prevention did not diminish. Since 
the timing of prophylaxis only slightly improved after the intervention, the positive 
effect of this improvement on the incidence of SSI might have been limited, although 
pharmacokinetic data indicate the desirability of administration as close as possible 
to the time of the first incision.40,41
The CHIPS multiple-site study was unique in several aspects. It involved 12 hospitals; 
measured SSIs as patient outcomes, in addition to the process-outcome parameters; 
and considered various common procedures in 4 surgical specialties. Of the many 
studies that have tried to implement an improved antibiotic prophylaxis policy, only 
a few considered an outcome parameter. A study by Gyssens et al. 17,42 recorded 
the number of nosocomial infections per 100 bed days. Two other implementation 
studies recorded the SSI rate but included only 2 hospitals 43 and 6 hospitals.44 
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Schell et al. 43 focused solely on bowel surgery, and Weinberg et al. 44 focused 
on cesarean section. The present CHIPS study was conducted within PREZIES. 
Therefore, SSI surveillance was performed according to a standardized protocol, 
which included postdischarge surveillance and validation of the data collection in 
the hospitals, which yielded reliable data on SSIs.
A limitation of our study is the lack of a control group. However, it did not seem 
feasible to include a control group of hospitals that would be motivated to invest 
a lot of effort in the data collection without the possibility of implementing the 
national guideline and improving the overall quality of antimicrobial prophylaxis. 
The participating hospitals had agreed not to introduce any other intervention 
during this study. Consequently, there was no change in surgical personnel, 
surgical methods, operating room protocols, or postoperative wound care in the 
participating hospitals. Despite this agreement, changes in SSI rates could still 
have been the result of a gradual change in practices not related to the study 
intervention. However, by using segmented time series analysis, trends over time 
not related to the intervention could be excluded.
Another limitation might be that the preintervention SSI rate was 5.4%, mainly 
because of overrepresentation of orthopedic procedures in the study, which is 
less than the 7.5% on which the power calculation was based. However, more 
procedures were included in the study than we had anticipated: 1,668 before and 
1,953 after intervention, instead of 1,600. With this sample size and given the 
preintervention SSI rate, the study had enough power to demonstrate a decrease in 
the overall SSI rate to 3.4% or lower or an increase to 7.7% or higher. However, we 
observed no change in overall SSI rate before and after intervention; the observed 
difference was minor, with overlapping 95% CIs. Unfortunately, this study had not 
enough power to demonstrate a significant change in SSI rate according to the type 
of procedure.
In this study, no data on antibiotic resistance were collected. Therefore, we were 
not able to investigate how antibiotic resistance was affected by the decreased 
use of antibiotics (from 121 to 79 defined daily doses per 100 procedures) and 
the decreased use of agents with a broader spectrum than cefazolin (from 85% to 
34% of procedures).20 However, it might be expected that the restricted antibiotic 
use that was achieved in this study will contribute to a decrease in antimicrobial 
selective pressure.13
Most aggregated procedure-specific SSI rates reported in the present CHIPS study 
were higher than the national SSI rates from PREZIES. It appeared that the national 
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rates during the CHIPS study (during 2000-2002) were, by coincidence, lower than 
the average infection rates during the total national surveillance period of 1996-
2004. A possible explanation for the higher rates in the CHIPS hospitals might be 
that the SSI surveillance during the CHIPS study was performed more accurately and 
thoroughly, resulting in a higher proportion of SSIs detected. Another explanation 
could be that not all hospitals participating in PREZIES performed postdischarge 
surveillance, whereas all CHIPS hospitals did perform postdischarge surveillance. 
However, when only SSIs that developed during hospitalization were considered, 
the trend of higher SSI rates in the CHIPS study was still apparent. The difference 
in SSI rates might also be caused by differences in present risk factors between 
the CHIPS and PREZIES study population, since only the crude infection rates were 
compared. 
In conclusion, this study shows that the implementation of an optimized and 
restrictive antibiotic policy had no detrimental effect on the outcome of clean and 
clean-contaminated surgery, as measured by SSI rate. 
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Abstract
Background: Surgical site infections (SSIs) following total hip arthroplasty can lead 
to prolonged hospitalization, increased morbidity and mortality, and high costs. This 
article analyzes the effect of various parameters of surgical antibiotic prophylaxis on 
the risk of SSI following total hip arthroplasty.
Methods: Data about SSI, and potential prophylaxis- patient- and procedure-related 
risk factors were prospectively collected for 1922 patients who underwent elective 
total hip arthroplasty in 11 hospitals that participated in the Dutch intervention 
project, Surgical Prophylaxis and Surveillance. Multivariate logistic regression 
analysis was performed to correct for random variation among hospitals. 
Results: SSIs (superficial and deep) occurred in 50 patients (2.6 %). The highest 
odds ratios for SSI were found in patients who received prophylaxis after incision 
(2.8, 95% confidence interval [CI], 0.9-8.6; P=0.07), had an American Society of 
Anesthesiologists score that was >2 (2.8, 95% CI, 0.8-9.2; P=0.09), and experienced 
a duration of surgery that was >75th percentile (2.5; 95% CI, 1.1-5.8; P=0.04). 
Prolonged prophylaxis after the end of surgery and the use of antibiotic-impregnated 
cement did not contribute to fewer SSIs in this study.
Conclusion: This study suggests that intervention programs in search of amendable 
factors to prevent SSI should focus on timely administration of antibiotic 
prophylaxis. 
Introduction
Surgical site infection (SSI) following total hip arthroplasty (THA) can lead to 
prolonged hospitalization, increased morbidity and mortality, and high costs.1,2 The 
health and economic burdens of SSI are not restricted to patients’ hospital stay.3 
Deep- implant SSI following THA is almost always diagnosed after discharge. Deep-
implant SSIs following THA occur infrequently (0.3 -1.3 %) 4-6 but can lead to severe 
incapacitation.7 Known risk factors for SSI are related to the environment, surgeon, 
and patient.8 Some of these factors are amenable to intervention (e.g., conditions in 
the operating room). Other factors, such as advanced age and diabetes mellitus, are 
intrinsic patient risks and cannot be modified.9 Antimicrobial prophylaxis contributes 
to the reduction in incidence of SSI and is standard practice for THA. Specific 
recommendations are available regarding the choice of the antibiotic, duration of 
prophylaxis, and timing of the first dose.8,10-12 The cephalosporins cefazolin and 
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cefuroxime are considered to have equal prophylactic efficacy. Available evidence 
suggests that administration of the first dose as near to the incision time as possible, 
will achieve a decreased likelihood of SSI. However, controversy exists regarding the 
optimal duration of prophylaxis in connection with THA. The US advisory statement 
recommends that antimicrobial prophylaxis be administered within 1 h before 
incision and discontinued within 24 h after the end of the operation.12 However, 
European guidelines recommend a single dose within 30 min before the incision.11,13 
In addition, despite the potential benefits of antibiotic-impregnated bone cement for 
joint arthroplasty, controversies remain regarding its use.12
Most studies that have analyzed risk factors for SSI following THA have mainly focused 
on patient, procedure, or hospital characteristics.4,14-16 However, prospective studies of 
the contribution of the qualitative aspects of surgical prophylaxis to the prevention 
of SSI following THA are scarce. We conducted a prospective, multisite intervention 
study (the Surgical Prophylaxis and Surveillance [CHIPS] project) to research the 
quality of surgical prophylaxis in the Netherlands and documented patient outcome 
by surveillance of SSI.17-19 This project aimed at narrowing the spectrum, shorten 
the duration, and optimizing the time of administration of prophylactic antibiotics 
without increasing the incidence of SSI by implementing the national guidelines for 
surgical prophylaxis. These guidelines, developed by the Dutch Working Party on 
Antibiotic Policy (SWAB), recommend intravenous single-dose cefazolin administered 
within 30 min before the first incision for THA.13 Here, we explore the contribution of 
the parameters of the prophylaxis process to the incidence of SSI for the population 
undergoing THA, with an emphasis on the timing of administration of prophylaxis.
Methods 
During 2000 - 2002, 11 of the 13 Dutch hospitals of the CHIPS project provided 
data on elective, primary THA before and after the implementation of the national 
guidelines for surgical prophylaxis. Procedures for revision of a hip prosthesis were 
excluded. 
Data collection
All hospitals participated in the national surveillance network PREZIES (Preventie 
van Ziekenhuis Infecties door Surveillance)(www.prezies.nl). Data about the surgical 
procedure, potential SSI risk factors, and infections for patients who developed 
SSI were collected according to the PREZIES protocol,20 using the criteria of the US 
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Centers for Disease Control and Prevention.21 Local infection-control professionals 
prospectively collected the data and identified cases of SSI. SSIs following THA were 
categorized as superficial (involving skin or subcutaneous tissue) or deep (involving 
fascia, muscle and joint space). Postdischarge surveillance was performed for all 
patients. Surgeons were requested to describe clinical symptoms and whether a 
patient had developed a SSI on a registration card that was added to the outpatient 
medical record. The records were reviewed by the local infection-control professional 
at 30 days and 1 year after discharge.15 Data about the quality of prophylaxis were 
collected from medical, anesthetic and nursing records and medication charts. 
The method of prophylaxis data collection and validation are described elsewhere.17 
The choice of the antibiotic, number of doses, time of administration of the first dose 
and subsequent doses, use of antibiotic-impregnated bone cement, time of induction 
of anesthesia, and the time of incision and closure of the wound were recorded.
Prophylaxis- , patient-, and procedure-related risk factors
Duration of prophylaxis was divided into 3 categories: single dose (1 or, in 
case of prolonged surgery, as recommended by the national guidelines), 24 h 
(postoperative dosing for 24 h), and >24 h (postoperative dosing for >24 h). Timing 
of administration of prophylaxis was assessed as the interval (in minutes) between 
the administration of the first dose and the incision. If prophylaxis was administered 
by intravenous infusion, the point at which one-half of the infusate had been 
administered was noted as the time of administration. Timing of administration 
was divided in 4 categories: within 30 min before incision (as recommended by the 
national guidelines), 31- 60 min before incision, >60 min before incision, and during 
or after incision. The use of antibiotic-impregnated bone cement was considered a 
potential confounder of the effect of systemic prophylaxis.
The selection of potential patient- and procedure-related risk factors for SSI 
included in the national PREZIES surveillance was based on the literature to allow 
comparison with data generated by surveillance systems of other countries and 
was limited by feasibility.20,22 The factors included sex, age, physical condition of 
the patient according to the American Society of Anesthesiologists [ASA] score,23 
wound class, duration of surgery >75th percentile, National Nosocomial Infections 
Surveillance (NNSI) score 24 and duration of preoperative of hospital stay (Table 
1). The annual volume of surgery and the teaching status of the hospital, which 
were recently described as important risk factors for THA,15 were also considered 
as possible confounders. Data about the quality of prophylaxis were linked to the 
PREZIES SSI database by matching date of birth, admission and surgery.
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Table 1. Univariate analysis: association of selected variables with surgical site infection (SSI) following 
THA.
SSI
(N=50)
No SSI
(N=1872)
Odds ratio
(95% CI) p-value a
Antibiotic prophylaxis variables
Duration of prophylaxis 
 single dose b
  multiple postoperative doses for ≤24 h 
 multiple postoperative doses for >24 h
 16 (33)
 26 (54)
 6 (13)
 633 (34)
 782 (42)
 427 (23)
reference
 1.4 (0.7-2.5)
 0.6 (0.2-1.4)
 
0.29
0.22
Timing of administration of first dose 
 >60 min. before incision 
 31-60 min. before incision
 1-30 min. before incision
 during or after incision
 5 (10)
 14 (28)
 25 (50)
 6 (12)
 110 (6)
 524 (28)
 1118 (60)
 120 (6)
 2.0 (0.8-5.4)
 1.2 (0.6-2.3)
reference
 2.2 (0.9-5.6)
0.16
0.60
0.08
Use of antibiotic-impregnated bone cement  25 (50)  732 (39)  1.5 (0.9-2.7) 0.14
Patient and procedure related variables
Age, mean years ± SD c 72 ± 10 68 ± 11  1.5 (1.1-2.0) 0.014
Female sex  40 (80)  594 (68)  1.9 (0.9-3.7) 0.08
ASA score [23] d
 1 
 2 
 3+ 
 8 (16) 
 29 (59)
 12 (24)
 507 (27)
 1130 (61)
 217 (12)
reference
 1.6 (0.7-3.6)
 3.5 (1.4-8.7)
0.23
0.007
NNIS-score [24] e
 0
 1
 2
 22 (46)
 20 (42)
 6 (13)
 1267 (69)
 516 (28)
 65 (4)
reference
 2.2 (1.2-4.1) 
 5.3 (2.1-13.6)
0.010
<0.001
Duration of preoperative hospital stay, days
 0-1 days
 ≥2
 47 (94)
 3 (6)
 1766 (94)
 106 (6)
reference
 1.1 (0.3-3.5) 0.92
Duration of surgery >75th percentile  20 (41)  435 (23)  2.3 (1.3-4.1) 0.006
Note. Data are no. (%) of patients, unless otherwise indicated. ASA, American Society of Anesthesiology; 
NNIS-score, National Nosocomial Infection Surveillance, surgical wound infection risk index.
a Univariate analysis Χ2 square and Student’s t-test.; b Zero postoperative doses; c Per 10 years increase; 
d 1, healthy; 2 mild systemic disorder; ≥3 severe systemic disorder; e Includes the following elements: 
ASA-score, wound contamination class, and duration of surgery.
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The CHIPS prophylaxis database contained 2031 consecutive patients who inderwent 
elective primary THA. Linkage with the SSI database of PREZIES was successful for 
1999 procedures. For 1922 (96%), the data on the timing of antibiotic administration 
were complete. This data`set was considered appropriate for analysis. Missing data 
for ASA score (n=19), duration of surgical procedure (n=7), and duration of surgical 
prophylaxis (n=32) were adjusted using the missing value indicator method.25 
Statistical analysis
Statistical analysis was performed using SAS Software, release 9.1 (SAS Institute). 
The correlation between antibiotic prophylaxis parameters and potential patient and 
procedure related risk factors for SSI was tested univariately with the Χ2 test or 
Student’s t test. Pearson’s correlation coefficient was used to assess the correlation 
between the annual number of arthroplasties performed per hospital and the incidence 
of SSI. Multivariable regression analysis was performed to account for these possibly 
confounding risk factors. According to our hypothesis, the variables duration and 
timing of prophylaxis and the use of antibiotic-impregnated bone cement were forced 
into the multivariable model. The patient- and procedure-related risk factors for SSI, 
with a threshold of statistical significance of P<0.1 in crude analyses, were included 
in the model. The NNIS-score was not included in the multivariate analysis because 
all procedures were clean (value, 0), and its other components (the ASA score and 
duration of surgery >75th percentile) were already included in the model. 
In the present multicenter study, patients were clustered by hospital. This level of 
hierarchy can introduce additional sources of variability and correlation (e.g., by 
hospital-specific treatment policies, risk factors, and the diagnostic accuracy of the 
infection-control professional). Therefore, a random coefficient model (procedure 
NLMIXED in SAS) was used to adjust the risk estimates for random variation among 
hospitals. In this model, both fixed and random effects can be entered nonlinearly. 
This model is basically a logistic regression model, supplemented with an extra 
term in the equation for the random effects associated with differences in infection 
risk among hospitals. Because regular logistic regression models do not take into 
account interhospital variability, they might overestimate the contribution of patient- 
and prophylaxis-related factors.
The final multivariate model was used to calculate the predicted probability of 
developing an SSI for each patient. These probabilities were averaged separately 
for patients with and for those without an SSI. The mean predicted probability for 
patients with an SSI was divided by the mean predicted probability for patients 
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without an SSI. This ratio represents a measure of the goodness of fit of the model, 
with a ratio of 1 indicating that the risk factors in the model do not contribute to 
the prediction of developing an SSI. Adjusted odds ratios were expressed with 95% 
CIs. P<0.05 was considered to be statistically significant. 
Results
All 11 hospitals had operating rooms with laminar air-flow conditions. Drains were 
routinely used in all hospitals. The annual number of THAs per hospital varied from 
47 to 249. Of the 1922 patients included in the analysis, 69 % were female, with a 
mean age (+SD) of 68.8 + 10.8 years. The ASA score was >2 for 12% of patients. The 
mean duration of preoperative stay (+SD) was 1.2 + 2.1 days, the mean duration of 
the procedure (+SD) was 78.6 + 35.3 min, and the mean duration of postoperative 
stay (+SD) was 8.8 + 5.6 days. All patients received antimicrobial prophylaxis. The 
antibiotics that were administered were classified according to the Dutch Working 
Party on Antibiotic Policy guidelines as effective with a narrow spectrum (cefazolin 
[n=947], flucloxacillin [n=48], and erythromycin [n=8] or clindamycin [n=1] (in cases 
of allergy) or with a broader spectrum (cefamandole [n=39], cefuroxime [n=873], 
amoxicillin plus netilmicin [n=1] and clindamycin plus gentamicin [n=1]. No antibiotic 
with a very short half-life (e.g, cephalothin; half-life, 0.5 h) was used. For the 2 
patients receiving >1 prophylactic antibiotic, the combination was assessed as 
a single course. In 49% of the procedures, the antibiotic choice was completely 
according to the guideline. Prophylaxis with an antibiotic of a broader spectrum 
was not associated with fewer SSIs than prophylaxis with an antibiotic with a more 
narrow spectrum (OR, 0.7 ; 95% CI, 0.5-1.4; P=0.43). Prophylaxis with an antibtiotic 
with a longer half-life (erythromycin [half-life, 1.75 h] and cefazolin [half-life, 2 h] ) 
was not associated with fewer SSIs than prophylaxis with an antibiotic with a shorter 
half-life (flucloxacillin and cefamandole [half-lives, 0.75 h] ) and cefuroxime [half-life,1 
h]; OR, 1.1; 95% CI, 0.5-2.3; P=0.75. For 34% of the procedures, no postoperative 
doses were administered, and for 59%, the first dose was administered within 30 
min before incision, according to the guidelines. Antibiotic-impregnated bone cement 
was used in 757 cases (39%). SSI occurred in 50 patients (2.6%). Of these infections, 
40 were superficial (2.1%), and 10 (0.5%) were deep (including prosthesis-related). 
The average duration of stay (+SD) for patients without SSI was 9.9 + 6.0 days, 
compared with 14.1 + 12.0 days for patients with SSI.
 Antibiotic prophylaxis and the risk for surgical site infections following total hip arthroplasty
119
Univariate analysis 
The crude association of the selected prophylaxis-, patient-, and procedure-related 
variables with SSI is presented in table 1. Administration of the first dose of 
prophylactic antibiotics after incision was associated with an increased (although 
statistically nonsignificant) incidence of SSI. Dividing the timing of prophylaxis into 
3 categories; within 60 min before incision, >60 min before incision, and during 
or after incision, did not change the results (OR for timing during or after incision, 
2.9; P=0.06). Postoperative antibiotic doses and the use of antibiotic-impregnated 
bone cement were not inversely associated with SSI risk. Older age, comorbidity 
expressed by ASA score of >2, and prolonged surgery were associated with a higher 
rate of SSI. Undergoing surgery in a teaching hospital did not affect the risk of a SSI 
(P=0.30, by Χ2 for risk). The incidence of SSI per hospital was not correlated with 
the annual volume of total hip procedures (Pearson R=-0.19, P=0.58). Rates of SSI 
according to the time of administration of the first dose are shown in Figure 1. 
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Figure 1. Association between the timing of prophylaxis and the incidence of SSI in total hip arthroplasty.
SSI; surgical site infection
Multivariate logistic regression analysis
The multivariable analysis confirmed that multiple-dose postoperative prophylaxis 
and the use of antibiotic-impregnated bone cement were not inversely associated 
with the rate of SSI. Of the 4 potential patient- and procedure-related risk factors 
that reached the threshold of statistical significance and therefore were included 
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in the model, only duration of surgery >75th percentile was independently and 
significantly associated with SSI (OR, 2.5; 95% CI, 1.1-5.8) (Table 2). Relatively 
high ORs could be calculated for the independent associations of rate of SSI with 
ASA score of >2 (OR, 2.8; 95% CI, 0.8-9.2) and with timing of administration of 
prophylaxis after incision (OR, 2.8; 95% CI, 0.9-8.6). 
The mean predicted probability of the model was 0.076 for patients with an SSI and 
0.024 for patients without an SSI. The ratio of the means was 3.2, which indicates 
that according to the model, the likelihood of developing an SSI was 3.2 times higher 
for patients with the selected risk factors than for patients without the risk factors.
Table 2. Multivariate analysis of risk factors for SSI following total hip arthroplasty corrected for clustering 
of effects within hospitals. 
OR 95% CI p-value a
Antibiotic prophylaxis variables
Duration of prophylaxis 
 single dose b
  multiple postoperative doses for ≤24 h 
 multiple postoperative doses for >24 h
Reference
2.0
1.4
(0.6-7.0)
(0.2-9.2)
0.26
0.69
Timing of prophylaxis
 >60 minutes before incision
 31-60 minutes before incision
 1-30 minutes before incision
 during or after incision
1.3
0.9
Reference
2.8
(0.4-4.4)
(0.4-2.1)
(0.9-8.6)
0.68
0.82
0.07
Use of antibiotic-impregnated bone cement 0.8 (0.3-1.9) 0.57
Patient- and procedure- related variables
Age, years c 1.4 (1.0-2.1) 0.08
Female sex 1.7 (0.7-3.9) 0.19
ASA score [23] d
 1
 2
 3+
Reference
1.5
2.8
(0.6-3.8)
(0.8-9.2)
0.39
0.09
Duration of surgery (>75th percentile) 2.5 (1.1-5.8) 0.04
Note. ASA, American Society of Anesthesiology score. a Random coefficient model procedure NL MIXED 
in SAS software (SAS Institute); b Zero postoperative doses; c Per 10-years increase; d 1, healthy; 2 mild 
systemic disease; ≥3, severe systemic disorder.
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Discussion
In this multivariable analysis of prophylaxis-, patient-, and procedure-related risk 
factors for SSI following THA, prolonged duration of surgery (>75th percentile) was 
the only independent and statistically significant confounding risk factor. Although it 
did not reach statistical significance, failure to administer the first dose of antibiotic 
before incision seemed the most important prophylaxis-related factor for increasing 
the risk of SSI. These findings are important for clinical practice. Although several 
other studies have made risk assessments for SSI in orthopedic surgery,4,14,15,26 this 
is, to our knowledge, the first study to have evaluated the association of SSI with 
duration of surgery, timing of administration of prophylaxis, and the use of antibiotic 
cement. In addition, by excluding emergencies and revisions, the findings indicate the 
net effect of antibiotic prophylaxis on incidence of SSI in patients undergoing primary 
elective THA; previous studies included both emergency and elective surgery.14,15,26 In 
our surveillance, postdischarge surveillance was performed until 1 year after surgery, 
and therefore, the incidence of SSI might be higher than in other studies that did 
not perform postdischarge surveillance. Yet, the SSI incidence of 2.6 % is comparable 
with incidence rates found in other surveillance studies of THA.4,27
Although not significant, the OR for timing of administration of prophylaxis after 
incision suggests that the relative risk of SSI increases in the presence of this 
factor. The number of patients in some timing categories was too small to draw 
firm conclusions about the optimal preincisional timing period. Previous studies 
of general and colorectal surgery also found that administering prophylaxis after 
incision had a detrimental effect on the incidence of SSI.28,29 
Previous experimental studies have shown the importance of the presence of 
antibiotics in the tissue at the moment of potential contamination.30,31 In another,32 
injection of antibiotics as an intravenous bolus immediately prior to incision resulted 
in adequate antibiotic levels in the tissue levels at the start of surgery. During 
orthopedic surgery, administration of cephalosporins during incision resulted in 
sufficiently high concentration in bone at the moment of removal of the femoral 
head.33,34 An advantage of the administration of antibiotics shortly before the 
incision is that, in most procedures, the concentration of the antibiotic will still be 
high enough to prevent infection at the end of the procedure, and repeated dosing 
during prolonged surgery is less often required. The importance of a sufficient 
concentration of an antibiotic at the time of closure of the wound on SSI rate was 
recently established for gentamicin in colorectal surgery.35 
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In the present analysis, duration of prophylaxis was not correlated with the rate of 
SSI. In a report that included data from 22,000 THA procedures in the Norwegian 
Arthroplasty Register (during 1987-2001), the incidence of SSI in the group who 
received single-dose prophylaxis was equal to that in the group who received 4 
doses. However, the incidence of aseptic loosening of the joint was higher in the 
single-dose group.36 Unfortunately, the authors did not provide data on dosing 
intervals and timing of administration of the first and subsequent doses, which may 
have confounded the effect on outcome in this long-term cohort. This is especially 
important because, in the majority of the cases, cephalothin was used _which has a 
very short half-life_ and consequently, tissue concentrations quickly decrease.37 It is 
likely that the use of cephalothin has confounded the results. Cefazolin, which has a 
much longer half-life and is recommended by many guidelines,11,13 is likely to negate 
the use of repeated dosing, as was convincingly demonstrated in our study.
The duration of surgery, identified in our study as the most important risk factor for 
SSI, could be potentially confounded by other unmeasured factors. Detailed data 
about complications that could affect duration of surgery (e.g, bleeding, resulting 
in low antibiotic concentrations) were not collected in our study. Furthermore, 
duration of surgery seems not readily amenable to change by an intervention. The 
unchangeable patient risk factors of older age and higher ASA score also resulted 
in higher ORs for SSI. These risk factors are also described in other studies.4,26,29 In 
contrast to findings by others, the duration of preoperative hospital stay could not 
be identified as a risk factor in our study. This discrepancy was probably because of 
the fact that almost 95 % of the patients in our study had a preoperative hospital 
stay of ≤1 day. 
Apart from patient- or procedure- related risk factors, hospital-related factors 
(e.g.surgical technique) can influence the incidence of SSI. By using the procedure 
NLMIXED in SAS with hospital as a level, we took the hierarchical structure of 
the data into account and thereby corrected for possible random variation among 
hospitals. 
Our study does have some limitations. First, the number of risk factors included 
in our study was limited to those reported within the PREZIES network. Although 
diabetes mellitus, malignancy, and corticosteroid use are reflected in the ASA-score, 
separate reporting of these known risk factors might have rendered risk assessment 
more precise. Other risk factors that are not reflected in the ASA-score (e.g., obesity, 
perioperative body temperature, and oxygenation) were shown to be relevant in 
other studies.38-40 Another limitation of our analysis was the relatively low number 
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of SSIs (n=50), which was the dependent outcome variable of our analysis. Of 
the 77 patients from the CHIPS database to whom prophylaxis was administered 
but who were excluded from this analysis because information on timing was not 
known, 8 patients (10.3%) developed an SSI, compared with 50 (2.6%) of 1922 
patients who were included in our analysis (P<0.0003). This difference could be 
because of the characteristics of these patients or could imply that reporting the 
time of administration of prophylaxis is in itself a marker of correct performance. 
Finally, the fact that the postdischarge surveillance depended on reporting by the 
surgeons could have resulted in the underreporting of SSI.
In conclusion, prolonged duration of surgery was the only significant risk factor 
for SSI following THA. Although it did not reach statistical significance, the timing 
of the administration of the first dose of an antibiotic after incision seems to 
be the most important prophylaxis parameter. Multiple postoperative dosing did 
not contribute to reduction of the incidence of SSI. We strongly recommend that 
intervention programs on surgical prophylaxis focus on timely administration of the 
prophylactic antibiotic.
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Abstract
Background: Timely administration of the first dose, dosage adjustment to renal 
function, switch from intravenous to oral administration and streamlining are 
important aspects of rational antibiotic prescription. The goals of this study were 
to investigate all of these parameters, compare them with predefined quality 
standards, and implement improvement with specific interventions.
Methods: At the departments of internal medicine, surgery, and neurology and the 
emergency department of a tertiary referral university medical center, all consecutive 
patients receiving therapeutic antibiotics were enrolled. Dosages, timing of first 
doses, dosing intervals, administration routes, and adjustment of the chosen drug 
to clinical data were investigated. After the preintervention period, barriers to 
change were identified, followed by specific interventions and a postintervention 
measurement.
Results: In the preintervention and postintervention periods, 247 and 250 patients 
were enrolled, receiving 563 and 598 antibiotic prescriptions, respectively. The mean 
time from the order to first dose at the wards improved from 2.7 to 1.7 hours in 
potentially severe cases (P=0.003). Dosage adjustment to renal function remained 
unchanged at 45% vs 52% (P=0.09) of cases where necessary. Switching of therapy 
from intravenous to oral improved from 46% to 62% (P=0.03) and was performed 
a mean of 1.6 days earlier (P=0.002). Streamlining was performed correctly in most 
cases, and thus no interventions were necessary.
Conclusions: Timing of antibiotic therapy and switch therapy may be improved 
with a combination of interventions. To improve poor adjustment of dosing to 
renal function, other strategies are needed. In our setting, streamlining was already 
correct in most cases.
Introduction
Evidence-based medicine is the driving force behind the development of practice 
guidelines. However, introduction of such guidelines does not automatically lead to 
changes in clinical behavior.1 Up to the present, guidelines in antimicrobial therapy 
have mainly focused on the choice of the antibiotic. However, many other steps in 
the process of administration are important to guarantee optimal use of a drug, 
including: the right drug at the right moment at the right dosage for the right patient.2 
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Timely administration of the first dose, dosage adjustment to renal function, switch 
from intravenous (IV) to oral administration, and streamlining to narrow-spectrum 
antibiotics are important aspects of antibiotic use. Prompt administration of antibiotics 
improves morbidity, mortality and length of hospital stay.3-6 A previous study in our 
hospital showed that a median delay of 5 hours after presentation of a patient with a 
severe infection to the emergency department could be improved to 3 hours.7, 8 To our 
knowledge, timely administration of antibiotics has not been studied at sites other 
than the emergency department. Beside the timing of the first dose, administration of 
antibiotics in proper intervals across 24 hours is important, especially for drugs with 
a short half-life.9 Dosage adjustment of antibiotics to renal function is recommended 
for many antibiotics that are eliminated by the kidney. Avoiding dose adjustment 
to renal function leads to unnecessarily high plasma concentrations,10 adverse drug 
reactions,11 unnecessary costs, and an increased workload for nurses. Actual dose 
adjustment of antibiotics to renal function has, until recently, been neglected in 
quality assessment studies. Switch therapy, the change from IV to oral treatment, 
has been studied by several investigators in the past few years,12-16 and it has been 
shown to save costs, shorten length of hospital stay, and decrease adverse reactions 
of IV administration, with equal therapeutic outcome. Conceptually, streamlining of 
antibiotics (i.e, adjustment to narrow-spectrum therapy, guided by culture reports) 
can contribute to the prevention of antimicrobial resistance,2, 17 and an adequate 
system of reporting culture reports can support this process.
The goal of our study was to investigate all aforementioned key variables of the 
administration of antibiotics. On the basis of this investigation, key processes 
amenable for improvement were identified, and an intervention for optimization 
was designed and performed.
Patients and methods
Study design
The study was performed at a tertiary referral, university hospital (953 beds). All 
antibiotic prescriptions at the wards of internal medicine (general internal medicine, 
nephrology, gastroenterology, endocrinology, and oncology), surgery, and neurology 
(a total of 234 beds) were investigated during 2 separate periods. A total of 248 
nurses, 92 residents and 95 specialists were involved in the study. The study was 
performed with the permission of the hospital’s ethics committee.
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Data were collected in a preintervention and a postintervention period of 3 months 
each. We aimed to enroll 250 patients in each period. 
Data Collection
Patients eligible for inclusion were identified by checking all antibiotic prescriptions 
in the prescription charts of all admitted patients. The case-records of patients to 
whom antibiotics were prescribed were investigated, and the prescribing resident 
was interviewed. All consecutive patients with a first prescription of antibiotics were 
included. Patients who started antibiotic therapy at wards that did not participate 
in the study, outside the hospital, or for prophylactic reasons were excluded. At 
the surgical ward, patients who started antibiotic therapy in the intensive care unit 
and in the operating room were also included. An antibiotic course was defined as 
therapy with one or more antibiotics. 
Timely administration of the first dose was investigated in the emergency department 
as well as at the wards. The time of first administration and the administration 
schedule were obtained from the prescription chart. If the order for antibiotic therapy 
was given in the emergency department, the time of arrival in the emergency 
department was used to calculate the delay of initiation of therapy. If the order was 
given at the wards, the time at which the physician gave the order was obtained 
by searching the records or asking the prescribing physician. A maximum delay of 
4 hours between arrival and administration in the emergency department and a 
maximum delay of 2 hours between order and administration at the wards were 
accepted as allowable. Indications for antimicrobial therapy were divided into a 
requirement for immediate administration (ie, potentially severe infections) and a 
less urgent start of administration (ie, mild infections). Cases were defined as mild 
if there was no fever, hypotension, tachypnea, or tachycardia and if the leukocyte 
count was within the reference range. All other cases were considered potentially 
severe.
The ideal dosing interval was defined as: 24 hours divided by the number of 
daily doses. The actual dosing intervals were compared to this ideal interval, and 
the largest deviation per prescription was expressed as a percentage of the ideal 
interval.
Renal function was calculated according to the formula of Cockroft and Gault.18 A 
table for dosage adjustment to renal function, based on generally accepted data,19 
was available for prescribers in the antibiotic guidelines booklet of the hospital. 
The prescribed dosage was compared with this guideline.
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Criteria for switch from IV to oral therapy that were based on the literature 14-
16, 20-26 were proposed. These criteria were discussed with the infectious diseases 
specialists, microbiologists, and pharmacists of the hospital. The basic consensus 
criteria used in this study are given in Table 1. The day the patient fitted these 
criteria was defined as the per-protocol moment to switch from IV to oral therapy.
To study the correctness of streamlining, culture reports were collected and advice 
given by microbiologists or infectious diseases physicians were recorded. These 
were compared with the spectrum of the antibiotic actually prescribed at the 
moment all of the above information was available to the prescriber.
Table 1. Guidelines for switching from intravenous to oral administration of therapy.
Basic criteria Not eligible Sometimes eligible*
Significant clinical 
improvement
Hemodynamic stability
Evident normalizing body 
temperature
Normalizing leukocyte count
Good patient compliance
No signs of malabsorption
Ability to take oral medication
Good pharmacokinetics of oral 
antibiotic
Suitable oral alternative for IV 
medication available
Staphylococcus aureus 
bacteremia
Endocarditis
Meningitis or cerebral 
abscesses
Undrained abscesses, 
empyemas, mediastinitis
Intravascular infection (ie, 
infected valve or vascular  
prothesia, infected thrombus
Immunosuppressive therapy
Immunodeficiency
Neutropenia
Severe sorft tissue infections
Pseudomonas bacteremia
Exacerbation of cystic fibrosis
Severe intra-abdominal 
infection or endometritis
Liver abscesses, drained 
abscesses and empyemas, 
osteomyelitis, and arthritis 
can sometimes be switched 
after 2 wk of IV therapy
Abbreviation: IV, intravenous. * Indicates infectious disease consultation required
Intervention strategy
After the first registration period, barriers to change were identified and, with 
the support of key persons in the process, strategies to solve these problems 
were designed. Implementation strategies for improvement consisted of audit and 
feedback for all physicians and nurses in peer discussions, combined with mailings; 
stickers providing additional recommendations to be inserted into all antibiotic 
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guidelines booklets; adjustment of computers; and presentations by a local opinion 
leader (continuous medical education strategy).1, 27-29 No specific advice was given 
at the individual prescription level.
Statistics
Previous studies have shown that of all patients starting with IV antibiotics, 
approximately 40% were eligible for switch therapy.14, 15 To reach a statistical power 
of 80%, a total of 90 patients eligible for switch therapy was necessary to prove 
a 20% increase in correct use (α=0.05). By considering that 10% of the initial 
prescriptions are given orally, a total of 250 patients was needed in every group. In 
the case of timing, 50 patients in each group proved enough statistical power in a 
previous study of our hospital.8 
Time intervals were tested nonparametrically with the Mann-Whitney test. Standard 
errors of the mean are displayed unless stated otherwise. Categorical variables 
were tested with the χ2 test. A P value less than 0.05 was considered statistically 
significant.
Results
Pre-intervention results
During the pre-intervention period, 247 patients were included, who received 298 
courses of antibiotics, consisting of a total of 563 antibiotic prescriptions. The 
distribution across the wards is given in Table 2. Two hundred seventeen orders 
for antibiotic courses were given at the wards; 62 were given in the emergency 
department, 11 in the operating room, and 8 in the intensive care unit. 
The mean time from arrival in the emergency department to administration of 
the first dose of antibiotics was 4.2 ± 0.3 hours. Of these 58 patients, 33 (57%) 
received their first dose within 4 hours after arrival and 11 (19%) received their first 
dose in the emergency department. 
At the wards, the interval between physician’s order to the first administration of 
antibiotics was measured. Exact prescription and administration times were known 
for 151 courses. The mean delay between the order and administration of first dose of 
antibiotics at the wards was 4.1 ± 0.5 hours. Of 113 potentially severe cases, therapy 
was started in 66 (58%) within 2 hours of prescription (mean, 2.8 ± 0.3 hours). 
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Table 2. Demographic characteristics* 
Preintervention
(n=247)
Postintervention
(n=250)
Wards, No. of patients
 Internal medicine
 Surgery
 Neurology
166
56
25
165
60
25
Sex, M/F 123/124 110/140†
Mean age, y 58.4 58.9
No.of courses 298 299
No. of prescriptions 563 598
Urinary tract infections 80 52‡
Respiratory infections 65 91‡
Abdominal infections 48 56
Sepsis without definite focus/ intravascular infection 20 28
Skin/wound infections 24 26
Fever and neutropenia 20 11
Fever without definite focus 13 11
Abscess/empyema/osteomyelitis/arthritis 11 8
Miscellaneous 17 16
Positive blood-culture findings 57 52
* Unless otherwise indicated, data are expressed as number of courses. † P<0.05. ‡ P<0.01
Exact administration schedules were known for 498 prescriptions. A maximum 
deviation of more than 50% of the ideal interval was found in 39 cases (8%). In 57 
prescriptions (11%), this deviation was more than 33%. For oral administration, 37 
(21%) of 180 were found to deviate by more than 33% and 26 (14.4%) were found 
to deviate more than 50% of the ideal interval. 
Renal function could be calculated for 225 of the 247 patients. A renal clearance 
rate less than 50 ml/min, at which most antibiotics require dosage adjustment, 
was present in 69 (31%) of 225 patients. These patients received 168 antibiotic 
prescriptions, of which 129 required dosage adjustment according to the antibiotic 
guidelines. The antibiotic dosage was adjusted in 58 (45%) of 129 cases. The risk 
for nonadjustment in elderly patients with an impaired renal function was high; 
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the odds ratio for nonadjustment was 3.1 in patients older than 65 years and 2.9 
in those older than 75 years. The finding of a serum creatinine level less than 1.13 
mg/dl (<100 µmol/l) may have masked an impaired renal function in elderly patients 
with low body weight. The odds ratio for nonadjustment of the antibiotic dose in 
patients with a creatinine clearance less than 50 ml/min and a serum creatinine 
level less than 1.13 mg/dl (<100 µmol/l) was 3.7. The percentage of failures in 
adjusting the dosage did not differ significantly between the specialties studied.
Antibiotic therapy was started intravenously in 184 of 247 first courses. Of these, 
98 were eligible for switch to oral administration. This procedure was actually 
performed in 45 cases (46%), with a mean delay of 2.3 days after the per-protocol 
moment. Unjustified switch therapy was performed in one case.
One or more culture specimens were taken in 225 (91%) of 247 cases. Streamlining 
of antibiotic therapy was considered necessary in 71 (51%) of 139 cases with positive 
culture results. It was not performed in 6 cases (8%), and it was performed improperly 
in 6 cases (8%). In 59 cases (83%), streamlining was performed correctly (Figure 1).
patients
n=247
culture taken
n=225
no culture taken
n=22
no growth
n=86
positive culture
n=139
streamlining not 
necessary
n=68
streamlining
necessary
n=71
correct
streamlining
n=59
incorrect
n=12
no streamlining
performed
n=6
improper choice 
of antibiotic
n=6
Figure 1. Profile of patients included in analysis of antibiotic streamlining.  Appropriateness of streamlining 
can only be assessed in case of cultures with positive results.
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Barriers to change
After the first registration period, the barriers to change were identified, in 
cooperation with all departments involved (Table 3). Barriers to change timely 
administration were several. At the wards, misinterpretation of the urgency of the 
order by nurses was often a serious cause of delay. In addition, time-consuming 
diagnostic procedures and decision making may have given nurses the unjustified 
feeling of nonurgent therapy. Transfer from the emergency department to the wards 
was an important cause of delay, if the patient had not received the first dose at 
the emergency department.
Table 3. Barriers to change 
Timing Order to nurse unclear
Urgency of antibiotic therapy not known
Time-consuming decision making 
Postponement of first dose to regular medication round 
Waiting for obtainment of cultures
Intravenous access not yet available
Antibiotics not immediately available at the ward
Transfer from emergency room to ward
Dosing intervals Administration of oral antibiotics with meals
No administration of drugs at nighttime
Dose adjustment to renal function Underestimation of the prevalence of renal insufficiency
Serum creatinine <1.6 mg/dl (<140 µmol/l) considered as 
safe, especially in elderly patients
Failure to calculate creatinine clearance
Switch Unawareness of the concept of switching therapy
Administration schedules used by nurses for orally administered antibiotics were 
not ideal for two main reasons. First, oral antibiotics were often given during 
the meals. Second, the dosing interval during the night was often prolonged for 
logistical reasons. Reasons for omitting dosage adjustment to renal function were 
underestimation of the prevalence of renal insufficiency; considering a serum 
creatinine value less than 1.6 mg/dl (140 µmol/l) as safe; no application of the 
formula of Cockroft and Gault and no easy access to this formula. The most 
important factor for not switching from IV to oral therapy was the unawareness of 
the principles of switch therapy. In most cases, streamlining was optimal, and no 
barriers to change could be defined.
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Interventions
To address the identified barriers to change, all physicians and nurses were 
approached by a direct mailing and the residents in internal medicine were addressed 
regularly during weekly courses in infectious diseases. Discussions with peers were 
held, and audit and feed back of the findings were performed for all physicians and 
nurses in attendance of a local opinion leader. In addition, the following specific 
interventions were made. To improve timely administration, several antibiotics 
were made more easily available at the wards. To improve dosage adjustment to 
renal function, all computers on the wards were equipped with the Cockroft and 
Gault’s formula on the desktop (Excel spreadsheet, Microsoft 1997; Microsoft Corp, 
Redmond, Wash). Surgeons received a sticker with a table containing estimated 
renal function, which could be pasted into their antibiotic guidelines booklet. To 
improve switch therapy, all physicians received stickers with switch criteria as well 
as possible oral alternatives to IV therapy (Table 1) to be pasted into their antibiotic 
guidelines booklet. Nurses were instructed to remind physicians to the possibility 
of switch after two days of IV therapy.
Post-intervention results
The number of patients, courses, and prescriptions and the distribution across the 
wards were similar to those of the preintervention period. Only the male-female 
distribution was significantly different. The basic demographic data of both periods 
are given in Table 2.
The mean delay from the order to first dose in the wards decreased from 4.1 to 
2.6 hours (P=0.003) for all cases and from 2.7 to 1.7 hours in potentially severe 
cases (Figure 2a; P=0.003). The number of first administrations in the wards within 
2 hours in potentially severe cases increased from 60% to 76% (P=0.02). For mild 
infections, the mean delay in the wards decreased from 8.0 to 4.1 hours (Figure 2b; 
P=0.006). The number of first administrations that were postponed until the next 
day decreased from 9 to 3 cases.
The mean time from arrival in the emergency department to the first dose decreased 
from 4.2 to 3.9 hours (Figure 2c; P=0.30). The number of first doses administered in 
the emergency department increased from 19% to 27% (P=0.13). 
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Figure 2. Timing of administration of the first dose of antibiotics, including time from the order to the 
first dose during the preintervention and postintervention periods at the wards in potentially severe 
cases (A) and mild cases (B), and time from arrival at the emergency department to the first dose in 
potentially severe cases (C). 
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Exact administration schedules were known for 549 prescriptions in the 
postintervention period. A maximum deviation of more than 33% of the ideal 
administration interval decreased from 11% to 8% of the prescriptions (P=0.045). 
For oral administration, deviations from more than one third of the interval improved 
from 21% to 14% (P=0.056).
In the postintervention period, creatinine clearance was less than 50 ml/min in 
68 (30%) of 224 patients for whom renal function could be calculated. Dosage 
adjustment was necessary in 129 of 171 antibiotic prescriptions. The number of 
correct prescriptions improved from 45% to 52% (P=0.09).
Of 180 first courses that were started as IV therapy in the postintervention period, 
97 were eligible for switch therapy. The amount of IV courses with appropriate 
switch to oral administration increased from 46% to 62% (P=0.03). The switch was 
performed 1.6 days earlier with a mean of 0.7 days after the per-protocol moment 
(P=0.002). In three cases, a switch back to IV therapy had to be performed, in one 
case because of noncompliance, in another because of clinical deterioration on the 
day of the switch, and in another because the choice of drug was not adequate.
Discussion
The present study shows that timely administration of the first dose, dosing intervals, 
dosage adjustment to renal function, and switch to oral administration of antibiotics 
are amenable for improvement in a hospital setting. By using a combination of 
audit and feedback, peer discussions, continuous medical education, stickers to be 
pasted into the antibiotic guidelines booklets, and provision of computer programs, 
the timing of first dose, dosing intervals, and switch therapy could be improved. 
However, dosage adjustment to renal function and timely initiation of therapy in the 
emergency department showed a small, nonsignificant improvement. Remarkably, 
streamlining was already performed correctly in most cases, and the number of 
failures was too small to achieve improvement.
An evident improvement was achieved in the delay to first dose administration 
at the wards. In contrast to our emergency department, no previous intervention 
has been performed on this subject at the wards. The delay to administration of 
the first dose in cases of a mild infection decreased by almost 50%. First doses 
postponed until the next day were less frequent, as a sign of rising awareness of 
the importance of antibiotic timing. 
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The increasing tendency to switch from IV to oral administration underscores the 
requirement of correct dosing intervals of orally administered antibiotics.30 In the 
Netherlands, drug orders are usually given as number of doses per day, rather than 
in terms of a fixed dosing interval. In most cases, the actual times of administration 
are chosen by the nurse, rather than by the physician. Nurses often try to give 
medication with meals to avoid inconvenient hours. The huge deviations from the 
ideal interval that may arise are especially undesirable in drugs with short serum 
half-lives. This problem improved significantly in our postintervention period.
The prevalence of patients with a severely impaired renal function was very high 
in the present study. Thus, a large number of prescriptions required dosage 
adjustment, but we were not yet successful at improving actual dose adjustment 
with our interventions. Especially in the elderly patients with serum creatinine 
levels in the reference range, renal function is erroneously considered normal, and 
overdosing of antibiotics occurs. Correct dosing will decrease adverse reactions, 
the workload for nurses, and antibiotic selection pressure, and will save money. 
The presence of a pharmacokinetics service, which monitors dosing of selected 
drugs on request, apparently does not prevent erroneous dosing in large number 
of cases. Computerized support systems linking patient data and laboratory results 
to prescriptions may help to solve the problem. 
In most studies on switch therapy, an infectious diseases consultation at the 
individual patient level governs the decision to switch to oral treatment. This is 
considered the most effective method to implement switch therapy.14, 31, 32 However, 
this method is costly and time-consuming, and not all patients who receive 
antibiotics may be traced and covered. Therefore, we implemented a stringent 
protocol aimed at the attending physician, without infectious diseases consultation 
unless in cases of doubt. In the present study, the percentage of patients eligible 
for switch therapy was slightly higher than in other studies, probably because not 
all of the departments were involved in the study. With combined interventions, 
we could improve switch therapy to 63% of applicable cases, suggesting that 
significant improvement can be achieved with relatively cheap but multifaceted 
interventions.
The motto “never change a winning team” may lead to continuation of broad- 
spectrum antibiotic therapy, even when this is unnecessary with respect to the 
causative microorganism. However, in the present study, optimal streamlining 
was performed in most cases, and thus no intervention was found necessary. The 
adherence to streamlining rules most likely is the result of an active policy of 
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unsolicited infectious diseases consultations in every case of positive blood culture 
results and to previous continuing education of residents.
Often the beneficial effects of educational campaigns are observed to be short-
lived unless the intervention is continuously applied. However, during the 3-
month postintervention period, there was no decrease in adherence to the various 
aspects of the intervention (data not shown). Since the previous intervention in 
the emergency room 7,8 4 years earlier, the delay to first dose administration had 
increased slightly. Repeated measurements are required to monitor continued 
adherence in the future.
Conclusions
The present study demonstrates that interventions supported by a multidisciplinary 
team consisting of infectious diseases specialists, medical microbiologists, clinical 
pharmacists, nephrologists, and nurses leads to improvements of the process of 
care in the area of administration of antibiotics. 
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Abstract
Objective: to study the barriers to change for implementation of a guideline for 
surgical prophylaxis.
Methods: Questionnaire, audits and on site visits in 13 Dutch hospitals participating 
in the Surgical Prophylaxis and Surveillance Study (CHIPS). 
Results: To achieve a change in antibiotic choice, the chairman of the antibiotic policy 
committee was the key player, and barriers for change were lack of agreement with 
antibiotic choice. To optimize the duration of prophylaxis, key players for change 
were the surgeons, and barriers were lack of agreement – especially in orthopaedic 
surgery –, and lack of outcome expectancy. Regarding timing of administration, the 
anaesthetists and, importantly, anaesthesiology nurses were the key players for 
improvement, whereas organisational constraints; for example time of arrival at the 
surgical suite and time spent in holding area, test-dose before actual administration 
and infusion instead of bolus injection, were the most important barriers to change. 
The nature of these organisational constraints differed per surgical specialty and 
per hospital.
Conclusion: Barriers to change involved in the implementation of a guideline for 
surgical prophylaxis differ per parameter of prophylaxis, between surgical specialties 
and within hospitals. Therefore, identification of the specific, local barriers to 
change, as well as identifying and working with the key players for change in the 
local setting is essential for the successful implementation of antibiotic policy.
Introduction
The administration of perioperative antibiotics is one of the tools used to reduce 
the incidence of surgical site infections (SSI).1 Misuse of antibiotics for prophylaxis 
however is quite common.2-5 In general, prolonged use of antibiotics and the use of 
broad spectrum antibiotics have been shown not to improve the efficacy of surgical 
prophylaxis 6-10 but rather lead to higher costs and increased risk of development of 
resistance.11 Inappropriate timing however, is associated with decreased efficacy.12,13 
Therefore, the Dutch Working Party on Antibiotic Policy (SWAB) has issued guidelines 
for surgical prophylaxis in the Netherlands, advocating prudent use of antibiotics in 
terms of single dose prophylaxis with the narrow spectrum antibiotic within 30 minutes 
before incision. In this guideline, cefazolin is the recommended drug, supplemented 
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by metronidazole for surgery at sites with a prevalence of anaerobic bacteria.14 Many 
guidelines however are abandoned in daily practice, and various implementation 
strategies have been used with mixed success.15,16 There is no magic implementation 
strategy, and a successful strategy in one setting can be totally ineffective in the 
other.17 Adherence to clinical guidelines may be hindered by a variety of barriers, 
which can be highly situational and depend upon the various health-care providers 
involved.18,19 In surgical prophylaxis, the stakeholders are antibiotic committees and 
infection control committees, in which surgeons, pharmacists, anaesthetists and 
microbiologists are represented, as well as the anaesthesiology nurses and nurses 
on the ward. Identification of barriers to change in these groups can help to target 
interventions and thereby facilitate the process of guideline implementation. 
The multisite intervention project CHIPS (Dutch acronym for Surgical Prophylaxis and 
Surveillance of Infection) was conducted from 2000 to 2002 in 13 Dutch hospitals to 
implement the national SWAB guidelines on surgical prophylaxis.20 The present article 
describes the barriers to change that were encountered during the implementation 
and their impact on the effect of the intervention at the various sites.
Methods
Design of the intervention study
The present intervention study aimed at optimizing antibiotic prophylaxis in terms 
of antibiotic choice, duration and timing by promoting single dose prophylaxis with 
cefazolin within 30 minutes before the surgical incision.14
The study was conducted in the surgical departments of 13 Dutch hospitals 
participating in the CHIPS study.20 Between January 2000 and October 2002, the 
quality of prophylaxis was audited before and after an intervention. A total number 
of 2097 orthopaedic, 344 vascular, 864 gynaecological and 508 intestinal procedures 
were investigated.
Method of intervention, process evaluation and inventory of barriers to change
The CHIPS intervention team consisted of an infectious disease physician and 
an infection control professional (ICP). This team was supported by two senior 
infectious disease physicians, an epidemiologist, and a consultant of the Quality 
Institute CBO. Opinion leaders from the surgical specialties involved served as an 
advisory committee. 
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Audit and feedback was used as the main intervention strategy to make participating 
hospitals aware of the local situation and to motivate them for change. 
A step-wise approach was followed:
Step one: Hospital specific audit data of the pre-intervention period were fed back 
as a written report, and specific recommendations for improvement were given to 
individual hospitals depending on the outcome of the audit.
Step two: The national guideline for surgical prophylaxis was distributed among 
surgeons, anaesthetists, pharmacists, microbiologists, the committee on antibiotic 
policy and the infection control committee. A questionnaire was sent to the 
chairpersons of the antibiotic policy committees of the participating hospitals to 
evaluate their opinion about the national guideline.
Step three: On site, meetings were organised with medical microbiologists, members 
of the antibiotic policy committee, surgeons, anaesthetists and anaesthesiology 
nurses to discuss the data, and to define, per parameter of prophylaxis, the key 
players for improvement as well as to make an inventory of barriers to change. 
Barriers to change were grouped according to the classification by Cabana 19,21 
whether they affect internal barriers, such as knowledge (lack of awareness or lack 
of familiarity) or attitude (lack of agreement, lack of self-efficacy, lack of outcome 
expectancy, inertia of previous practice) or external barriers, i.e., organisational 
constraints. 
Step four: Depending on the results of the barriers to change, local implementation 
strategies were formulated and a local intervention team was formed.
Step five: Implementation of revised guidelines by local intervention teams was 
facilitated by the CHIPS team by organising educational meetings and by providing 
plasticized reminder cards which could be pasted on the wall of the operating 
theatre. 
Step six:  Audit of prophylaxis after intervention, evaluation of success, identification 
of features to failure or success.
Results
Thirteen hospitals were included in the study, 5 teaching hospitals, including two 
university hospitals, and 8 community hospitals. The chairpersons of the antibiotic 
policy committees (9 microbiologists, 3 hospital pharmacists, 1 infectious diseases 
physician) from all 13 hospitals returned the questionnaire. 
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Antibiotic choice
The audit revealed that in 12 of the 13 hospitals, independent of surgical specialty, 
the administered antibiotic was not cefazolin but mostly a second generation 
cephalosporin. In 11 of these 12 hospitals, the local guidelines did not recommend 
cefazolin and needed to be updated. 
Inventory of barriers to change
The questionnaire showed that the antibiotic policy committee chairperson agreed 
on cefazolin as the first choice agent in 10 out of 12 hospitals.
During discussions of the results of the audit with the physicians, it became clear that 
surgeons generally follow the recommendations of the antibiotic policy committee 
(APC) regarding the antibiotic choice. For the intervention team, this meant that 
key players for improvement of antibiotic choice in these hospitals should be the 
members of the APC. Results of the discussions with APC representatives showed 
only minimal barriers to antibiotic change at this level. Only in two hospitals the 
APC disagreed with the choice of cefazolin, which confirmed the results of the 
questionnaire. This barrier was classified as lack of agreement (Table 1). 
In two other hospitals, there were barriers affecting behaviour. In these hospitals, the 
APC experienced organisational constraints, (Table 1) as they preferred simultaneous 
hospital-wide implementation of a new antibiotic choice, rather than in those 
specialties involved in the present study only. This hospital-wide implementation 
was considered not feasible within the time schedule of the study. Therefore, 
guideline changes in these hospitals were postponed. In one hospital, where the 
guideline recommended cefazolin, an additional barrier affecting knowledge was 
identified: a lack of awareness of orthopaedic surgeons with a recent APC guideline 
change favouring cefazolin.
Implementation and evaluation
The representatives of the APCs of 8 hospitals prepared guideline changes by 
organising local consensus meetings with all members of the APCs and the surgeons. 
After reaching consensus, updated prophylaxis guidelines were disseminated on 
paper and presented at local educational meetings. The hospital pharmacists 
made sure that cefazolin was in stock at the theatres and that other prophylactic 
antibiotics were removed. The role of the CHIPS team was mainly one of support, 
e.g., by giving oral presentations or by providing hospitals with reminder cards 
which could be pasted on the wall of the theatres.
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When guidelines were updated by the local APCs, surgeons confined themselves to 
these guidelines, and a significant improvement in antibiotic choice was achieved 
(Table 2); In hospital F, increased awareness of the original APC guideline after the 
intervention led to a major increase of cefazolin prophylaxis in orthopaedic surgery.
Table 2. Determinants of timing of prophylaxis
Determinants 
Effect on timing of 
administration
Suggestions for improvement in case of 
incorrect timing
More time spend at holding area 
prior to surgery
Earlier In case of general surgery; timing mostly 
too late: earlier arrival at holding area.
In case of othopaedic surgery; timing 
mostly too early: delay administration 
untill transfer to operating theatre.
Intubation before administration 
of antibiotics
Later Administration of antibiotic before 
intubation 
Test dose before administration 
of full dose of antibiotic
Later Only test dose in case of presumed 
allergy
Mode of administration of 
antibiotic as infusate 
Later If possible, administer antibiotic as push
Indication for prophylaxis written 
down in record 
Earlier Provide written instruction in medical 
record
Duration of prophylaxis
As was assessed in the audit, prolonged administration of prophylactic antibiotics 
after surgery was extended at the ward in 8 hospitals. There were large differences 
between surgical specialties. Extended prophylaxis was a problem almost exclusively 
encountered in orthopaedic surgery, except for one hospital where general surgeons 
also continued the prophylactic antibiotics postoperatively. In total, six hospitals 
recommended a duration of 24 hours of prophylaxis in their local guideline 
(D,F,G,H,I,K).
Inventory of barriers to change
The questionnaire showed that the chairperson of the APC of all 8 hospitals agreed 
on single dose prophylaxis.
After discussing the results with the microbiologists and the orthopaedic surgeons 
during on-site meetings, it became clear that the APCs had aimed to change the 
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local guidelines in the past, but orthopaedic surgeons were not convinced about 
the efficacy of single-dose prophylaxis. Although antibiotic policymakers 14,22 refer 
to a Dutch study of prophylaxis in 2651 hip replacements 23 to support single 
dose prophylaxis, orthopaedic surgeons referred to the same study to favour 24 
h prophylaxis. After discussions with the orthopaedic surgeons, the barriers to 
change affecting attitude, i.e., lack of agreement and a lack of outcome expectancy 
with single dose prophylaxis, remained in 5 hospitals. (Table 1). Thus, the inventory 
of barriers identified orthopaedic surgeons as key players for improvement, and 
convincing these surgeons of the efficacy of single dose prophylaxis was necessary 
before implementing new guidelines. 
In hospital H, the general surgeons were motivated for a change to single dose 
prophylaxis in bowel surgery. The major barrier for prolonged administration of 
prophylaxis in this hospital was an inadequate stop order at the ward, a barrier of 
organisational constraint (Table 1).
Implementation and evaluation
In order to convince orthopaedic surgeons to switch to single dose prophylaxis, the 
CHIPS team presented the audit reports containing discussions of the literature in 
the various hospitals. Because no consensus could be obtained, the primary author 
of the aforementioned Dutch trial on duration of prophylaxis in orthopaedic surgery, 
who was asked to act as opinion leader, wrote a personal comment on his own 
study supporting the use of single dose prophylaxis. This comment was sent to all 
orthopaedic surgeons involved. 
Ultimately, single dose recommendations were accepted by the orthopaedic 
surgeons in only two hospitals (G,I). In these hospitals, a significant increase in 
single dose administration was achieved. In hospital H, were the lack of clear stop 
orders resulted in prolonged administration, the nurses were requested to check 
whether administration of the prophylactic antibiotic was stopped after surgery. 
This resulted in a significant shortening of the duration of prophylaxis in intestinal 
surgery.
Timing of antibiotic administration
According to the audit results, timing of the first dose was not within 30 minutes 
before the surgical incision in at least 28% of the surgical procedures in all 
participating hospitals. In some hospitals, this occurred in up to 80 % of the 
procedures. In four hospitals, the local guidelines recommended to administer the 
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first dose before the incision, but there was no exact recommendation for the 
appropriate timing. Marked differences between surgical specialties in the way 
timing was discordant with the SWAB-guideline were observed in all hospitals. The 
moment of administration of the first dose was significantly earlier in orthopaedic 
surgery than in intestinal and gynaecological surgery. In orthopaedic surgery, the 
first dose was most often administered between 30 and 60 minutes before the 
incision instead of within 30 min. as recommended in the guideline. In most 
gynaecological and intestinal procedures however, the antibiotic was administered 
after the incision. In one hospital (H), the first dose was administered at the ward 
before the operative procedure in more than half of the patients. This led to too 
early administration of prophylaxis in orthopaedic as well as intestinal surgery. 
Inventory of barriers to change
The questionnaire showed that the chairperson of the APC of 13 hospitals agreed 
on optimal timing within 30 minutes prior to the incision. 
In all hospitals, anaesthetists and local ICPs attended the on-site meetings. In 
half of the hospitals, the anaesthesiology nurses could also be interviewed. In 12 
out of 13 hospitals, administration of the antibiotics was the anaesthetist’s duty, 
most often delegated to the anaesthesiology nurse. The intervention team should 
therefore focus on the anaesthetist and anaesthesiology nurses as key players of 
improvement. Not all anaesthetists considered timing within 30 minutes before 
incision a high priority, and there were barriers affecting attitude, such as lack of 
motivation to change or a lack of outcome expectancy (Table 1). In discussing the 
process of preparing the patient for surgery, the anaesthetists and anaesthesiology 
nurses pointed out several determinants of the timing of the administration of the 
first dose of prophylaxis that could be identified as organisational constraints. 
These determinants are time of arrival at the surgical suite and time spend in the 
holding area, the need of a test dose before the actual administration of the full 
dose of the antibiotic, delaying administration after intubation, administration as 
infusion in stead of bolus injection and a written order for prophylaxis in stead of 
the need to wait for instructions (Table 2). The way these factors influenced the 
timing could differ per surgical specialty. For example, in orthopaedic surgery, which 
is often performed under loco-regional anaesthesia, the patient usually arrives 
amply before the start of surgery, which enables the anaesthetist to administer 
prophylaxis early. Intestinal and gynaecological surgery however, are generally 
performed under general anaesthesia, and the interval between time of arrival 
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at the operating theatre and start of surgery is much shorter, which leaves less 
time for the proceedings of the anaesthetist and can result in administration of 
prophylactic antibiotics after the incision. In intestinal surgery, metronidazole has 
to be administered as an infusion, which takes more time than push administration 
of cefazolin. 
Several anaesthesists argued that postponing the administration of antibiotics until 
after intubation was preferred, to have airway access in case of anaphylaxis. As 
most antibiotics in intramural and extramural health care are administered without 
prior intubation, it may be argued that this notion is debatable. 
Implementation and evaluation
The CHIPS team initiated educational meetings with anaesthesiology nurses and 
gave suggestions to remove the barriers to change (Table 2).
In general, improvement of the timing was a difficult process, and changing logistics 
was not easy. In particular, the unpredictable time of arrival of the patient at the 
surgical suite was a structural problem that could not be solved easily in most 
hospitals. 
Only in those hospitals in which both the anaesthetists considered timing to be a 
priority issue and a special meeting was organised for the anaesthesiology nurses, 
the organisational constraints could be overcome and improvement in timing could 
be achieved (Table 3). The timing in hospital E showed no improvement, and it even 
deteriorated in hospital F. In that hospital, timing had improved in gynaecological 
surgery, i.e., the number of patients for whom timing was too late did decrease. On 
the other hand, in orthopaedic surgery, prophylaxis was administered more than 30 
minutes before the incision, i.e., too early, for significantly more patients, as a result 
of implementing new hospital-wide guidelines for administration of prophylaxis in 
the holding area. This example underscores the notion that specific strategies to 
improve timing have to be developed for each specialty. In orthopaedic surgery, 
too early administration may be prevented by withholding the administration of 
the antibiotic until patient is transferred from the holding area to the theatre. In 
intestinal surgery however, timing can be improved when antibiotics are administered 
earlier, that is in the holding area, instead of waiting until the surgeon arrives in the 
theatre to approve on administration. This is particularly important for antibiotics 
that have to be administered as an infusion and thus require additional time to 
reach adequate tissue concentrations.
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Table 3. Effect of implementation on improvement of timing in relation to meetings with anaesthesiology 
nurses 
Hospital
Meeting with 
anaesthesiology 
nurses
Facilitators 
involved in 
meeting
before
% within 30 min 
to incision
after
% change to 
within 30 min
G yes no 20 +71
H yes yes 13 +54
K yes no 16 +45
J yes no 35 +28 
E yes yes 61 +13
M no no 49 + 11
C no no 57 +10
L no no 37 +7
B no no 49 +3
A no no 72 -3
F * yes yes 62 -6
D no no 72 -12
I no no 72 -12
* in this hospital timing after the intervention improved in gynaecological but detoriated in orthopedic 
surgery.
Discussion 
This study shows that an identical set of interventions to implement a national 
guideline in hospitals, i.e., audit and feedback, dissemination and update of 
guidelines, and use of opinion leaders, can have variable process outcome results 
when used at different sites. There is a lack of evidence on which implementation 
methods are most effective. In most studies, audit and feedback showed modest 
effects with mixed results 15,16,24 and little is known about how and when it works 
best.25,26 Dissemination of printed material is considered to be less efficacious. 
Reminders and educational outreach perform best, but these strategies are very 
costly and time-consuming. In the present study, resources for implementation were 
limited, and the funding was used to appoint one infectious diseases specialist and 
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one coordinating ICP for 13 sites. They could therefore only serve as moderators of 
local initiatives. Within this setting, audit and feedback was considered the most 
feasible method. 
Whatever implementation method is used, an inventory of barriers to change is 
essential to develop local strategies to facilitate guideline adherence.18 The existence 
of local barriers is one of the main reasons why the same implementation strategy 
shows divergent results in different settings. Identification of, and access to the 
key players for improvement was essential for successful implementation and this 
differed per hospital but also per item that had to be changed. Our inventory of 
barriers to change showed that when evidence for the guideline was weak, e.g., in 
case of duration of prophylaxis, the success of the implementation was limited. This 
is in line with results from previous studies on guideline adherence.19,27 
In case of changing the timing of prophylaxis, our study showed that organisational 
constraints played a central role. A recent study by Tan e.a, exploring obstacels for 
proper timing, also pointed out that the issue of workflow was a main reason for 
inappropriate timing.28 To overcome these barriers our study showed that those 
who were directly involved in patient care, were to be reached.
In conclusion, this study shows that an implementation method of audit and 
feedback can yield divergent results when applied in different hospitals, in different 
surgical specialties, and even according to the item that one wants to change. 
Barriers to change involved in a specific aspect of a guideline may be different 
between hospitals, even in a homogenous set of hospitals within one country, and 
thus should be assessed locally. Identifying and getting access to the key players 
for change is essential for success as well as identification of barriers to change. 
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General discussion 
In this thesis, the results of studies aimed at improving the quality of antibiotic 
use in prophylaxis as well as in therapy are presented. The major part of the thesis 
concentrates on the CHIPS project, which aimed at improving surgical prophylaxis 
and measured both process and patient outcome. Our study proved that, even 
in a country with a history of prudent antibiotic use, important improvements in 
quality of surgical prophylaxis may be achieved, and cost savings could be obtained 
while maintaining efficacy in terms of prevention of surgical site infections. Timely 
administration of antibiotics in prophylaxis as well as in therapy is appreciated in 
the literature as a factor that determines patient outcome. 
Our study has shown that, even though influencing the process of timing of antibiotic 
administration may be complicated, improvements can be achieved.
Methods of the CHIPS study
By using the operational national surveillance network of PREZIES, patient outcome 
data could be collected and correlated to process outcome, which made the CHIPS 
study unique. Due to the extensive experience of local infection control professionals 
(ICPs), the quality of the data collection was excellent. In Chapter 1.2 we showed 
however that recruitment of hospitals for such a large study without any prospect of 
financial compensation was cumbersome. Data collection and processing were very 
time-consuming. Auditing and intervention projects could not always be prioritized, 
due to vacancies for ICPs in the hospitals. 
In the early days of the study, the established contacts of PREZIES acted as the 
hospital contacts for the CHIPS study, i.e., mainly ICPs and chairpersons of infection 
control and antibiotic policy committees, of which the majority were medical 
microbiologists or hospital pharmacists. Promotion of prudent use of antimicrobial 
drugs appealed to these professionals, as was their awareness of the problem of 
antimicrobial resistance. At a later stage of the study, surgeons were involved in 
most hospitals, who feel safer with maximal prophylaxis rather than a prudent and 
cost-effective regimen, and tend to administer prophylaxis a little longer rather 
than for a short period. In discussing the targets of the CHIPS study, surgeons were 
better motivated for prophylaxis changes that would reduce the incidence of SSI 
rather than for prudent use of antibiotics without an increase in SSI. 
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Auditing adherence to local guidelines for prophylaxis
The inventory of the local guidelines for surgical prophylaxis (Chapter 2) showed 
that, compared to other countries, local antibiotic policies on duration and timing 
of surgical prophylaxis in the Netherlands were already relatively strict before the 
intervention.1,2 The majority of the hospital policies recommended single dose 
prophylaxis, or a duration of no more than 24 hours. The adherence to these local 
guidelines in terms of antibiotic choice and duration was high, again reflecting 
the general pattern of prudent antibiotic use in the Netherlands.3 Reasons for not 
following local guidelines were lack of awareness, due to ineffective distribution of 
the most recent version of the guidelines, or lack of agreement by surgeons with the 
guidelines established by the antibiotic policy committee. As an example, in some 
hospitals orthopaedic surgeons did not agree with hospital guidelines advocating 
single dose prophylaxis, and had developed their own guidelines recommending 
24h prophylaxis, subsequently fully adhering to their revised guidelines. Although 
antibiotic policy committees prefer to develop local guidelines that are in line with 
national and international guidelines, issuing guidelines with which the stakeholders 
disagree is known to lead to poor adherence.4 The compliance with local guidelines 
for timing of administration was much lower. This has been described earlier in the 
international literature.5,6 
Intervention on the quality of surgical prophylaxis; process outcome
In Chapter 3, the effect of an intervention on the quality of surgical prophylaxis 
was assessed. The intervention was aimed at implementation of the national SWAB 
guideline, which promotes prophylaxis with a single i.v. dose of cefazolin (plus 
metronidazole if coverage of anaerobic bacteria is warranted) within 30 minutes 
before the incision. The intervention by the CHIPS team resulted in important 
improvements of all aspects of prophylaxis and showed that, even in a country with 
a tradition of prudent use, antibiotic cost savings could be made while containing 
efficacy in terms of prevention of SSI. By using segmented regression analysis with 
an interrupted time series design, our study met the criteria for a proper intervention 
study as recommended by The Cochrane Effective Practice and Organisation of 
Care Group (EPOC). The possibility that the improvement had been the result of a 
gradual change over time not related to the intervention could be excluded. This is 
in contrast to a variety of other recently published implementation studies with a 
suboptimal design, where confounding by changes over time has not been taken 
into account.1,7-9 
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It may be argued that any national clinical guideline should be easily applicable 
in everyday clinical work. From this point of view, it is alarming that only every 
fourth patient received completely appropriate prophylaxis despite our intervention. 
Although the intervention resulted in improvement on all three parameters – choice, 
duration, and timing of prophylaxis –, establishing a change in timing of the first 
dose and in duration of prophylaxis was more difficult than antibiotic choice. Recent 
surveillance data from the Surgical Infection Prevention Project from the US showed 
that, even when goals were less ambitious, i.e. aiming at a duration no longer than 
24 hours or timing of administration within 60 minutes before the incision, adherence 
to that guideline after two years of surveillance and intervention only improved 
from 40.7 to 52.9%.10 Timing improved from 47.6% to 69.7% concordant cases. 
Adherence to antibiotic choice, however, was correct in 92.2% after intervention. 
Intervention on quality of surgical prophylaxis; patient outcome
Our study was unique as it did not only provide data on process outcome but also 
on patient outcome. As shown in Chapter 4, the more prudent use of antibiotics as 
established by implementation of the guideline did not have any detrimental effect 
on the rate of surgical site infections (SSI). Due to the overrepresentation of clean 
procedures, the actual SSI rate (5.4% before intervention) was lower than expected 
(7.5%). Therefore, although we included more procedures than the number that 
was originally required by the power calculations, i.e. 1668 before and 1953 after 
the intervention, the power of the study may have been suboptimal to detect small 
differences. The confidence intervals of the SSI rates before and after intervention, 
however, were narrow: the SSI rate before intervention was 5.4% (95% CI: 4.3–6.5) 
and the SSI rate after intervention 4.5% (95% CI: 3.6-5.4).
Timing of antibiotic administration; an important amenable factor for intervention 
in prophylaxis as well as in therapy
The extensive data collection on all parameters of prophylaxis and on patient 
outcome in the CHIPS study made it possible to study the correlation between these 
parameters and the rate of SSI. For this purpose, data were selected from the largest 
subgroup, comprising patients with total hip arthroplasty. The effect of timing of 
prophylaxis in this patient group has been described in Chapter 5. In the multivariate 
analysis of patient characteristics, procedures and accuracy of prophylaxis, the 
duration of surgery was the only independent significant risk factor for development 
of SSI. Of the factors amenable for intervention, failure to administer the first dose 
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of the antibiotic before the moment of incision was most important (OR 2.8; 95% CI 
0.9-8.6). Timing within 30 minutes before the incision seemed most favourable for 
preventing SSI, and this finding is in agreement with the landmark study by Classen 
et al.11 Although experimental studies have shown that antibiotics administered close 
to, or at the moment of incision were most effective,12 the optimal timing in surgery 
remains unclear. Most international guidelines recommend administration of the 
antibiotic within 60 or within 30 minutes before the incision.13-17 In addition, it has 
been demonstrated that, for efficacy of prophylaxis, it is essential that antibiotics still 
be present at a substantial level at the time of closure of the wound.18 Administration 
as close as possible to the moment of incision decreases the need for repeated 
dosing in case of prolonged surgery. 
Interestingly, in our prospective cohort of 1922 patients undergoing total hip 
arthroplasty, the rate of SSI was not correlated with the total duration of prophylaxis. 
This finding is in disagreement with the retrospective analysis of data from the 
Norwegian cohort of 22000 total hip arthroplasties performed between 1987 and 2001. 
That study has suggested a higher incidence of loosening of the prosthesis during 
a 0 to 14 years follow up in patients who had received a single-dose prophylaxis. 
However, these data should be interpreted with caution. Firstly, cephalothin, a drug 
with a short half life, was used in the majority of cases in that cohort.19 Because of 
its short half life, the use of cephalothin is not recommended by most international 
guidelines.15-17,20 It is not surprising that repeated administration of a short-acting 
drug may be required, whereas this is not the case for an antibiotic with prolonged 
activity, such as cefazolin. Secondly, no data on timing of prophylaxis were collected 
in that study, and timing may have been inappropriate in patients that subsequently 
experienced prosthesis failure. In particular, the use of a short-acting drug may have 
impacted the deleterious effect of too early administration of a single dose. 
Correct timing of antibiotic administration was a main goal of our intervention 
study on quality of antibiotic therapy performed in a single University Hospital. In 
Chapter 6, the implementation of guidelines on timing, dosage adjustment to renal 
function and i.v. to oral switch therapy are described. The intervention was most 
successful in improving the optimal timing of administration at the wards. After 
the intervention, the median delay from order to administration of the first dose of 
antibiotics decreased from 4.1 to 2.6 hours (P=0.003) for all prescriptions, and from 
2.7 to 1.7 hours (P=0.003) in patients with severe infections. This finding is highly 
relevant for clinical practice, as multiple studies have recently demonstrated the 
benefit of timely administration of the antibiotic on patient outcome.21-23 
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Barriers to change
In Chapter 7, an analysis of the barriers to change the process of antibiotic 
prophylaxis in the CHIPS study is presented. Several important observations 
were made in this study. Firstly, regarding the choice of the antibiotic agent for 
prophylaxis, surgeons follow the recommendations of antibiotic policy committees. 
Restricting the antibiotics in stock in the surgical suite to the recommended drug 
will automatically lead to adherence to the recommendation. Regarding duration 
of prophylaxis, however, orthopaedic surgeons were particularly reluctant to switch 
to single-dose prophylaxis. The barrier they experienced was a lack of agreement 
with the guideline. Existing evidence from the literature, in particular a prospective 
trial of 1 versus 3 doses of cefazolin for arthroplasty 24 was interpreted differently 
by antibiotic policy makers 16,17 and orthopaedic surgeons;25 the latter did argue 
that the study may have been underpowered to reveal a benefit of multiple-dose 
prophylaxis. It is however very unlikely that a prospective study with a greater 
statistical power will ever be performed to definitively answer this question. 
Although observational data from large cohorts, such as the American Surgical 
Intervention Project (SIP) 10 may provide additional insights, such cohort studies 
must be interpreted cautiously, as retrospective, non-randomised studies may suffer 
from multiple confounders. This was exemplified by the Norwegian cohort study on 
total hip arthroplasty, as described earlier.19 As for our own prospective study, a 
detailed analysis of the 1922 patients undergoing total hip arthroplasty (THA) showed 
that duration of prophylaxis, either single dose or for 24 hours, was not correlated 
with the incidence of SSI (Chapter 4). In a large intervention study in a tertiary 
hospital implementing single-dose prophylaxis in orthopaedic surgery, Fonseca et 
al. compared over 1600 procedures before and after intervention and reported no 
increase in SSI.8 A limitation of that study was that post-discharge surveillance 
was only achieved in 50 % of the patients. In case of total hip arthroplasty, post-
discharge surveillance, as was performed in our study, is mandatory, as a recent 
study has shown that this has a large impact on the rate of SSI detected.26 
The inventory of barriers to change revealed that multiple logistical problems 
had to be overcome in the process of improving timing of administration. The 
issues varied greatly dependant of the local situation and of the surgical specialty 
involved. Important determinants influencing appropriate timing in our study were 
the presence of a written order, the time the patient spent in the holding area before 
surgery, and the administration of the drug as a bolus injection or intravenous 
infusion. Organisational constraints was also found to be a major obstacle in proper 
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antibiotic timing in a recent study by Tan et al,27 and a written order for prophylaxis 
was recently found to be a positive predictive factor for a timely first dose by 
Turnbull et al.28 
Importantly, a logistical change to improve the timing could have opposite 
effects in various patient groups. For example, the recommendation to administer 
prophylaxis in the holding area led to improvement in gynaecological surgery in one 
hospital, i.e., the number of patients for whom timing was too late did decrease. 
In orthopaedic surgery however, more patients received prophylaxis more than 30 
minutes before the incision, i.e., too early, as a result of the new policy (Chapter 
6). This example underscores the notion that specific strategies to improve timing 
have to be developed for each specialty and setting. 
Not all anaesthetists were convinced of the importance of appropriate timing as 
recommended in the SWAB guideline. After consensus on the appropriateness 
of the guidelines had been reached, the anaesthetists and, most importantly, 
anaesthesiology nurses were the key players for implementation of timely 
administration of prophylaxis.
In conclusion, the prudent use of antibiotics is the cornerstone of good clinical 
practice in combating infectious diseases, in order to limit the spread of resistance 
and to contain costs. Although the field of surgical prophylaxis may be easier to 
address compared to changing behaviour in therapeutic use of antimicrobial therapy, 
the present study has emphasized that there is no universal general improvement 
strategy. Audits remain an important instrument to assess the problem and to get 
healthcare workers involved and motivated for change. An inventory of barriers is 
essential to identify key players and achieve their involvement in the implementation 
process, especially when working attitudes have to be changed. Strategies that are 
effective in one situation may not necessarily work in other situations. In addition, 
changing behaviour is a continuous process that needs reflection and repetition.
Future prospects
Several issues remain to be addressed in the area of surgical prophylaxis. Our 
studies have identified the need for better data on the efficacy of single-dose 
versus prolonged prophylaxis in patients undergoing hip arthroplasty. In view of the 
questions remaining after publication of the randomised study by Wymenga et al.,24 
a larger and sufficiently powered randomised controlled trial is warranted. Only 
additional scientific evidence will lead to consensus between orthopaedic surgeons 
and antibiotic policy makers on this subject. 
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In addition, the question on the optimal timing of the first dose of prophylaxis to 
prevent SSI has not been conclusively answered. Potential advantages of keeping 
strict timing intervals, e.g., 60-30 min., 30-15 min., or 15-0 min. before incision, 
have not been investigated in sufficient detail. Data from our study suggest that it 
may be worthwhile to compare these timing intervals in a prospective randomised 
controlled trial.
After completion of the CHIPS study, several steps have been taken to further 
implement strategies to optimise surgical prophylaxis, as recommended by our 
studies. First, the Dutch Institute for Healthcare Improvement (CBO) has been using 
the results of our study to highlight the importance of a correct timing of prophylaxis 
in their “Doorbraak” project, a multidisciplinary national quality improvement project 
to decrease the number of SSI in Dutch hospitals. 
Second, the recommendation that awareness and accessibility of evidence-based 
guidelines is crucial to improve adherence, has contributed to the ongoing process 
at the Dutch Working Party on Antibiotic Policy (SWAB) aimed at improving the 
development and implementation of their guidelines. SWAB develops guidelines 
according to the recommendations for evidence-based guideline development 
(EBRO)29 and the AGREE instrument (www. agreecollaboration.org). All members of 
the professional societies involved are now consulted during guideline development, 
using a web-based module. In addition, SWAB has been developing a National 
Antibiotic Guide, based on evidence-based guidelines and expert opinion, which 
is available both online and as downloadable PDA application. Local antibiotic 
committees are encouraged to adopt these guidelines, and to create a version 
adapted to local resistance patterns and policies, which will be accessible online 
and as a PDA application using the SWAB server and software. These types 
of collaboration between national and local policy makers will facilitate the 
dissemination and credibility of guidelines among healthcare workers, addressing a 
key issue revealed by our studies.
In addition, a series of recommendations for clinicians and investigators has resulted 
from our studies:
Recommendations for the clinician
– Surgeons should perform surveillance of SSI, and should take the opportunity 
to participate in national surveillance networks. 
– Communications between surgeons and anaesthetists about surgical prophylaxis 
should be clear, and make use of written orders.
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– Prudent use of antibiotics preserves the therapeutic armamentarium for the 
future without affecting outcome in the present.
Recommendations for the investigator
– Audits and intervention studies should provide financial compensation for local 
professionals performing the surveillance and interventions. 
– Surgeons should be actively involved at an early stage of implementation studies 
on surgical prophylaxis, as they act as facilitators.
– Intervention studies to improve processes should also measure patient outcome, 
as this provides assurance to safety concerns of the individual physician. The 
more robust the evidence on favourable patient outcomes, the more chance for 
success.
– Intervention studies should use time-series analysis to evaluate the effect of the 
intervention. When a control group is lacking, interrupted time series analysis is 
the strongest quasi-experimental approach to evaluate longitudinal effects of an 
intervention.30 
Recommendations for the policy makers
– Hospitals should invest in infection control practitioners, as they are indispensable 
for performing audits as an important basis for quality interventions.
– National guideline committees on surgical prophylaxis should put more effort 
into recruiting surgeons as participants in quality improvement projects. 
– The knowledge that prudent antibiotic use for prophylaxis is safe should be 
disseminated among surgeons and, importantly, surgical residents.
– National and international guidelines should serve as basis for locally-developed 
guidelines. In addition, consensus among the users of the guideline is crucial for 
proper implementation.
– Timely administration of prophylaxis should be part of every program aimed at 
reducing the incidence of SSI, and should also play a crucial role in intervention 
studies on antibiotic therapy. 
– Recommendations on improving timing in prophylaxis should be tailored to the 
local situation and the specific surgical specialty.
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Summary
This thesis comprises several studies on implementation of guidelines for 
antimicrobial use in prophylaxis as well as in therapy. The main part focuses on the 
data of the CHIPS-study; a quality improvement project of surgical prophylaxis in 
the Netherlands. 
Chapter 1.1. In this Chapter, the recruitment for and the methodology of the CHIPS 
study (Surgical Prophylaxis and Surveillance Study) is described. The aim of the CHIPS 
study was to improve the quality of prophylaxis in Dutch hospitals, and to promote 
prudent use while maintaining or improving the efficacy of prophylaxis in reducing 
surgical site infections (SSI). This would be achieved by implementing the SWAB 
guideline for surgical prophylaxis, using audit and feedback as intervention method, 
and monitoring patient outcome by recording the quality of surgical prophylaxis and 
the incidence of surgical site infections before and after the intervention. The PREZIES 
(Preventie van Ziekenhuisinfecties door Surveillance) national surveillance network 
for nosocomial infections served as a basis for recruitment of the hospitals for the 
CHIPS study. The study was supported by a grant from The Netherlands Organization 
for Health Research and Development (ZonMw), but there was no additional funding 
for the hospitals to support the data collection. Infection control practitioners of the 
participating hospitals played a central role in the data collection and implementation 
process. Thirteen out of 135 Dutch hospitals, were recruited for the study. Ten of these 
hospitals had participated in the PREZIES–surveillance network before the start of the 
study. The hospitals collected data on process outcome, i.e., qualitative parameters 
of antimicrobial use, and patient outcome, i.e., surgical site infections (SSI), including 
post-discharge surveillance, in a preintervention and a postintervention period.
Chapter 1.2 describes the guidelines for perioperative antimicrobial prophylaxis issued 
by the Dutch Working Party on Antibiotic Policy (SWAB), which were implemented in 
the CHIPS study. SWAB promotes the use of single-dose prophylaxis with cefazolin 
(plus metronidazole in cases where anaerobic flora is expected), to be administered 
within 30 minutes before the incision.
In Chapter 2, the adherence to the local guidelines for surgical prophylaxis that 
had been established by the Antibiotic Policy Committee (APC) of the participating 
hospitals is described. Overall, the willingness to adhere to local guidelines was 
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high. Adherence to guidelines for antibiotic choice was 92%, for duration 82%, 
for dosage 89%, but for timing 50% only. When surgeons had developed their 
own guidelines, for example, guidelines on duration of prophylaxis in orthopaedic 
surgery, the compliance with these guidelines was 100%.
The most important barriers to local guideline adherence were lack of awareness. 
due to ineffective distribution of the most recent version of the guidelines, lack of 
agreement of surgeons with the local hospital guidelines established by the APC, 
and environmental factors, such as organisational constraints in the surgical suite 
and in the ward. 
In Chapter 3, the results on the process outcome, i.e., the quality of surgical 
prophylaxis after implementing the SWAB guideline in the hospitals participating 
in the CHIPS study are described. The parameters antibiotic choice, duration, 
timing, volume, and costs were assessed in four surgical disciplines; orthopaedic, 
gynaecological, vascular and intestinal surgery. Only elective procedures were 
included in the study. Segmented regression analysis was used to estimate the 
effect size of the intervention. Patient outcome was documented by the incidence 
of surgical site infections. Before the intervention, 1763 procedures were recorded, 
and 2050 after intervention. Antimicrobial use decreased from 121 to 79 Defined 
Daily Doses (DDD) /100 procedures, and costs decreased by 25 % per procedure. 
After the intervention, antibiotics were administered inappropriately in 37.5% of 
the cases, compared to 93.5% expected cases had the intervention not occurred. 
Prolonged prophylaxis was observed in 31.4 % compared to 46.8 % expected cases 
and inappropriate timing in 39.4 % compared to the expected 51.8%. There was a 
marked difference between surgical specialties. Extended prophylaxis was mainly 
recorded in orthopaedic departments. As for inappropriate timing, in orthopaedic 
and vascular surgery, administration was too early in the majority of the cases, 
and too late in intestinal and gynaecological surgery. Time series analysis showed 
that all improvements after the intervention were statistically significant (P<0.01) 
and that they could be fully attributed to the intervention. The intervention led to 
improved quality of surgical prophylaxis. Although in The Netherlands prudent use of 
antibiotics is custom, volume and costs could still be reduced by the intervention.
In Chapter 4, the results of the implementation of the SWAB guideline on the 
incidence of SSI in elective procedures in four surgical disciplines are described. 
Included procedures were total hip arthroplasty, femoral hemiprosthesis, abdominal 
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and vaginal hysterectomy, colorectal surgery, reconstruction of the aorta, and 
femoropopliteal and femorotibial bypass. Data on SSI were recorded before and 
after the intervention, using the criteria of the Centers for Disease Control, including 
postdischarge surveillance. For vascular implant surgery and for total hip arthroplasty, 
the period of postdischarge surveillance was one year. 
Data on 1668 procedures before and 1953 after the intervention could be analysed. 
The analysis included the risk factors sex, age, ASA-score, wound contamination 
class, duration of surgery and length of hospital stay before surgery. The overall 
SSI rate decreased from 5.4 % to 4.5 % (P=0.22). Crude and adjusted odds ratios 
showed that there were no significant changes in procedure-specific SSI rates after 
the intervention. The study showed that, for the selected procedures, a prudent use 
of antimicrobial prophylaxis had no detrimental effect on the incidence of SSI.
In Chapter 5, the correlation between parameters of surgical prophylaxis and the 
incidence of SSI is described for total hip arthroplasty (THP), which was the main 
surgical procedure recorded in the CHIPS-study. In 1922 elective THP procedures, 
potential prophylaxis-, patient-, and procedure-related risk factors were collected 
and multivariate logistic regression analysis, correcting for random variation among 
hospitals, was performed. SSI (superficial and deep) occurred in 50 patients (2.6%). 
The highest odds ratios for SSI were found in patients who received prophylaxis after 
incision (2.8, 95% CI 0.9-8.6, P=0.07), had an American Society for Anesthesiologists 
score >2 (2.8, 95% CI 0.8-9.2, P=0.09), or experienced a duration of surgery that 
was >75th percentile (2.5, 95% CI 1.1-5.8, P=0.04). Prolonged prophylaxis after the 
end of surgery and the use of antibiotic impregnated cement did not contribute to 
fewer SSIs in this study. The results of the study suggest that intervention programs 
in search of amendable factors to prevent SSI should focus on timely administration 
of antibiotic prophylaxis.
In Chapter 6, the results of a quality improvement program of antibiotic therapy 
in various departments of a University are described, reporting process outcomes 
before and after an intervention program that focussed on timely administration 
of the first dose, dosage adjustment to renal function, switch from intravenous to 
oral administration, and streamlining. After a preintervention period, in which data 
that were collected on all these parameters were fed back to the clinicians, an 
inventory of barriers to change was made, and a tailored set of interventions was 
used for improvement. After the intervention, the mean time from the order of the 
Summary
180
first dose at the wards improved from 2.7 to 1.7 hours in potentially severe cases 
(P=0.003). Switching therapy from intravenous to the oral route improved from 46% 
to 62% (P=0.03). Dosage adjustment to renal function showed no improvement, and 
streamlining was already performed correctly in most cases before the intervention. 
Chapter 7 describes the results of an inventory of the barriers to change encountered 
during the implementation of the SWAB guideline for surgical prophylaxis in the 
hospitals participating in the CHIPS study.
In order to achieve a change in antibiotic choice, the chairman of the antibiotic 
policy committee was a key player for improvement. The main barrier to change was 
lack of agreement with antibiotic choice. 
Regarding the duration of prophylaxis, key players for change were the surgeons, 
and barriers were lack of agreement – especially in orthopaedic surgery –, and lack 
of outcome expectancy. Evidence from the literature was interpreted differently by 
orthopaedic surgeons and antibiotic policy makers.
Regarding the timing of administration, the anaesthetists and, importantly, 
anaesthesiology nurses were the key players for improvement. Organisational 
constraints (for example time of arrival at the surgical suite and time spent in the 
holding area, administering a test dose before actual administration, and infusion 
instead of bolus injection) were the most important barriers to change.
The barriers to change differed per surgical specialty and per hospital. Therefore, 
identification of the specific local barriers to change, as well as identifying and 
working with the key players for change in the local setting is essential to achieve 
improvements.
An important conclusion of this thesis is that, even in a country with a history of 
prudent antibiotic use, important improvements in quality of surgical prophylaxis could 
be achieved, and cost savings could be obtained while maintaining efficacy in terms of 
prevention of surgical site infections. Our study showed that timely administration of 
antibiotics is an important parameter that improves patient outcome, i.e. the incidence 
of SSI. Finally, we found that there is no general improvement strategy that is applicable 
to all surgical specialties. Audits and inventories of barriers are important instruments 
to assess the problem, to identify key players, and to get healthcare workers involved 
and motivated for change. Strategies that are effective in one situation may not 
necessarily work in other situations, and local, tailor-made interventions may be the 
best approach to improve the quality of antibiotic use in hospitals.
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Samenvatting
In dit proefschrift worden diverse studies besproken die betrekking hebben op de 
implementatie van richtlijnen voor antibioticagebruik in zowel profylaxe als therapie. 
Een belangrijk deel van het proefschrift beschrijft de resultaten van het Chirurgische 
Profylaxe en Surveillance project (CHIPS), een interventiestudie op het gebied van 
peri-operatieve antimicrobiële profylaxe in Nederland. 
Hoofdstuk 1.1. In dit hoofdstuk wordt beschreven hoe de ziekenhuizen voor het 
CHIPS–project werden gerekruteerd en wordt de methodologie van de studie 
besproken. Het doel van de CHIPS-studie was om de kwaliteit van de perioperatieve 
antimicrobiële profylaxe in de Nederlandse ziekenhuizen te verbeteren en om een 
restrictief antibiotica beleid te bevorderen met behoud van of misschien zelfs met 
verbetering van de effectiviteit ten aanzien van het voorkomen van postoperatieve 
wondinfecties (POWI). Om dit te bereiken werd de richtlijn perioperatieve antimicrobiële 
profylaxe van de Stichting Werkgroep Antibioticabeleid (SWAB) geïmplementeerd en 
werden gegevens over de kwaliteit van de chirurgische profylaxe en de incidentie 
van postoperatieve wondinfecties voor en na de interventie geregistreerd. Door 
terugkoppeling van de gegevens uit de voorregistratie werd het interventieproces 
op gang gebracht. Het nationale surveillance netwerk voor nosocomiale infecties, 
Preventie van Ziekenhuisinfecties door Surveillance (PREZIES), diende als basis voor 
inclusie van de ziekenhuizen. De studie werd gesubsidieerd door de Nederlandse 
organisatie voor Gezondheidsonderzoek en Zorginnovatie (ZonMw), maar er waren 
geen financiële middelen beschikbaar om de ziekenhuizen te ondersteunen bij 
de dataverzameling. De ziekenhuishygiënisten van de deelnemende ziekenhuizen 
speelden een centrale rol in de dataverzameling en in het implementatieproces. 
Van de 135 Nederlandse ziekenhuizen namen er 13 deel aan de studie. Tien van 
hen hadden eerder deelgenomen aan PREZIES. Voor en na de interventie werden 
van opeenvolgende ingrepen data verzameld over de procesuitkomst, de kwaliteit 
van de profylaxe, en van de zorguitkomst, het aantal POWI’s geregistreerd tijdens 
opname maar ook na ontslag. 
Hoofdstuk 1.2 beschrijft de door de SWAB ontwikkelde richtlijnen voor perioperatieve 
antimicrobiële profylaxe, die werden geïmplementeerd in de CHIPS-studie. De SWAB 
adviseert een éénmalige dosis van cefazolin (in combinatie met metronidazol indien 
anaërobe flora verwacht wordt), toe te dienen binnen 30 minuten voor de incisie.
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In Hoofdstuk 2 wordt beschreven hoe men zich in de deelnemende ziekenhuizen hield 
aan de lokale richtlijnen voor perioperatieve profylaxe zoals die waren opgesteld 
door de antibioticacommissies van de ziekenhuizen. Over het algemeen was de 
bereidheid in de deelnemende ziekenhuizen om lokale richtlijnen te volgen groot. 
Aangaande de keuze van het antibioticum volgde men in 92 % van de gevallen de 
richtlijnen, aangaande de duur van de profylaxe in 82%, aangaande de dosis in 89 
%, maar aangaande het tijdstip van toedienen van de eerste dosis slechts in 50 % 
van de gevallen. Indien chirurgen, bijvoorbeeld orthopeden, zelf richtlijnen hadden 
ontwikkeld in plaats van of naast de algemene ziekenhuisrichtlijn, dan volgden zij 
deze eigen richtlijnen in 100 % van de gevallen op.
De belangrijkste belemmerde factoren voor het opvolgen van de lokale richtlijnen 
waren onvoldoende kennis over het bestaan ervan door inadequate verspreiding 
van de meest recente richtlijnen, gebrek aan instemming met de inhoud, en 
organisatorische zaken die te maken hadden met de werkwijze in de operatiekamer 
of op de verpleegafdeling. 
In Hoofdstuk 3 worden de effecten beschreven van de implementatie van de SWAB-
richtlijnen op de kwaliteit van de perioperatieve profylaxe in de aan de CHIPS studie 
deelnemende ziekenhuizen. In 4 snijdende specialismen; orthopedische chirurgie, 
gynaecologische chirurgie, vaatchirurgie en gastro-intestinale chirurgie, werden van 
de volgende procesindicatoren gegevens verzameld: de antibioticumkeuze, de duur 
van de profylaxe, het tijdstip van toedienen, de hoeveelheid toegediende antibiotica 
en de kosten. Alleen electieve ingrepen werden geïncludeerd. Gesegmenteerde 
regressie-analyse werd gebruikt om de grootte van het effect van de interventie 
te kunnen schatten. Als maat voor de zorguitkomst werd de incidentie van de 
postoperatieve wondinfecties geregistreerd. 
Er werden 1763 ingrepen voor en 2050 ingrepen na de interventie geregistreerd. 
Het gebruik van antibiotica nam af van 121 naar 79 Defined Daily Doses (DDD) / 
100 ingrepen, en de kosten namen af met 25 % per ingreep. Na de interventie was 
de keuze van het antibioticum in slechts 37.5 % van de gevallen incorrect, terwijl 
berekend werd dat 93.5 % van de gevallen incorrect zouden zijn geweest als de 
interventie niet had plaatsgevonden. De profylaxe werd na de ingreep in 31.4 % van 
de gevallen ten onrechte te lang voortgezet, in plaats van 46.8 % verwachte gevallen 
van de langdurige profylaxe. Het toedienen van de eerste dosis op een incorrect 
tijdstip gebeurde in 39.4 % van de gevallen in plaats van de te verwachten 51.8%. 
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Er was een duidelijk verschil tussen de diverse specialismen. Te langdurige profylaxe 
vond vooral plaats op de orthopedische afdelingen. Te vroege toediening van de eerste 
dosis van de profylaxe werd vooral gezien bij orthopedische en vasculaire chirurgie, 
en te late toediening vooral bij gynaecologische en gastrointestinale chirurgie. Uit 
de time-series analyse kwam naar voren dat alle verbeteringen na de interventie 
statistisch significant waren en dat zij volledig toegeschreven konden worden aan 
de interventie zelf. Hoewel er in Nederland al een restrictief antibioticagebruik is, 
konden door de interventie toch de hoeveelheid voorgeschreven antibiotica en de 
kosten verminderd worden.
In Hoofdstuk 4 wordt het effect van de implementatie van de SWAB-richtlijnen 
op de incidentie van het aantal POWI’s in 4 snijdende specialismen beschreven. 
De volgende ingrepen werden onderzocht: implantatie van totale heup prothese, 
plaatsen kop/hals prothese, abdominale en vaginale uterusextirpatie, reconstructie 
van de aorta, femoropopliteale en femorotibiale bypass en diverse colorectale 
ingrepen. Voor en na de interventie, werden data betreffende POWI’s verzameld 
volgens de criteria van de Centers for Disease Control, inclusief surveillance na 
ontslag (SNO). Voor vaatreconstructies met kunstmateriaal en implantaten van de 
heup, bedroeg de periode van SNO 1 jaar. 
Uiteindelijk konden de gegevens van 1668 ingrepen voor en 1953 na de interventie 
worden geanalyseerd. De volgende risicofactoren werden hierbij in het model 
meegenomen: geslacht, leeftijd, American Society of Anesthesiologists (ASA)-
score, wondklasse, duur van de ingreep, en preoperatieve opnameduur. Het totale 
percentage wondinfecties daalde na de interventie van 5.4 % naar 4.5 % (P=0.22). 
De ongecorrigeerde en gecorrigeerde odds ratios per ingreep lieten geen significante 
veranderingen zien in de incidentie van POWI’s na de interventie. De studie liet zien 
dat, voor de geselecteerde ingrepen, een restrictief antibioticumbeleid geen nadelig 
effect had op de uitkomst maat in de zin van de incidentie van POWI’s. 
In Hoofdstuk 5 wordt de relatie tussen de diverse parameters van perioperatieve 
profylaxe en de incidentie van POWI’s bij totale heupprothese (THP) operaties 
beschreven. In 1922 electieve THP operaties werden potentiële profylaxe-, patiënt- 
en procedure-gerelateerde risicofactoren verzameld en geanalyseerd middels een 
multivariate logistische regressie, waarbij gecorrigeerd werd voor de variatie tussen 
de ziekenhuizen. Bij 50 patiënten trad een POWI op (2.6%; oppervlakkig en diep). 
De hoogste odds ratios voor POWI werd gevonden bij patiënten die de eerste 
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profylactische dosis na de incisie kregen toegediend (2.8, 95% CI 0.9-8.6, P=0.07), 
bij hen die een ASA –score >2 hadden (2.8, 95% CI 0.8-9.2, P=0.09) en bij patiënten 
met een operatieduur boven de 75e percentiel (2.5, 95% CI 1.1-5.8, P=0.04). In deze 
studie droegen verlengde profylaxe na de ingreep en het gebruik van met antibiotica 
geïmpregneerd cement niet bij aan een vermindering van het aantal wondinfecties. 
De resultaten van deze studie suggereren dat interventieprogramma’s die op zoek 
zijn naar beïnvloedbare factoren om het ontstaan van wondinfecties te beperken, 
zich zouden moeten richten op het tijdig toedienen van de profylaxe. 
In Hoofdstuk 6 worden de resultaten besproken van een interventieprogramma in een 
academisch ziekenhuis dat gericht was op kwaliteitsverbetering van antibiotische 
therapie. Dit interventieprogramma werd uitgevoerd op diverse afdelingen en 
richtte zich op: het tijdig toedienen van de eerste dosis van het antibioticum, dosis 
aanpassing aan de nierfunctie, switch therapie van de intraveneuze naar de orale 
toedieningsvorm, en op stroomlijnen, d.w.z. aanpassen van de therapie op geleide 
van kweekresultaten. Data van de audit in de pre-interventie fase betreffende 
genoemde parameters werden teruggekoppeld naar de artsen. Na een inventarisatie 
van eventuele belemmerende factoren voor verandering werden diverse interventies 
gedaan om verbetering te bewerkstelligen. Na de interventies verbeterde op de 
afdelingen, in potentieel ernstige gevallen, de gemiddelde tijd tussen order en de 
daadwerkelijke toediening van de eerste gift van het antibioticum van 2.7 naar 
1.7 uur. (P=0.003). Switch therapie van de intraveneuze naar de orale route nam 
toe van 46 % naar 62 % (P=0.03). Dosisaanpassing aan de nierfunctie verbeterde 
niet en stroomlijnen gebeurde al correct in een zeer groot aantal gevallen voor de 
interventie.
In Hoofdstuk 7 worden de resultaten beschreven van een inventarisatie van de 
belemmerende factoren voor verandering die tijdens de implementatie van 
de SWAB-richtlijnen voor perioperatieve profylaxe in de CHIPS-studie werden 
ervaren. Ten aanzien van het veranderen van de keuze van het antibioticum 
bleek de voorzitter van de antibioticumcommissie een belangrijke sleutelfiguur. 
De belangrijkste hindernis die werd ervaren was gebrek aan consensus over de 
antibioticumkeuze die door de SWAB-richtlijn werd voorgesteld. Ten aanzien van 
de duur van de profylaxe bleken de chirurgen de sleutelfiguren. Vooral sommige 
orthopeden waren het niet eens met de richtlijn en twijfelden aan de effectiviteit 
hiervan. De beschikbare data uit de literatuur werden anders geïnterpreteerd door 
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de orthopeden dan door antibioticabeleidsmakers. Ten aanzien van het tijdstip van 
toedienen van de profylaxe waren de anesthesisten en zeker ook de anesthesie-
verpleegkundigen de sleutelfiguren. Organisatorische zaken, zoals het moment van 
arriveren van de patiënt in de operatiekamer en in de voorbereidingsruimte, het 
toedienen van een testdosis voor de uiteindelijke toediening van het antibioticum, 
en het toedienen per infuus in plaats van als bolus injectie, bleken de belangrijkste 
belemmerende factoren voor een correct tijdstip van toedienen.
De aard van de belemmerende factoren verschilde per snijdend specialisme en 
per ziekenhuis. Het is daarom essentieel dat men, om veranderingen te kunnen 
bewerkstelligen, zich eerst op de hoogte stelt van deze locaal aanwezige barrières. 
Een belangrijke conclusie van de dit proefschrift is dat, in een land met een historie 
van een restrictief antibioticumbeleid, duidelijke verbeteringen in de kwaliteit van 
perioperatieve chirurgische profylaxe konden worden bewerkstelligd en dat kosten 
konden worden gereduceerd met behoud van effectiviteit in termen van preventie 
van postoperatieve wondinfecties. In onze studie werd aangetoond dat het tijdig 
toedienen van antibiotica een belangrijke parameter is die de zorguitkomst, c.q. de 
incidentie van postoperatieve wondinfecties, verbetert. 
Tenslotte vonden we dat er geen algemene verbeterstrategie is, die toepasbaar is bij 
alle chirurgische disciplines. Audits en inventarisaties van belemmerende factoren 
voor verandering zijn belangrijke instrumenten om de aard van het probleem helder 
te krijgen, om sleutelfiguren voor het veranderingsproces te identificeren, en om te 
zorgen dat gezondheidswerkers betrokken en gemotiveerd raken om te veranderen. 
Strategieën die in de ene situatie effectief blijken, hoeven dit niet automatisch 
te zijn in andere situaties, en lokale op de werkvloer afgestemde interventies 
lijken de beste benadering om de kwaliteit van antibioticagebruik te verbeteren in 
ziekenhuizen.
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Dankwoord
Ik had niet gedacht dat ik nog ooit toe zou komen aan het schrijven van het dankwoord 
van mijn proefschrift, maar het is zover!
Velen hebben aan de totstandkoming hiervan bijgedragen. Een aantal wil ik, zonder 
anderen hiermee tekort te doen, in het bijzonder noemen:
Mijn co-promotor, Dr. Inge Gyssens. Beste Inge, zonder jou was hier geen proefschrift. 
Zonder de energie die jij in het CHIPS-onderzoek hebt gestopt, je niets aflatende 
enthousiasme en nauwkeurigheid, had ik vandaag hier niet gestaan. Ik bewonder 
je enorme gedrevenheid en deskundigheid. Ik weet dat ik je soms grijze haren heb 
bezorgd, iets waar je eigenlijk zo’n hekel aan hebt. Op het moment dat het echt 
moeilijk voor mij werd om door te zetten was jij het die nog vasthield en….. je hebt 
gelijk gehad. 
Mijn promotor, Prof dr. Kullberg. Beste Bart-Jan, jouw kennis en zorgvuldigheid hebben 
zowel bij mijn opleiding tot infectioloog als bij de totstandkoming van dit proefschrift 
zijn vruchten afgeworpen. Menig uurtje sleutelde je aan de database om zo alle 
gegevens in te kunnen voeren en de exacte timing en kosten te kunnen berekenen. 
Je kritische houding bij het doornemen van de manuscripten zorgde er voor dat de 
stukken er steeds beter van werden. 
Mijn promotor, Prof.dr. J.van der Meer. Beste Jos, kwaliteit van antibioticumbeleid is 
iets wat jou altijd zeer aan het hart gelegen heeft. Met jouw vraag of ik een jaar voor 
de SWAB richtlijnen voor antibioticumbeleid wilde gaan ontwikkelen, is het allemaal 
begonnen en daarmee werd uiteindelijke de basis voor dit proefschrift gelegd. Je 
enorme wetenschappelijke kennis gecombineerd met een zeer brede klinische kennis 
èn blik, hebben mij altijd zeer geïnspireerd. 
Mevr Marja Ridderhof, hygieniste. Beste Marja, drie jaar lang zijn wij samen, met een 
OV kaart op zak, 13 ziekenhuizen in Nederland af gegaan om alle data te verzamelen, 
in te voeren, te valideren en richtlijnen te implementeren. Je hebt heel wat uurtjes 
geïnvesteerd om alles rond te krijgen waarvoor veel dank. 
De hygiënisten van de deelnemende ziekenhuizen die belangeloos een enorme 
hoeveelheid data verzamelden over de kwaliteit van de profylaxe en de wondinfecties: 
Frans, Annelies, Louise, Noortje, Marianne van Mierlo, Marianne Pelk, Marieke, 
Marianne Poessé, Bertie, Martin, Jeanine, Truus, Robin, Ine, Margriet, Mary, Cora, en 
Marfa, jullie inzet was geweldig.
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Judith Mannien, epidemioloog in het RIVM. Beste Judith, door jou zijn heel wat analyses 
gedraaid voor de diverse studies. Vaak was je sneller dan het geluid zodat ik nogal 
eens, na even te hebben zitten denken, alweer met nieuwe vragen kwam. Zonder 
jouw hulp had ik de dataverwerking en statistische analyse niet rond gekregen.
Annette de boer, epidemioloog in het RIVM. Beste Annette, jouw andere kijk als 
epidemioloog op het onderzoek was zeer verfrissend en heeft in belangrijke mate 
bijgedragen aan de kwaliteit van diverse stukken.
Prof dr. Nico Nagelkerke, statisticus.  Beste Nico, dank voor je hulp bij de gecompliceerde 
time-series analysis van de interventie studie. 
Dr. A. Ott, medisch microbioloog en epidemioloog. Beste Alewijn, met jou samenwerken 
was zeer stimulerend en heeft me enorm geholpen met de analyse van timing in relatie 
tot de wondinfecties. Jij weet klinische relevantie te combineren met epidemiologische 
en statistische kennis en dat is voor veel medisch wetenschappelijk onderzoek van 
essentieel belang. 
Nils Vogtlander, nefroloog en destijds collega arts-assistent interne, bedankt voor de 
vruchtbare samenwerking tijdens de interventie studie in het Radboud. 
Mijn beide paranimfen, en mijn overzeese paranimf. Tijdens het werken aan een 
proefschrift staat het leven niet stil en gaat, net als onderzoek doen, gepaard met 
hoogte- en dieptepunten. Lieve Tien, Lieve Jacq en Lieve Denise, ik prijs me gelukkig 
met jullie als vriendinnen!
Beste maten, Fred, Saskia, Wiek, Job, Cees, Marina, Willy-Anne, Wouter, Ulrike, 
Laurens en last but not least mijn maatje van het eerste uur Anne-Marie, ik heb 
geen dag spijt gehad van mijn terugkeer naar het EZ. Ik hoop dat we nog heel lang 
in zo’n prettige sfeer kunnen samenwerken.
Mijn zus, lieve Ilma, je bent er onvoorwaardelijk voor mij, altijd!
Mijn ouders die me steeds hebben gesteund bij alle stappen in mijn leven. Ik weet dat 
jullie trots zouden zijn geweest. Vandaag ben je er toch nog een beetje bij Mam. 
Ik heb me altijd voorgenomen mijn dankwoord niet af te hoeven sluiten met 
verontschuldigingen:
Lieve Koen, jij bent mijn mooiste parel en ik ben er dankbaar voor dat ik geen dag 
verzaakt heb om die te koesteren!
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Curriculum vitae
De auteur van dit proefschrift werd op 13 juni 1962 geboren te Goirle. Na het behalen 
van het Gymnasium-β diploma aan het Theresialyceum te Tilburg, volgde zij de 
opleiding tot fysiotherapeut te Breda, alwaar zij in 1984 afstudeerde. Aansluitend 
studeerde zij Geneeskunde aan de Katholieke Universiteit Nijmegen (doctoraal 
examen 1988, artsexamen in 1991 (beiden cum-laude). In 1991 begon zij met de 
opleiding tot internist in het St Elisabeth ziekenhuis te Tilburg (opleider Dr C. van der 
Heul) en in 1994 werd de opleiding voortgezet in het Universitair Medisch Centrum 
St. Radboud te Nijmegen (opleider Prof.dr. J.W.M. van der Meer). Zij onderbrak in 
1997 voor 1 jaar haar opleiding om te werken aan de ontwikkeling van richtlijnen 
voor de Stichting Werkgroep Antibioticabeleid (SWAB), waarbij 1 van deze richtlijnen 
de basis vormde voor dit proefschrift. In oktober 1998 werd zij geregistreerd als 
internist om vervolgens begin 1999 zowel te starten met de opleiding tot internist-
infectioloog (opleider Prof dr. Kullberg) als met het onderzoek dat vermeld staat in 
dit proefschrift. Zij werd in oktober 2002 geregistreerd als internist-infectioloog en 
is als zodanig sinds juli 2003 werkzaam in het St. Elisabethziekenhuis te Tilburg. Zij 
is de moeder van een zoon, Koen.

